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Abstract 
Organisms across the tree of life have evolved diversity-generating immune 
mechanisms (DGMs) to counteract selective pressures imposed by their para-
sites. Increased host diversity has a major impact on parasite epidemics as well 
as host evolution. Being virtually ubiquitous, bacteria and their predators, bacte-
riophage (phage), are essential to every ecological niche on earth and key play-
ers in industrial and healthcare applications. Bacterial DGMs include CRISPR-
Cas and Restriction-Modification (RM) shufflons. Type I RM methylates self-DNA 
and cleaves unmethylated invasive DNA, however phage can escape from this 
response by becoming methylated themselves. Shufflons recombine genes cod-
ing for the RM specificity subunit, creating population-level diversity in recognition 
sequences; this is thought to limit phage escape. We investigate the Mycoplasma 
pulmonis Mpu shufflon, which has the capacity to generate 30 different specificity 
subunits, of which we predict at least 12 to be functional. We create a model 
system by adapting the Mpu shufflon for expression in Pseudomonas aeruginosa 
PA14. Transforming a CRISPR-deficient PA14 host with RM, we uncover large 
autoimmune costs when inducing a novel RM system with only limited benefits of 
low-level phage resistance. When expressed together, CRISPR-Cas and RM 
provide PA14 with complete resistance against most Pseudomonas phages 
tested and partial resistance against lipopolysaccharide-specific phage LMA2. 
Surprisingly, the RM restriction subunit is not an essential component for this ef-
fect; the mechanistic basis of this synergistic interaction between DNA methyla-
tion and CRISPR-Cas systems requires further investigation. The lack of detect-
able spacer acquisition, required for CRISPR-Cas to effectively target the infect-
ing phage, suggests these effects are likely due to altered host gene expression 
that in turn impacts the ability of phage to infect. Future studies need to address 
questions about the molecular basis of resistance in this model system. 
  
 3 
Acknowledgments 
Firstly, I would like to thank my supervisor Dr Edze Westra who not only sup-
ported me throughout my Master’s project, but also encouraged me to pursue an 
MbyRes degree in his laboratory in the first place. I could not have wished for a 
more proactive supervisor who continued to challenge, inspire, and set time aside 
to help me from start to finish. Secondly, it is thanks to Dr Mariann Landsberger 
that I don’t feel like a beginner in the laboratory anymore, and can successfully 
pretend to know my way around to any new students. She also supported me 
throughout my whole degree, taking great interest in a project that wasn’t hers 
whilst giving very helpful academic, technical, and personal advice.  
Furthermore, I would like to thank other members of the Westra Group for their 
general comradeship and making the group a joy to work in. Thanks to Dr Stineke 
van Houte (who rescued me from going crazy over in silico work by leading me 
through a lab side-project, and apparently wasn’t put off enough to stop her from 
wanting to be my PhD supervisor), Jack (who was always happy to help and chat, 
and whom I still want to help with his evolution experiment), Dan (my fellow MRes 
student), the two Ellies, Jenny, Sean, Clare (who kindly read through my thesis 
draft), Devi, and Hélène. Furthermore, thanks to all Buckling group lab members 
(including Prof Angus Buckling, whom I had to surprise with the information that 
he was my second supervisor, and who gave helpful insights throughout), other 
ESI lab users and anyone I may have forgotten. I am sad to be abandoning Re-
striction-Modification and this project, but grateful that I will be able to spend an-
other few years in this laboratory with these great people.  
Lastly, thanks to my friends and especially my fiancée Sophie for reminding me 
what really matters and keeping me sane throughout, and who made living in 
Cornwall so much better.    
 4 
Table of Contents 
 
Title page…………………………………………………………………………….…1 
Abstract……………………………………………………………………………....…2 
Acknowledgments…….…………………………………………………………….…3 
Table of Contents…..……………………………………………………………….…4 
List of Tables and Figures………………………………………………………….…5  
Author’s Declaration ……………………………………………………………….….7 
Abbreviations………………..……………………………………………………....…8 
General Introduction……………………..……..…………………………………....10 
Chapters 
I. Mechanisms and consequences of diversity-generating immune strate-
gies………………………………………………………………...…………..13  
II. Restriction-Modification shufflons are a means of generating population-
level diversity………………………………………………………………….32 
III. Restriction-Modification in Pseudomonas aeruginosa………….………..51 
IV. Restriction-Modification and CRISPR act synergistically to provide high 
levels of phage resistance………………………………….…………….…70 
General Discussion…………………………………………………………………..88 
Appendix……………………………………..…………………………….……........93 
Bibliography………………………………………………………………………....102 
  
 5 
List of Tables and Figures 
 
Figure i: Self/non-self discrimination through Restriction-Modification. 
 
Figure I/1: Untargeted diversity-generating mechanisms. 
Figure I/2: Targeted diversity-generating mechanisms. 
Figure I/3: Anti-diversity-generating mechanism strategies. 
 
Figure II/1: Type I RM target recognition.  
Figure II/2: Diversity-Generating Type I RM Mechanisms. 
Figure II/3: The Mpu shufflon as an ON/OFF switch. 
Figure II/4: hsdS gene segments. 
Figure II/5: Structure of MpuUI and MpuT11 genes and their proteins. 
Figure II/6: Structure of MpuUV and MpuUIV genes and their proteins. 
Figure II/7: Small and large sized HsdS proteins. 
Table II/1: Nucleotide sequences of hsdS gene segments. 
Table II/2: hsdS variants produced by the Mpu shufflon.  
 
Figure III/1: Synthetic gene constructs coding for the M. pulmonis Mpu shufflon. 
Figure III/2: pHERD30T_SRM lysate can cleave genomic DNA. 
Figure III/3: pHERD30T_SRM reduces EOT in the presence of arabinose. 
Figure III/4: SRM reduces growth in unmethylated strains. 
Figure III/5: Adaptation to high arabinose concentrations restores Csy3::LacZ 
pHERD30T_SRM viability but causes loss of RM function.  
Figure III/6: Arabinose-adapted unmethylated Csy3::LacZ pHERD30T_SRM do 
not show reduced growth. 
Figure III/7: Premethylation of Csy3::LacZ restores EOT of pHERD30T_SRM at 
moderate arabinose concentrations.  
Figure III/8: Premethylated Csy3::LacZ pHERD30T_SRM grows slower than 
bacteria without RM system. 
Figure III/9: pHERD30T_SRM confers low-level phage resistance to some 
premethylated Csy3::LacZ transformants. 
 
Figure IV/1: Coexpression of CRISPR and RM leads to phage resistance. 
Figure IV/2: RM expression can promote CRISPR spacer acquisition. 
 6 
Figure IV/3: WT pHERD30T_SRM transformants resemble surface mutants. 
Figure IV/4: HsdR is not essential for synergistic RM and CRISPR resistance. 
Figure IV/5: Novel RM induction seems less toxic when CRISPR is expressed. 
Table IV/1: Phenotypes of pHERD30T_SRM transformants. 
Table IV/2: Partial matches of CRISPR spacers with PA14 genome.  
 
Table S1: Plasmids, Vectors, and Primers used throughout the thesis. 
Table S2: Bacterial Strains and phage used throughout the thesis.  
  
 7 
Author’s Declaration  
Chapter I is a collaborative effort that has since been published as a literature 
review. I wrote the initial review proposal and researched data and papers for 
inclusion in the article. I wrote first drafts of the Introduction, Targeted DGMs, 
Cost of DGMs, and DGM-associated Coevolution sections, and created figure 1, 
and parts of figures 2 and 3. Furthermore, I was involved in content and figure 
discussion throughout the writing process. The article can be found as follows:  
 
Westra, E. R., Sünderhauf, D., Landsberger, M., & Buckling, A. (2017). Mecha-
nisms and consequences of diversity-generating immune strategies. Nature Re-
views Immunology. https://doi.org/10.1038/nri.2017.78  
 
I would like to thank and acknowledge my co-authors for their work and do not 
claim sole ownership over this article and thesis chapter.  
  
 8 
Abbreviations 
 
Acr   anti-CRISPR 
AID   activation-induced cytidine deaminase 
ARD   arms-race dynamics 
ATP   adenosine triphosphate 
BCR   B cell receptor 
Cas   CRISPR-associated 
CFU   colony-forming units 
CRISPR  clustered regularly interspaced short palindromic repeats 
CSR   class-switch recombination 
DGM   diversity-generating mechanism 
DNA   deoxyribonucleic acid 
EOP   efficiency of plaquing 
EOT   efficiency of transformation 
FSD   fluctuating selection dynamics 
gDNA   genomic DNA 
GM50   50 μg/ml gentamycin 
Hsd-   host specificity for DNA -  
       -S  -specificity 
       -R  -restriction 
       -M  -methylation/modification 
hrs   hsd recombination site 
kb   kilobases (1000 base pairs) 
LPS   lipopolysaccharide 
LRR   leucine-rich repeat 
MCS   multiple cloning site 
MOI   multiplicity of infection 
MHC   major histocompatibility complex 
nt   nucleotide 
PCR   polymerase chain reaction 
pfu   plaque-forming units 
phage   bacteriophage 
qPCR   quantitative PCR 
RA   restriction alleviation 
 9 
RAG   recombination-activating gene 
RBS   ribosome binding site 
RISC   RNA-induced silencing complex 
RM   Restriction-Modification 
RNA   ribonucleic acid 
RNAi   RNA interference 
SNP   single-nucleotide polymorphism 
TCR   T cell receptor 
TRD   target recognition domain 
vip   vipareetus 
viRNA   virus-derived small interfering RNA 
VLR   variable lymphocyte receptor 
VSG   variant-specific glycoprotein 
  
 10 
General Introduction 
Where unlimited resources and space exist, plants, animals, and other organisms 
can theoretically thrive indefinitely. However, most living beings are subject to 
predation or parasitism. In all domains of life, interactions of hosts with their par-
asites are crucial to evolutionary dynamics and can define ecosystem functions. 
In particular, parasites are known to sweep through populations with very low 
diversity, such as crop monocultures (Zhu et al., 2000).  
Bacteria and their parasites bacteriophage (phage) comprise an excellent model 
system to study host-pathogen interactions thanks to their relative simplicity and 
the ease with which these dynamics can be influenced in a very controlled way 
in laboratory environments. Additionally, they are intrinsically interesting owing to 
them being the most abundant organisms on the planet with key ecological func-
tions such as nutrient cycling. Understanding the coevolutionary dynamics of bac-
teria and phage can lead to applications in a range of fields including agriculture, 
the food industry, and healthcare. As the most abundant life-form on this planet 
(Breitbart and Rohwer, 2005), phage have the capacity to limit bacterial growth 
in virtually any environment. Similar to our own viruses, phage inject their DNA 
into a bacterial host to either remain latent over a period of time or to hijack the 
host’s replication machinery and generate progeny phage. Generally, bacteria 
can evolve resistance to phage by preventing phage adsorption, through muta-
tion, masking or downregulating the phage receptor, or by one of several more 
sophisticated immune responses (Labrie, Samson and Moineau, 2010). The 
most prevalent immune mechanism, Restriction-Modification (RM), functions by 
methylating bacterial self-DNA, and cleaving unmethylated invasive DNA (Fig i). 
Alternatively, CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic 
Repeats-CRISPR associated) can integrate short phage DNA sequences into its 
own genome as spacers, and later use their transcripts as guides to specifically 
cleave target DNA with the same sequence. As innate and adaptive immune re-
sponses respectively, RM and CRISPR-Cas are associated with constitutive or 
inducible costs respectively and distinct evolutionary dynamics. This means that 
immunity through either response is driven by phage exposure and nutrient avail-
ability (Westra et al., 2015).  
As phage can escape from RM with relative ease when they become methylated 
by chance, RM is predicted to provide the largest benefit to bacteria when they 
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are invading a new ecosys-
tem, whereas phage in an en-
vironment with established 
bacterial populations are 
more likely to be methylated 
and therefore invisible to this 
immune response (Korona 
and Levin, 1993). Bearing this 
in mind, RM systems none-
theless provide a long-term 
advantage to their hosts over 
strains without this immune 
system (Sneppen et al., 
2015). Benefits to bacteria 
can be further mitigated by 
autoimmunity, which is toxic 
and occurs when RM acci-
dentally cleaves the bacterial genome (Pleška et al., 2016). Furthermore, RM can 
also have roles beyond immunity that are not directly attributed to their DNA 
cleaving function (reviewed in Vasu and Nagaraja, 2013), which can complicate 
predictions of costs or benefits. These include: directing the rate of evolution 
through modulating genetic variation; facilitating recombination; regulating gene 
expression through methylation patterns; and in some cases even metabolic 
functions of phage. Additionally, RM can trigger altruistic apoptosis 
(Nagamalleswari et al., 2017). Although not as common, CRISPR-Cas can fulfil 
alternative roles, too (reviewed in Westra, Buckling and Fineran, 2014). These 
include gene regulation as well as bacterial virulence. Additionally, both immune 
systems act as selfish genetic elements in some cases. Data has shown that RM 
and CRISPR-Cas are not only compatible immune responses (Dupuis et al., 
2013), but that RM might actively aid CRISPR spacer acquisition (Hynes, Villion 
and Moineau, 2014).  
Our model organism Pseudomonas aeruginosa is a gram-negative bacterium 
found in soil, water, and animals, which is equipped with a Type I-F CRISPR-Cas 
system. In humans, P. aeruginosa is an opportunistic pathogen of the lung and 
other tissues (Lyczak, Cannon and Pier, 2000), and in soil it can cause plant 
Figure i. Self/non-self discrimination through 
Restriction-Modification.  
A simplified diagram of a Type I RM system se-
lectively cleaving foreign DNA. Bacterial DNA is 
methylated (m) at recognition sites by the RM 
complex, while foreign bacteriophage DNA is 
cleaved (red x) when the RM complex recog-
nises unmethylated sites. 
 12 
disease. Its interactions with phage (especially DMS3vir, a lytic Pseudomonas 
phage) have been thoroughly studied (Zegans et al., 2009; Chabas et al., 2016; 
van Houte et al., 2016; Morley et al., 2017). In high nutrient conditions and ex-
posed to a large amount of phage, P. aeruginosa evolves phage resistance by 
surface modification, through mutational loss of the pilus. When nutrients are 
scarce or the phage load is low, CRISPR-Cas is the preferred mechanism of re-
sistance (Westra et al., 2015). P. aeruginosa PA14, the strain used for our exper-
iments, does not have a native RM system.  
 
In this thesis, I discuss the benefits of RM shufflon-associated diversity as well 
as costs and benefits of RM expression in bacteria. First, I review diversity-gen-
erating immune mechanisms across the entire tree of life and discuss what diver-
sity-dependent predictions on host/parasite coevolution can be made (Chapter I). 
I then focus on Type I RM and its unique capacity for evolution of diversity, ex-
amine the Mycoplasma pulmonis Mpu shufflon for its recombinatory properties, 
and predict which diversity subunits it can generate (Chapter II). I adapt this shuf-
flon for expression in Pseudomonas aeruginosa PA14 to establish an experi-
mental system for investigations of RM diversity as well as coordinated impact of 
CRISPR-Cas and RM on bacteria-phage coevolution. I explore RM expression in 
a CRISPR-deficient host and pose questions about the costs and benefits asso-
ciated with inducing novel RM systems (Chapter III). Finally, I express RM in con-
junction with CRISPR-Cas in an attempt to ascertain the joint impact of these 
bacterial immune systems on phage resistance (Chapter IV). 
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Chapter I: Mechanisms and consequences of diversity-
generating immune strategies 
 
Edze R. Westra, David Sünderhauf, Mariann Landsberger, and Angus Buckling 
Nature Reviews Immunology 2017. doi:10.1038/nri.2017.78 
 
Abstract 
Species from all five kingdoms of life have evolved sophisticated mechanisms to 
generate diversity in genes that are involved in host–pathogen interactions, con-
ferring reduced levels of parasitism to both individuals and populations. Here, we 
highlight unifying concepts that underpin these evolutionarily unrelated diversity-
generating mechanisms (DGMs). We discuss the mechanisms of and selective 
forces acting on these diversity-generating immune strategies, as well as their 
epidemiological and co-evolutionary consequences. We propose that DGMs can 
be broadly classified into two classes — targeted and untargeted DGMs — which 
generate different levels of diversity with important consequences for host–para-
site co-evolution. 
 
Introduction 
Over the past few decades, theoretical, correlational and experimental studies 
have linked increased host diversity to lower levels of pathogen infection (re-
viewed in Keesing, Holt and Ostfeld, 2006). This observation initially came from 
agriculture, where it is known as the monoculture effect (Elton, 1958), but also 
applies to animals. For example, natural populations with low levels of genetic 
diversity (such as endangered species (O’Brien et al., 1985) and inbred animals 
(Acevedo-Whitehouse et al., 2003)) tend to have higher pathogen loads, and ex-
perimental increases in host diversity result in decreased pathogen abundance 
(Altermatt and Ebert, 2008; van Houte et al., 2016). 
 
Consistent with these observations, many organisms across the five kingdoms of 
life have evolved sophisticated diversity-generating mechanisms (DGMs) that 
provide benefits to both individuals and populations in the presence of infectious 
disease. In this Opinion article, we first summarize the mechanistic basis of the 
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most well-known DGMs, which have been studied in detail over the past few dec-
ades by immunologists, geneticists and molecular biologists, and highlight unify-
ing concepts across the different immune strategies. We then link these molecu-
lar data with insights from evolutionary biology and epidemiology to discuss when 
and why different DGMs are particularly beneficial and their broader implications 
for disease epidemics and host–pathogen co-evolution (that is, their reciprocal 
adaptation). Understanding the link between these molecular and macroscopic 
processes can guide future molecular immunology research into the scale of the 
host diversity of resistance alleles in space and time. Key questions to address 
involve how much diversity can be generated in one individual and between indi-
viduals as well as how such diversity is maintained over time. An increased 
knowledge of resistance-allele diversity could help to predict the emergence and 
spread of infectious diseases. 
 
We propose that DGMs can be broadly classified into two groups: those that 
function across the entire host genome (for example, mutation and sexual repro-
duction; referred to here as untargeted DGMs) and those that are targeted to 
specific loci involved in host–pathogen interactions (for example, V(D)J recombi-
nation and prokaryotic CRISPR–Cas; referred to here as targeted DGMs). Untar-
geted DGMs tend to generate relatively low levels of diversity that pathogens can 
overcome by genetic mutation or recombination, whereas the higher levels of 
diversity that are typically generated by targeted DGMs drive the evolution of 
more sophisticated anti-DGM strategies as part of an arms race between the host 
and its pathogens. 
 
Untargeted DGMs 
Untargeted DGMs, which include any mechanism that creates diversity across 
the entire genome of a host species, are widespread. We discuss how germline 
mutation and sexual reproduction generate untargeted diversity and detail the 
selective advantage of these mechanisms when hosts are exposed to pathogens. 
 
Germline mutation. The simplest mechanism for generating genetic diversity 
between parents and their offspring is through germline mutations, such as sin-
gle-nucleotide polymorphisms (SNPs), indels, gene duplications, inversions and 
transposable element insertions (Fig. I/1a). Mutation rates vary between species 
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and between strains of the same species. For example, SNPs are typically gen-
erated at frequencies from 10−7 to 10−10 base substitutions per nucleotide per 
generation, which is well above the biochemical limit to proofreading during DNA 
replication. Whereas it has been suggested that variation in mutation rates be-
tween species may result from genetic drift (Lynch et al., 2016), the selection of 
beneficial mutations may also help to explain variation within species (Taddei et 
al., 1997). Theoretical analyses predict that host–pathogen co-evolution can se-
lect for increased mutation rates (Pal et al., 2007; Zaman et al., 2014) that allow 
for the more rapid generation of resistance mutations. Consistent with this pre-
diction, bacteria co-evolving with bacteriophage (phage) frequently evolved 10- 
to 100-fold increased mutation rates (mutator strains), and these strains were 
Figure I/1. Untargeted diversity-generating mechanisms. 
a Schematic overview of the five main mechanisms of mutation that can in-
crease genetic diversity within a population: DNA insertion or deletion (indel), 
sequence inversion, single-nucleotide polymorphism, gene duplication and 
transposable element insertion. b Sexual reproduction creates novel allele com-
binations within a population by crossing over (the exchange of genetic material 
between homologous chromosomes) during gamete production and by combin-
ing novel alleles (in the case of biparental sex). 
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more likely to drive phage to extinction compared with non-mutator strains (Pal 
et al., 2007). Selection for mutator strains increases upon exposure to multiple 
phage (Wielgoss et al., 2016), which may drive the high frequencies of these 
strains in natural (LeClerc et al., 1996; Matic et al., 1997) and clinical environ-
ments (Oliver et al., 2000).  
Although such germline mutations are often thought of as random, mutation fre-
quencies tend to be distributed non-uniformly across genomes as a result of nu-
cleotide composition and genomic context (Lynch, 2010; Lee et al., 2012), gene 
transcription (Herman and Dworkin, 1971; Datta and Jinks-Robertson, 1995) and 
chromatin organization (Wolfe, Sharp and Li, 1989; Hardison et al., 2003; Makova 
and Hardison, 2015). The existence of mutational hot and cold spots across ge-
nomes has selected for genes that are involved in rapid adaptation (for example, 
genes associated with pathogen defence) to be located in hot spots, whereas 
genes that are involved in conserved processes (such as transcription and trans-
lation) reside in cold spots (Chuang and Li, 2004). 
 
Sexual reproduction. A more sophisticated form of untargeted DGM is sexual 
reproduction. Sex generates population-level diversity through recombination 
during meiosis, which breaks up existing allele combinations and generates novel 
ones, and (in the case of biparental sexual reproduction) by combining alleles 
from different individuals in a population during cross-fertilization (Fig. I/1b). In 
theory, the maintenance of sex as a means of reproduction can be driven by a 
need to escape pathogens (Hamilton, Axelrod and Tanese, 1990; Lively, 2010a). 
Specifically, if pathogens are specialized with respect to host genotypes, then 
sexual reproduction can generate rare genotypes that are susceptible to infection 
with fewer pathogens in the short term. Many correlational and experimental stud-
ies support this idea (reviewed in Lively and Morran, 2014). For example, anal-
yses of the distributions of sexual and parthenogenic forms of a freshwater snail 
(Potamopyrgus antipodarum) show that sexual forms are more common in habi-
tats with high pathogen densities and vice versa (Lively, 1987; King and Lively, 
2009; King et al., 2009). In mixed populations, sexual forms tend to be less fre-
quently infected than asexual forms (Vergara, Jokela and Lively, 2014). In Cae-
norhabditis elegans, it has been shown that presence of the bacterial pathogen 
Serratia marcescens selects for outcrossing (Morran et al., 2011). As is the case 
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for germline mutation, recombination hot spots during sexual reproduction gen-
erate relatively large amounts of diversity at genes that are associated with path-
ogen immunity (for example, MHC genes (Paigen and Petkov, 2010)). 
 
To increase the pathogen resistance of their offspring, females may prefer to 
mate with males who have optimal resistance alleles (Hamilton and Zuk, 1982). 
Non-random mating based on MHC genes has been shown for several species 
(reviewed in Kamiya et al., 2014), including mouse and fish (Potts, Manning and 
Wakeland, 1991; Reusch et al., 2001). Such mating preferences could be based 
on chemosensory signals associated with MHC molecules (Leinders-Zufall et al., 
2004). Other organisms, such as social insects, are thought to lack this mating 
preference; instead, females may prefer to mate with multiple males to increase 
heterogeneity among offspring, presumably to decrease disease spread (Baer 
and Schmid-Hempel, 1999, 2001, 2003). 
 
Unifying concepts. These examples illustrate how untargeted DGMs generate 
diversity across genomes and detail their benefits in the presence of infectious 
disease. However, as these untargeted mechanisms also generate diversity at 
loci that are not involved in host–pathogen interactions, they can enhance adap-
tation to other selective pressures, such as environmental change. Therefore, the 
evolution of untargeted DGMs is not driven by pathogens alone (de Visser and 
Elena, 2007). For example, germline mutation has an important role in adaptation 
in general, and increased mutation rates are commonly observed in the absence 
of pathogens (Sniegowski, Gerrish and Lenski, 1997; Taddei et al., 1997; Giraud 
et al., 2001). Likewise, sexual reproduction has an important role in adaptation 
(Morran, Parmenter and Phillips, 2009) by reducing clonal interference (competi-
tion between genotypes that carry different advantageous mutations) and break-
ing the linkage between beneficial and deleterious mutations (McDonald, Rice 
and Desai, 2016), and it helps to maintain population fitness through sexual se-
lection of the fittest males (Lumley et al., 2015). 
 
Targeted DGMs 
Unlike mutation and sexual reproduction, which generate diversity between gen-
erations (with the exception of somatic mutations (Forsberg, Gisselsson and 
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Dumanski, 2017)) and across entire genomes, targeted DGMs can generate di-
versity upon pathogen exposure specifically in genetic loci that are important for 
host–pathogen interactions (Fig. I/2). Targeted DGMs generate higher levels of 
diversity than untargeted DGMs, and this diversity can be generated both be-
tween and within hosts. 
 
Vertebrate adaptive immunity. The adaptive immune response of jawed verte-
brates involves arguably the most thoroughly studied DGMs (Rast and Litman, 
1994). The main sources of diversity are B cells and T cells, which generate large 
repertoires of B cell receptors (BCRs) and antibodies, and T cell receptors 
(TCRs), respectively, that can interact with diverse pathogen antigens (Weinstein 
et al., 2009; Jiang et al., 2011). As outlined below, the adaptive immune response 
generates both within- and between-host diversity in the resistance alleles en-
coding these receptors. Note that — aside from the direct transfer of antibodies 
from mother to offspring — only the propensity to generate diversity is heritable 
in this case, not the diverse BCR and TCR resistance alleles themselves (re-
viewed in Boulinier and Staszewski, 2008). 
One of the key mechanisms in this diversity-generating process is V(D)J recom-
bination, which acts on multi-copy V (variable), J (joining) and sometimes D (di-
versity) gene segments by semi-randomly linking together single copies of each 
to generate unique variable antigen-recognition domains (Early et al., 1980) (Fig. 
I/2a). This DGM involves many enzymes, including the hairpin-forming trans-
posase recombination-activating gene 1 (RAG1) and its cofactor RAG2 (Schatz, 
Oettinger and Baltimore, 1989). High-resolution models of the RAG1–RAG2 pro-
tein complex (Kim et al., 2015) help to explain why mutations in these genes can 
cause severe combined immunodeficiency (Schwarz et al., 1996). By contrast, in 
species such as chicken, almost all diversity comes from gene conversion, in 
which gene segments in the antibody variable region recombine with gene seg-
ments from pseudogenes (Maizels, 1987). 
Following V(D)J recombination, the primary antibody repertoire produced by B 
cells goes through a process known as affinity maturation, which is mediated by 
activation-induced cytidine deaminase (AID; also known as AICDA). This process 
takes place in germinal centres, where B cells undergo repeated cycles of muta-
tion (known as somatic hypermutation) in the variable regions of immunoglobulin 
genes and selection based on affinity for antigen (Allen et al., 2007; Victora et al., 
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2010; Gitlin et al., 2015). Somatic hypermutation can increase antibody affinity 
by orders of magnitude and, for example, is essential for generating broadly neu-
tralizing antibodies against influenza virus (Pappas et al., 2014). Although some 
of the antibody diversity that is generated is inevitably lost during selection as a 
result of clonal expansion (Gitlin, Shulman and Nussenzweig, 2014), the extent 
of this loss is variable, and it has been shown that antibodies with different affin-
ities for the same antigen can coexist in the same host (Kuraoka et al., 2016; Tas 
et al., 2016). In addition to mutation of the variable sequence, antibodies also 
undergo class-switch recombination (CSR), whereby variable regions are linked 
to genes encoding alternative constant regions (encoding the non-variable parts 
of the antibody), which results in a switch of antibody class and therefore interac-
tions with different effectors. The type of switch is determined by cytokine levels 
as well as genetic factors (Horns et al., 2016).  
Lampreys and hagfish are primitive jawless vertebrates that lack BCRs, TCRs 
and MHC molecules but encode an alternative adaptive immune system that 
Figure I/2. 
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uses antigen receptors termed variable lymphocyte receptors (VLRs) (Pancer et 
al., 2004). In their mature form, VLRs are composed of up to eight highly variable 
leucine-rich repeat (LRR) modules flanked by conserved LRR modules and other 
conserved sequence elements. Three types of VLR have been identified that are 
expressed by separate lymphocyte lineages (reviewed in Boehm et al., 2012). 
Lymphocytes somatically diversify their incomplete germline VLR alleles through 
gene conversion to assemble mature VLRs that contain a unique combination of 
variable LRR modules derived from the hundreds of different LRR modules that 
Figure I/2. Targeted diversity-generating mechanisms. 
a To form an antibody heavy chain gene, one of each of multiple variable (V), 
diversity (D) and joining (J) segments are joined together and linked to one con-
stant (C) segment, which encodes the constant region. During such V(D)J re-
combination, V, D and J segments are semi-randomly linked together by the 
enzymes recombination-activating gene 1 (RAG1) and RAG2, resulting in di-
verse heavy chain antibody genes. The same process is involved in light chain 
gene diversification (not shown), but here, only V and J segments recombine. 
During affinity maturation, activation-induced cytidine deaminase (AID) induces 
point mutations at cytosine bases within the immunoglobulin variable region, 
which further increases antibody variation. b After a virus invades a cell, Dicer 
cleaves double-stranded (ds) viral RNA and processes it into virus-derived small 
interfering RNAs (viRNAs) spanning 21–24 nucleotides in length. A single 
strand of viRNA gets incorporated into the RNA-induced silencing complex 
(RISC), which targets and degrades complementary single-stranded (ss) viral 
RNA. c Upon phage infection of a bacterial host, a short phage sequence is 
incorporated into the bacterial CRISPR array as a spacer. CRISPR transcripts 
are processed into CRISPR RNA (crRNA), which associates with Cas proteins. 
The crRNA–Cas ribonucleoprotein complex binds and cleaves complementary 
nucleic acid sequences (in this example, DNA) in the phage, resulting in immun-
ity. d Type I restriction–modification (RM) systems encode a restriction endonu-
clease (HsdR), a methylase (HsdM) and a specificity subunit (HsdS). HsdM 
methylates recognition sequences on the bacterial genome, and HsdR cleaves 
the same sequences when unmodified (for example, in phage DNA). RM shuf-
flons have a second pseudogene copy of hsdS (and in some cases, up to six 
pseudogene copies), which can recombine with the main hsdS gene, resulting 
in altered sequence specificity of the RM system. 
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flank the germline VLR allele. The diversity, specificity and affinity of VLRs that 
result from this combinatorial assembly are comparable to those of antigen re-
ceptors in jawed vertebrates (Alder et al., 2005).  
 
RNA interference. RNA interference (RNAi) has an important role in antiviral 
immunity in plants and invertebrates (Hamilton and Baulcombe, 1999; Li, Li and 
Ding, 2002; Lu et al., 2005; van Rij et al., 2006; Wang et al., 2006), and recent 
studies proposed a role in mouse embryonic stem cells, which lack a functional 
interferon response (Li et al., 2013; Maillard et al., 2013). In antiviral RNAi, an 
RNaseIII enzyme known as Dicer recognizes and cleaves viral double-stranded 
RNA into viral small interfering RNA (viRNA) that is typically 21–24 nucleotides 
in length (Fig. I/2b). These viRNAs are loaded onto Argonaute enzymes, which 
are a key component of the RNA-induced silencing complex (RISC), to guide the 
binding and cleavage of complementary viral RNA (reviewed in Ding and Voinnet, 
2007). The propensity to generate a diversity of viRNAs is encoded by the host 
RNAi genes, but generating resistance-allele diversity does not require any ge-
netic change to the host genome. The sampling of viRNAs from viral RNA is non-
random (Molnar et al., 2005), but it leads to viRNA diversity within and between 
individuals. In the absence of such diversity of viRNAs, rapid virus evolution can 
overcome RNAi-mediated resistance through mutations of the viral target se-
quence that disrupt complementarity to the viRNA (Lafforgue et al., 2011; Holz et 
al., 2012; Martinez et al., 2012). As a consequence of the rapid escape of viruses 
from a single viRNA, the mainstream approach to developing transgenic crops 
with RNAi-mediated virus resistance depends on the production of multiple viR-
NAs (Swaney et al., 1995). 
 
CRISPR–Cas. Although some prokaryotes do encode Argonaute enzymes 
(Swarts et al., 2014), the main prokaryotic DGM is the CRISPR–Cas adaptive 
immune system (Fig. I/2c). CRISPR–Cas systems integrate parasitic DNA se-
quences (spacers) into CRISPR loci on the host genome (Barrangou et al., 2007), 
which provides heritable immunity against pathogens with a matching nucleotide 
sequence. Cas enzymes use processed transcripts of CRISPR loci as guides 
(Brouns et al., 2008) to mediate the sequence-specific cleavage of (usually) com-
plementary DNA (Garneau et al., 2010) and sometimes RNA (Abudayyeh et al., 
2016; East-Seletsky et al., 2016) or both (Goldberg et al., 2014; Samai et al., 
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2015; Jiang et al., 2016). Although the sampling of pathogen-derived spacers is 
often not random (Richter et al., 2014; Modell, Jiang and Marraffini, 2017), most 
bacterial clones acquire unique spacers (Westra et al., 2015). Hence, CRISPR-
Cas systems rapidly generate population-level diversity at CRISPR loci. One 
study showed that this diversity is an important fitness determinant, as it limits 
the evolution of CRISPR escape phage, which carry point mutations that allow 
evasion from the CRISPR-mediated immune response (van Houte et al., 2016). 
CRISPR–Cas systems can also generate within-host diversity through the acqui-
sition of multiple spacers from the same pathogen, which also limits the evolution 
of escape phage (Levin et al., 2013; van Houte et al., 2016). 
 
Phase variation. Another example of a bacterial DGM is phase variation, which 
can generate population-level heterogeneity by switching genes on or off through 
slipped-strand mispairing, inversions or site-specific recombinations (Bikard and 
Marraffini, 2012). A key example in bacterial immunity is provided by type I re-
striction–modification (RM) shufflons (Fig. I/2d). RM systems function through ep-
igenetic modification of specific host DNA sequences and cleavage of the same 
sequences when unmodified, such as those encoded on phage genomes (re-
viewed in van Houte, Buckling and Westra, 2016). Type I RM shufflons encode 
specificity subunits (HsdS), which determine the sequence specificity; methyl-
ases (HsdM), which catalyse methylation of the corresponding sequences; and 
restriction endonucleases (HsdR), which catalyse cleavage of these sequences 
when unmodified. Phage can rapidly evolve to overcome RM systems, for exam-
ple when HsdM modifies phage sequences before cleavage by HsdR (Levin, 
Antonovics and Sharma, 1988; Korona and Levin, 1993), which enables unchal-
lenged spread of the methylated escape phage through the bacterial population. 
However, HsdS in type I RM shufflons can rapidly diversify through recombination 
between multiple hsdS genes, hence generating population-level diversity in RM 
specificity (Dybvig, Sitaraman and French, 1998; Tettelin et al., 2001). These 
systems often generate diversity between hosts, but sometimes, when one host 
encodes multiple HsdS at multiple loci that can be active simultaneously (Dybvig, 
Sitaraman and French, 1998), they can also generate within-host diversity. Both 
levels of diversity are predicted to limit the evolution and spread of RM escape 
phage (Sneppen et al., 2015). 
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Unifying concepts. As outlined above, targeted DGMs tend to generate high 
levels of diversity, often both between and within hosts. This diversity is exclu-
sively generated in genes involved in host–pathogen interactions, and therefore, 
these DGMs do not usually provide benefits in the absence of pathogens. How-
ever, exceptions in which these DGMs have been co-opted for other processes 
do exist. For example, RNAi is involved in many processes including gene regu-
lation, epigenetic modification and transposon regulation, and it therefore has a 
crucial role in organismal homeostasis and phenotypic plasticity (Ketting, 2011). 
Bacterial CRISPR-Cas systems sometimes also have a role in (virulence) gene 
regulation (Westra, Buckling and Fineran, 2014), such as bacterial lipoprotein 
expression by Francisella novicida during infection to avoid triggering a host im-
mune response (Sampson et al., 2013). Bacterial RM systems can regulate gene 
expression through epigenetic changes, such as capsule gene expression in 
Streptococcus pneumoniae, which is a key virulence determinant (Manso et al., 
2014). However, targeted DGMs usually have specialized roles in immunity, and 
where they have non-immune functions, their role in immunity may be less im-
portant (Seo et al., 2013). 
 
Benefits of DGMs 
Most DGMs are likely to have evolved because they increase an individual's re-
sistance to pathogens. For example, sexual reproduction can generate rare gen-
otypes that can escape infection with common pathogens (Hamilton, Axelrod and 
Tanese, 1990), and increased mutation rates in bacteria increase the rate at 
which mutations that confer resistance to phage are generated (Pal et al., 2007; 
Morgan, Bonsall and Buckling, 2010). In these cases, DGM-associated genes 
can increase in frequency together with the beneficial alleles or allele combina-
tions they generate owing to genetic linkage; for example, bacterial mutator al-
leles, such as mutations in the methyl-directed mismatch repair system, can be 
selected for based on their linkage with beneficial phage resistance mutations 
that are generated in the same genetic background; these resistance mutations 
occur at higher frequencies in mutator strains compared with wild-type bacterial 
strains because of the increased mutation rate (Taddei et al., 1997). Other sys-
tems, such as RNAi and the adaptive immune response, are also likely to have 
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arisen because of their benefits in terms of an individual's resistance to patho-
gens, and the within-host diversity that they generate will reduce the probability 
of pathogens overcoming host defences. 
However, theory and data show that host diversity (and therefore DGMs, pro-
vided that the diversity that they generate is maintained) can also provide popu-
lation-level benefits. Increased host diversity can decrease the pathogen repro-
ductive rate (epidemiological effect) and can make it more difficult for the patho-
gen to adapt to the host population (evolutionary effect). As targeted DGMs usu-
ally generate higher levels of diversity in resistance genes than do non-targeted 
DGMs, they provide greater epidemiological and evolutionary benefits in the 
presence of infectious diseases. 
 
Epidemiological effect. The first population-level benefit of host diversity is a 
reduction in the size of disease epidemics. If host–pathogen interactions are spe-
cific (in other words, pathogen genotypes infect a restricted and non-overlapping 
range of host genotypes), then the reproductive rate of a pathogen is predicted 
to be larger in homogeneous compared with heterogeneous host populations 
(Lively, 2010b). This epidemiological effect results from a reduction in the fre-
quency of productive infections (in other words, the host genotypes that can be 
infected by a particular pathogen genotype become diluted amidst other host 
genotypes that are not susceptible to infection, which is known as a dilution effect 
(Keesing et al., 2010)), as well as an increase in the frequency of failed infections 
when pathogens infect resistant host genotypes. Above a threshold level of host 
diversity, the reproductive rate of the pathogen becomes smaller than 1, and it 
will become extinct unless it can evolve an altered host range. 
 
Evolutionary effect. The diversity of host-resistance alleles is also predicted to 
limit pathogen evolution because it is more difficult for pathogens to adapt to het-
erogeneous host populations than to monocultures (Hamilton, Axelrod and 
Tanese, 1990) and because the reduction in pathogen reproductive rate in het-
erogeneous host populations reduces the evolutionary potential for the pathogen 
to adapt to the host population (Antia et al., 2003). For example, a field study 
carried out in China that examined the effect of mixing pathogen-resistant and -
susceptible rice crops found that mixed crops had a greatly decreased severity 
of rice blast compared with monocultures, and the results suggested that there 
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was reduced pathogen adaptation to the plants' resistance alleles in the long term 
when the crops were mixed (Zhu et al., 2000). A laboratory evolution study 
showed that population-level diversity generated by CRISPR–Cas adaptive im-
mune systems limits the evolution of CRISPR escape phage. When bacterial 
hosts were grown in monoculture, CRISPR escape phage emerged rapidly, but 
when the same bacterial CRISPR clones were mixed, escape phage were never 
observed and the phage were driven to extinction (van Houte et al., 2016). Diver-
sity in terms of antibodies and viRNAs is likely to be associated with similar ben-
efits — in these cases applying to both individuals (owing to within-host diversity) 
and populations (owing to between-host diversity). 
 
Costs of DGMs 
DGMs may be selected against if they carry fitness costs that outweigh their ben-
efits. These costs will differ between DGMs and may be particularly high for un-
targeted DGMs. For example, most random mutations are either neutral or detri-
mental, being the underlying cause of various diseases (Forsberg, Gisselsson 
and Dumanski, 2017; Tubbs and Nussenzweig, 2017). However, the costs asso-
ciated with high mutation rates can be alleviated through mechanisms for tissue-
specific mutation (for example, in B cells), site-specific mutation (for example, 
somatic hypermutation of antigen receptor genes) or stress-induced mutation (as 
occurs in some bacteria) (Foster, 2007). Sexual reproduction is also associated 
with a large cost compared with parthenogenesis, the most important cost being 
the reduced number of offspring per adult, as males do not contribute to repro-
ductive output during sexual reproduction (known as the twofold cost of sex) 
(Maynard Smith, 1971, 1978). 
Targeted DGMs can be associated with both immunopathological costs, whereby 
the immune response damages the host, and energetic costs. These costs can 
be manifested both in the short term (for example, when immunological activity 
contributes to or worsens disease symptoms (reviewed in Graham, Allen and 
Read, (2005))) and in the long term (for example, by decreasing the lifespan of 
individuals with strong immune responses (Finch and Crimmins, 2004)). Minimiz-
ing these costs has probably had an important role in shaping the evolution of 
immune systems (reviewed in Graham, Allen and Read (2005)). For example, 
the production and disposal of large numbers of B and T cells owing to non-pro-
ductive gene rearrangements during V(D)J recombination and CSR impose an 
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energetic cost on the individual, which has led to the evolution of specific mech-
anisms to reduce the frequency of deleterious conformations, such as orientation-
specific joining of gene fragments in the same transcriptional orientation (Dong 
et al., 2015). In the case of CRISPR–Cas, the immune response is associated 
with a fitness cost that is induced upon infection, which may be an energetic cost 
as a result of induced expression of CRISPR–Cas or an immunopathological cost 
owing to self-reactivity, or it could result from pathogen-induced damage to the 
host before pathogen clearance (Vale et al., 2015; Westra et al., 2015). Fitness 
costs resulting from immunopathology are frequently observed in the context of 
vertebrate immune systems (Kobasa et al., 2007; Graham et al., 2010), as well 
as bacterial innate (Pleška et al., 2016) and adaptive (Stern et al., 2010) immune 
systems. One example of immunopathology associated with the antibody re-
sponse is that which is mediated by RAG1. During V(D)J recombination, RAG1 
often binds cryptic recombination sequences in non-immunoglobulin sequences, 
leading to genome instability; the cost of this is mitigated by reducing the genome-
wide frequency of such sites (Teng et al., 2015). 
Whether the benefits of a particular DGM outweigh the costs will depend on the 
environment, most notably pathogen density. In the cases of mutation and sexual 
reproduction, the fitness costs are constitutive, and hence, these DGMs may be 
selected against in the absence of pathogens (Ashby and King, 2015). This is 
consistent with the observation that sexually reproducing snails are more abun-
dant in environments with high pathogen densities (discussed above). By con-
trast, targeted DGMs tend to have relatively low fitness costs in the absence of 
pathogens and are therefore less likely to be strongly selected against when path-
ogens are absent (Westra et al., 2015). 
 
DGM-associated co-evolution  
The individual- and population-level benefits of DGMs indicate that pathogens 
that are unable to evolve to overcome host resistance owing to genetic con-
straints, such as their smaller genome size (Morgan, Gandon and Buckling, 
2005), may become extinct. For example, during co-evolution between the bac-
terium Pseudomonas fluorescens and its phage under laboratory conditions, host 
resistance and pathogen infectivity increase over time in a process known as 
arms-race dynamics (ARD). This process is associated with selective sweeps of 
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host and pathogen genotypes with increased resistance and infectivity, which be-
come rapidly fixed in the population (Buckling and Rainey, 2002), resulting in the 
maintenance of low levels of host and pathogen diversity. An increase in the bac-
terial mutation rate resulting from mutations in the methyl-directed mismatch re-
pair system allows bacteria to outpace the phage, as it becomes increasingly 
difficult for the phage to adapt to the most common but rapidly evolving host gen-
otype (Morgan, Bonsall and Buckling, 2010), resulting in an increased probability 
of phage extinction (Pal et al., 2007). 
However, in other cases, the diversity of host resistance alleles and pathogen 
infectivity alleles is maintained in the population, and host resistance can be quite 
specific for particular pathogen genotypes (Luijckx et al., 2011, 2013). Indeed, 
this assumption is crucial to explain pathogen-mediated maintenance of sexual 
reproduction (Hamilton, Axelrod and Tanese, 1990; Lively, 2010a). In this case, 
pathogens would typically adapt to counter resistance of the most common host 
genotype (Lively and Dybdahl, 2000). This would provide an advantage to rare 
host genotypes (Lively, Craddock and Vrijenhoek, 1990), which theoretically 
leads to ongoing co-evolution between the host and pathogen through fluctuating 
selection dynamics (FSD), whereby fitness and therefore frequencies of host and 
pathogen genotypes fluctuate over time (Hamilton, Axelrod and Tanese, 1990). 
Co-evolutionary FSDs have been observed in several host–pathogen interac-
tions (Decaestecker et al., 2007; Gomez and Buckling, 2011). Unlike ARD, FSD-
type co-evolution can in theory continue indefinitely, which allows for the mainte-
nance of host and pathogen diversity. 
However, not all DGMs that generate high levels of diversity will cause FSD-type 
co-evolution. In addition to the requirement for a high specificity of infection (dis-
cussed above), pathogens need to be able to adapt to a common host genotype 
for FSD to occur. This depends both on the molecular mechanism of the DGM 
(for example, genetic constraints on the pathogen to overcome host resistance 
will be different for an antibody response, where pathogens need to evolve a 
modified epitope, compared with RNAi or CRISPR–Cas, where a SNP in the tar-
get sequence leads to escape) and on the levels of host diversity that are gener-
ated. In the case of untargeted DGMs, which generate relatively low levels of 
diversity, pathogen adaptations by mutation or recombination alone are often suf-
ficient to overcome host resistance. As discussed above, the high levels of diver-
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sity generated by targeted DGMs can limit pathogen adaptation by mutation, re-
sulting in pathogen extinction (van Houte et al., 2016). For example, despite the 
rapid evolution of CRISPR escape phage (Deveau et al., 2008) and the high 
specificity of interactions between CRISPR-mediated resistant hosts and escape 
phage (one escape phage can infect only a single CRISPR-mediated resistant 
clone (Morley et al., 2017)), FSD-type co-evolution is not observed owing to the 
high levels of CRISPR diversity (Chabas et al., 2016; van Houte et al., 2016), 
which limit the ability of phage to adapt to dominant host genotypes. This rela-
tionship, in turn, imposes a strong selection pressure on pathogens to evolve 
more sophisticated strategies to evade host immunity. As the evolution of such 
anti-DGM strategies requires genetic innovation, this process occurs over longer 
timescales as part of an arms race between hosts and pathogens. 
 
Evolution of anti-DGM strategies. One way in which pathogens can escape the 
host resistance mediated by targeted DGMs that generate high levels of diversity 
is by evolving high levels of diversity themselves. Probably the best-known ex-
ample of this is capsule switching in the human pathogen Streptococcus pneu-
moniae, which allows the pathogen to evade the human immune system during 
infection (Griffith, 1928). Another example is antigenic variation in Trypanosoma 
brucei, the causative agent of sleeping sickness, which has approximately 1,000 
copies of the variant-specific glycoprotein (VSG) gene that encodes the main sur-
face antigen (Fig. I/3a). Each pathogen expresses only one VSG gene and the 
immune response targets the most abundant VSG genotype, which allows rarer 
genotypes to evade the immune response (Schwede et al., 2015). Similarly, Plas-
modium falciparum, the human malaria pathogen, encodes a large number of var 
genes, which are differentially expressed in different pathogen lines. These 
genes encode surface proteins responsible for antigen variation in infected red 
blood cells, which are key determinants of immune evasion and virulence (Su et 
al., 1995). Other examples include influenza virus reassortment (Gerber et al., 
2014) (Fig. I/3b) and diversity-generating retroelements found in the tail genes of 
phage (Doulatov et al., 2004; Paul et al., 2015) (Fig. I/3c). In the case of the 
nematode Strongyloides ratti, pathogen sexual reproduction helps the pathogen 
to adapt to the host immune system; compared with wild-type rats, the infection 
of immunocompromised rats is characterized by a decreased proportion of facul-
tatively sexual S. ratti (Gemmill, Viney and Read, 1997). 
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A second common strategy by which pathogens can escape host resistance is 
through the evolution of pathogen-encoded mechanisms that specifically antag-
onize host DGMs. For example, anti-DGM strategies seem to be nearly ubiqui-
tous in plant viruses, which almost invariably encode antiviral silencing suppres-
sion genes that interfere with the RNAi pathway (reviewed in Pumplin and 
Voinnet (2013) (Fig. I/3d). Many vertebrate parasites and pathogens also encode 
proteins that block the immune response (Belkaid et al., 2002; Young, Hussell 
Figure I/3. 
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and Dougan, 2002), and many bacteriophage encode anti-RM (Atanasiu et al., 
2002) and anti-CRISPR proteins (Bondy-Denomy et al., 2013) (Fig. I/3e). The 
latter were first discovered in Pseudomonas phage (Bondy-Denomy et al., 2013) 
Figure I/3. Anti-diversity-generating mechanism strategies. 
a VSG encodes the variable surface glycoprotein (VSG) coat of Trypanosoma 
brucei. VSG alleles are encoded in the VSG array, on mini-chromosomes (not 
shown), and in alternative VSG loci. Translocation of alleles into the single ac-
tive locus or activation of an alternative promoter causes population-level diver-
sity in VSG expression. b Genetically distinct strains of influenza virus infect an 
epithelial cell. During progeny virus assembly, RNA strands reassort to create 
diverse influenza virus particles. c Some phage encode diversity-generating 
retroelements for diverse tail fibre genes. An invariable template repeat (TR) is 
copied into a variable repeat (VR) within the major tropism determinant (mtd) 
gene. This process of mutagenic homing requires an RNA intermediate and a 
unique low-fidelity reverse transcriptase. avd, accessory variability determinant 
(cofactor for brt); brt, Bordetella reverse transcriptase. d Many plant virus pro-
teins affect RNA interference (RNAi). Sweet potato chlorotic stunt virus 
(SPCSV) RNase III cleaves viral dsRNA into 14-nucleotide (nt)-long segments 
that are inaccessible to the RNA-induced silencing complex (RISC). Tombusvi-
ral p19 achieves this by binding virus-derived small interfering RNA (viRNA) 
molecules. Turnip crinkle virus (TCV) p38 binds Argonaut proteins to block 
viRNA loading. Polerovirus (PLRV) p0 and potato virus X (PVX) p25 promote 
degradation of RISC. e Bacteriophage anti-CRISPR (Acr) proteins inhibit 
CRISPR–Cas (left side of panel). AcrF1 and AcrF2 interact with the Cascade 
complex to prevent it from binding complementary DNA; AcrF3 blocks recruit-
ment of Cas nuclease to Cascade, which prevents DNA cleavage. Phage anti-
restriction–modification (RM) proteins inhibit phage restriction (right side of 
panel). Phage λ protein Ral stimulates methylase (HsdM) to methylate phage 
DNA, phage Mu-encoded Mom protein modifies adenine bases in phage DNA, 
and phage P1 proteins DarA and DarB bind to restriction sites; these three 
mechanisms protect phage DNA from degradation. T7 protein Ocr binds to the 
restriction endonuclease and stops it from binding DNA. T4 protein Stp changes 
the conformation of the endonuclease to disrupt its activity. 
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but are now recognized to be extremely widespread, to have little sequence sim-
ilarity (Pawluk, Staals, et al., 2016) and to be mechanistically diverse (Bondy-
Denomy et al., 2015; Pawluk, Amrani, et al., 2016; Rauch et al., 2017).  
The evolution of anti-DGM strategies by pathogens can result in an arms race 
with the host that takes place over long evolutionary timescales, whereby hosts 
continuously evolve to escape anti-DGM activity and pathogens evolve to in-
crease anti-DGM activity. Indeed, genes that are involved in antiviral RNAi are 
among the most rapidly evolving genes in the Drosophila genome (Obbard et al., 
2006). Such co-evolutionary interactions are likely to have an important role in 
shaping immune systems, including their genetic and functional diversification. 
 
Conclusion and future prospects 
Many hosts encode DGMs that are involved in host–pathogen interactions. Here, 
we propose that although their molecular mechanisms are diverse, many DGMs 
have common features with regards to their selective benefits and epidemiologi-
cal and co-evolutionary consequences. Understanding the link between these 
microscopic and macroscopic processes will be important for designing effective 
public-health strategies to prevent or limit the emergence of infectious diseases. 
Vaccination programmes and crop protection strategies in agriculture rely on in-
creasing the proportion of resistant hosts in the population, but they often do not 
take into account the diversity of resistance alleles. Most of our current under-
standing of the interaction between diversity and disease relies on theoretical 
models, but many of these models have not been experimentally validated. Fu-
ture work aimed at understanding how environmental variables such as pathogen 
diversity and population structure impact the benefits of host diversity will be an 
important step forward in our understanding of the evolutionary epidemiology of 
pathogens, which can help to develop durable strategies to control human, plant 
and animal disease. Understanding the epidemiological and evolutionary impli-
cations of resistance-allele diversity may also guide further molecular studies to 
improve our understanding of how diversity in resistance alleles, such as antibod-
ies and small RNA molecules, is generated and the scale at which diversity is 
maintained over time both within and between individuals. 
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Chapter II: Restriction-Modification shufflons are a 
means of generating population-level diversity 
 
Abstract 
Restriction-Modification (RM) is the most widespread bacterial immune system 
and protects bacteria from bacteriophage (phage) by cleaving foreign DNA se-
quences, while methylating its own genome to avoid self-recognition. In type I 
RM systems, specificity subunit HsdS confers DNA sequence specificity when 
associating with methyltransferase and restriction endonuclease. Because phage 
can escape from this response by becoming methylated themselves with relative 
ease, it is unclear whether RM provides a large benefit when bacteria coevolve 
with phage over a longer period. Many bacteria have evolved mechanisms to 
obtain novel RM recognition sequence specificities which could improve the ben-
efits of RM to bacteria. Here, by means of a combination of bioinformatics, in 
silico, and literature analyses, we estimate that at least 8% of Type I RM systems 
have the capacity to switch specificity. The simplest of these mechanisms in-
volves a switch in expression of alternative hsdS genes, which encode the se-
quence specificity subunit of the RM system. Others acquire novel hsdS se-
quences through plasmids, and the more sophisticated shufflons recombine mul-
tiple hsdS pseudogenes to rapidly generate new specificities. Mycoplasma pul-
monis has two RM-encoding hsd loci with two copies of hsdS containing several 
recombination sites each. Analysing this Mpu shufflon in silico revealed a reper-
toire of 30 different possible recombinations, with 12-14 of these specificities 
likely to be active in vivo as they encode the traditional number of 1-2 target 
recognition domains.  Shufflons such as this are likely to drastically change the 
coevolutionary dynamics of bacteria and phage, providing a large benefit to bac-
teria through generation of population-level diversity. 
 
Introduction 
As discussed in the previous chapter, diversity-generating mechanisms are inte-
gral to host-parasite interactions and can be greatly beneficial to hosts in the face 
of an epidemic (Westra et al., 2017). The bacterial adaptive immune response 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-
CRISPR associated) can generate population-level diversity of bacteriophage 
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(phage) recognition and cleavage (van Houte et al., 2016). The more abundant 
innate bacterial immune response of Restriction-Modification (RM) typically only 
recognises predetermined DNA sequences and therefore does not confer the 
same benefits. As a nearly ubiquitous immune mechanism (about 90% of bacte-
ria and archaea encode one or more RM systems (Stern and Sorek, 2011)), RM 
is nonetheless an important barrier to horizontal gene transfer and plays a role in 
many coevolutionary dynamics of bacteria with phage. However, in some cases 
RM diversity can be generated too. 
RM systems utilise methylation of the bacterial genome as a simple means of 
self/non-self discrimination to cleave unmethylated foreign DNA. When invading 
a bacterium, a phage’s DNA can accidentally become methylated by RM. This 
protects the phage and its progeny from cleavage and allows them to become 
invisible to the immune response. Due to the relative ease with which phage can 
escape, it has been argued that RM systems only provide a transient advantage 
to bacteria when invading a different ecosystem with new phage (Korona and 
Levin, 1993). These dynamics are likely to change when an RM system has the 
ability to change its specificity, which is highly beneficial to bacteria: a bacterial 
population with a reservoir of different RM specificities is protected from an es-
cape phage sweeping through the entire population.  
Mechanistically there are four types of RM systems, most of which have a me-
thyltransferase and a restriction endonuclease to achieve self/non-self recogni-
tion and cleavage of invasive DNA. The methyltransferase modifies bacterial 
DNA at a specific sequence, while the restriction endonuclease recognises the 
same sequence and catalyses cleavage when it is unmethylated. Type IV sys-
tems are the exception to this rule, these lack a methyltransferase and cleave 
modified DNA while leaving the bacterial genome unmethylated (Ershova et al., 
2015). Both Type II and III systems are comprised of only two genes, mod and 
res, coding for these two essential components. In these systems, specificity for 
the same DNA sequence is separately defined in both genes (Type II), or in the 
methyltransferase only (Type III). In contrast, Type I RM systems encode a spec-
ificity subunit that associates with the methylase and restriction endonuclease. 
The Type I hsd (host specificity for DNA) locus encodes this specificity subunit 
HsdS (S) and HsdM (M) (Arber and Linn, 1969), which together form a functional 
methyltransferase complex with a M2S1 stoichiometry that methylates target DNA 
sequences. The last hsd-encoded component, the restriction subunit HsdR (R), 
 34 
can further associate with the other proteins to form the R2M2S1 complex that has 
the ability to both methylate and cleave unmodified target sequences (Burckhardt 
et al., 1981; Dryden et al., 1997). Upon encountering an unmethylated target se-
quence, both HsdR subunits in this complex will begin to ATP-dependently trans-
locate DNA, until one encounters another activated HsdR subunit and cleavage 
is catalysed (Janscak et al., 1999). Due to this requirement, DNA cleavage can 
only be catalysed if at least two unmodified target sequences are present on the 
same DNA strand and cleavage occurs at a random position in between the two 
targets. Target sequences consist of two sequences of 3-4 nucleotides separated 
by a stretch of several, often 5-8 unspecific nucleotides (e.g. EcoKI’s recognition 
sequence of 5’-AACNNNNNNGTGC-3’ (Kan et al., 1979)). This is due to the 
structure of HsdS, which contains two DNA-binding target recognition domains 
(TRDs) separated by a 
linker domain (Fig II/1). 
This structure allows dif-
ferent kinds of mutations 
of hsdS (either within the 
TRDs to alter recognition 
sequence, or within the 
linker sequence to alter 
spacing between them) 
to have a great impact 
on DNA specificity. Com-
pared to Type II or III RM 
systems, hsdS and its 
structure allow for rapid 
evolution of new diver-
sity in Type I systems, 
because a single gene 
which has large capacity 
to be altered confers 
specificity to the entire 
RM system. Therefore, 
while diversity-generat-
ing mechanisms can be 
Figure II/1. Type I RM 
target recognition. 
a HsdS (specificity),  
HsdM (methyltransferase), and HsdR (restriction en-
donuclease) subunits are the three components of 
the RM protein complex. Two subunits each of HsdM 
and HsdR associate with HsdS. HsdS consists of two 
target recognition domains (blue) which bind specific 
DNA sequences and two spacer domains (beige) 
which separate the TRDs. b Structure of a typical 
hsdS gene. Beige regions get translated as spacer 
domains, blue regions as TRDs. Figure adapted from 
Murray (2000); Fig. 2. 
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found in Type III RM systems too (e.g. in Helicobacter pylori (Kojima et al., 2016)), 
the capacity for these is far greater for Type I systems (Murray, 2000).  
In this chapter, I perform a bioinformatics analysis to understand how common 
diversity generating Type I RM systems are, and an in silico analysis of one such 
RM shufflon from Mycoplasma pulmonis to examine its potential for diversity gen-
eration. 
  
In silico analysis, Results, and Discussion 
The ability to generate population-level diversity is likely a key benefit of Type I 
RM shufflons, whose unique architecture allows for rapid evolution of new RM 
specificities. In order to understand how widespread these diversity-generating 
mechanisms might be, we conducted a search for Type I RM systems with mul-
tiple hsdS genes listed on REBASE (Roberts et al., 2015) as of September 2016. 
While this search did not reveal RM systems in which S subunits have different 
names (e.g. M. pulmonis Mpu shufflon, see below), and may include some non-
functional RM systems that have lost hsdR, it nevertheless provides an overview 
of how many RM systems have a reservoir of hsdS genes as a basis of diversity. 
We found that 1117 (8%) Type I RM systems encode at least two different spec-
ificity subunits. Of these, only 18 encode two methylases, indicating that the vast 
majority are single RM systems with multiple specificities. 295 (2%) encode at 
least three, and 69 (<1%) encode four or more HsdS subunits. Two RM systems, 
both found in different Myoplasma haemofelis strains, encode 13 different hsdS 
variants. Notably, other RM systems with high numbers of hsdS genes (7-9 vari-
ants) are also encoded by M. haemofelis strains. Specifically, M. haemofelis 
strains were found to have up to 21 hsdS genes, not all of which are functional 
(Santos et al., 2011). RM systems with 6 hsdS genes can be found in Enterococ-
cus cecorum and Mycoplasma capricolum. In Mycoplasma species, presence of 
multiple S subunits points towards regulation of their expression by inversions for 
phase variation (Brocchi, de Vasconcelos and Zaha, 2007). However, often this 
can be associated with regulation of gene expression rather than phage defense. 
Overall, this data shows that at least 8% of Type I RM systems have the capacity 
for either switching, or even generating new specificity.  
Literature research and more detailed analysis of the identified Type I RM DGMs 
reveals two main ways to generate diversity: horizontal transfer of novel specific-
ity subunits and recombination (Fig II/2).  
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For example, some Lactococcus lactis 
strains chromosomally encode a Type 
I RM system which can acquire new 
specificities if the bacteria take up one 
of several hsdS plasmids that can be 
transferred through a population 
(Schouler et al., 1998). Plasmid-en-
coded RM systems in other L. lactis 
strains can acquire novel specificity 
through acquiring hsdS plasmids or 
through recombination between hsdS 
genes on different plasmids 
(O’Sullivan et al., 2000). Salmonella 
typhimurium hsdS genes have been 
found to recombine with a Salmonella 
potsdam hsdS gene to generate a 
novel specificity (Gann et al., 1987). 
Taking basic recombination to the ex-
treme, shufflon RM systems generally 
utilise short inverted repeats within 
hsdS to recombine two or several 
hsdS pseudogenes, generating novel 
specificity. Few examples of shufflon 
RM systems are known, but they are 
broadly distributed across different 
bacterial species. In Bacteroides fra-
gilis strains, inverted repeats within hsdS of several closely related shufflons fa-
cilitate TRD rearrangements. Shufflon BB in B. fragilis NCTC 9343 has the ca-
pacity for eight HsdS variants (Patrick et al., 2010). A Streptococcus pneumonia 
strain was found to encode two additional hsdS pseudogenes which recombine 
to create up to four novel specificities (Tettelin et al., 2001). A related S. pneu-
monia strain encodes a shufflon that can generate up to six specificities, however 
in both strains a switch in RM specificity is associated with phase variation 
through differential gene expression by methylation patterns rather than phage 
resistance (Manso et al., 2014). For the M. pulmonis Mpu shufflon, eight hsdS 
Figure II/2. Diversity-Generating 
Type I RM Mechanisms. 
a Bacteria such as Lactococcus lactis 
can horizontally acquire hsdS plas-
mids, which confer a novel RM speci-
ficity. b Recombination can occur with 
chromosomally encoded hsdS 
pseudogenes or with hsdS genes en-
coded on plasmids (not shown). This 
can lead to altered phage resistance or 
epigenetic phase variation. 
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variants have been characterised, although this shufflon with multiple recombi-
nation sites has an even larger capacity for novel specificities (Dybvig, Sitaraman 
and French, 1998). As the M. pulmonis shufflon has unprecedented capacity for 
recombination and the differential phage restriction capabilities of its various 
specificities are well documented, we will analyse this Mpu shufflon in detail for 
the remainder of this chapter. A greater understanding of this diversity-generating 
mechanism will allow the creation of a model system in which we can study 
phage-bacteria interactions in the presence of multiple RM specificities as well 
as the interactions of RM with other bacterial immune systems.  
M. pulmonis is a Firmicute murine pathogen implicated in airway infections. 
Closely related Mycoplasma species, such as M. pneumonia, are implicated in 
human infections. While a switch in HsdS expression in M. pulmonis can be as-
sociated to a certain extent with the bacterium’s infection stage in rats (Gumulak-
Figure II/3. The Mpu shufflon as an ON/OFF switch. 
a Layout of the Mycoplasma pulmonis hsd loci with genes drawn to scale. 
b A single inversion event using hsdS recombination sites leads to RM ex-
pression where all genes can be transcribed. This is the same for hsd2 (not 
shown). 
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Smith et al., 2001), this is far from its only role: a different restriction profile ren-
ders a bacterial host immune to Mycoplasma phage amplified on a host with a 
different RM specificity. The Mpu shufflon consists of two hsd loci, both encoding 
nearly identical HsdR and HsdM subunits (Fig II/3a). Each locus contains one 
copy of hsdS as well as one hsdS pseudogene (Sitaraman and Dybvig, 1997). 
Short vip (vipareetus) and hrs (hsd recombination site) recombination sequences 
within hsdS allow recombination with matching sequences on the opposing 
pseudogene of the same locus (Dybvig, Sitaraman and French, 1998). Due to 
the directionality of Mpu hsd operons, HsdR and HsdM are only expressed after 
an inversion has occurred in either locus (Fig II/3b), for this reason the Mpu shuf-
flon had initially been discovered as a RM on/off switch regulated by inversions 
(Dybvig and Yu, 1994). Recombination between vip and hrs sites is catalysed by 
a recombinase which curiously also triggers genetically and phenotypically unre-
lated vsa (variable surface antigen) recombination in M. pulmonis (Sitaraman, 
Denison and Dybvig, 2002). While all vip sequences within hsdS pseudogenes 
are identical, some hrs sequences contain a single nucleotide insertion which is 
not sufficient to prevent recombination. Due to the similarity of hsdM and hsdR 
between the loci, an HsdS subunit can associate with HsdR and HsdM from either 
locus to form a functional R2M2S1 complex. 
hsdS genes in both loci are composed of 3-4 gene segments, which we defined 
as the sequence between two adjacent recombination sites (Fig II/4). Three hsd2 
gene segments (red, yellow, violet) are identical to their homologues in hsd1. 
Grey and orange segments are nearly identical, with only 7 and 2 nucleotide sub-
stitutions corresponding to 3 and 2 amino acid changes between the loci respec-
tively (Table II/1). The only gene segment unique to hsd2 (green) shares 98% 
homology with the grey segment in the final ¾ of its sequence. Therefore, disre-
garding the minor differences in grey and orange segments as we will do from 
here on, there is a reservoir of 7 unique gene segments for hsdS variants, 
whereby grey is always the first segment within a sequence.  
To determine the capacity for hsdS diversity in the Mpu shufflon, we simulated 
inversions between homologous recombination sequences in silico and deter-
mined all unique hsdS sequences that could arise through single, double, or triple 
inversions. Any additional inversions would revert the gene back to a sequence 
that can be produced by fewer recombination events. We found that the Mpu 
shufflon can produce hsdS genes with 30 different sequences (Table II/2), 7 of 
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which (MpuUI-VI, MpuUVIII) had previously been sequenced and tested against 
phage by Dybvig, Sitaraman and French, (1998). Subunits not previously defined 
were named MpuT1-29 (T for theoretical), adhering to the convention of odd- 
numbered subunits being produced by hsd1 and even-numbered subunits being 
 
 
Figure II/4. hsdS gene 
segments. 
a Gene segments of hsd1, 
same colours denote 
sequence identity. 
Recombination sites are 
listed at segment 
junctions. b Recombina-
tion site sequences and 
exact positions of gene 
segment junctions. Col-
ours correlate to gene 
segments in a. c Gene 
segments of hsd2, same 
colours denote sequence 
identity to segments in 
hsd1. Stars indicate gene 
segments with only minor 
changes (see text). 
Recombination sites are 
listed at segment 
junctions. Note that the 
black gene segment in 
hsdS2A is never 
transcribed as it cannot be 
moved in front of the 
promoter. For exact gene 
segment sequences refer 
to Table II/1. 
pro-
moter 
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hsdS1B 
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b 
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MpuUI gene segment sequences as in hsd1: 
atggaaatttataaacttggtcagatatt
aaatttagaaaagggcaaatcaaaatata
atgcaaaatatgtttctcaaaatatcgga
atttataatttgtactcttcaaaaacaaa
agatcaaggtatatttggaaaaatcaatt
catatgactttaatggtgaatatatttta
attaccactcatggtgcatatgcaggaac
agttaaatatgtaaatgaaaagttttcca
caacaagtaattgttttattctaaaagtt
aatgaaaatattgttaagacaaaattttt
aagttatttattattgttacaagaaaaaa
cattcaatgatatggctataggttctgca
tatggttatttaaaaaactataacataaa
tgattttgaagttaatttacctaacttaa
aaattcaaagtgcaa 
taattaa
gattatt
gaaccta
aagaaga
tttattt
tttaggc
ataaaaa
tcttgta
agaattg
atagtga
agaaaat
acaaaaa
aagattt
aagtata
t 
taattaagattattgaacctttagaaaaacaaataaat
gcatttgatgaactgattttgagtgagcaaaaaagtct
ccaacattatttaaattattttttaaataaacttgcat
caattaatccttcaattttcaaaaattataaacttggt
gaaatagcaaaaatattaagtggtaaaactccttccac
tgcaaaaaaggaactatgaaaaaaggaaataccttttt
ttggtccgggagatcttgataatatggttccaaaaaga
tttattacttttaatgaaaaaatgataaaaagatctgg
caccattttattttcttctgcagcaacaattgggaaag
tgggtattttagacaatttatcttgatttaaccaacaa
ataacttcaatagaggcaaataataactatgttatgga
taagtttttattttttcttcttaaaaaaataagttcaa
aaataaaatttgaaaattcaagcggaacaatatttcct
acaattaaaaaaaaatattttgaaaattttacactaga
aattcctaatctaaaaactcaaagtgcaa 
tattaggtat
tattgaacca
ttgcataaaa
aaattaatct
tttaaaacaa
aagaaaaaat
tgcttgaaaa
aagatttata
tactatcaaa
atcacttaat
caaggagaaa
atcaaagatg
agtag 
hsd2 gene segment sequences, differences highlighted white 
atggaaatttataaacttggtcagatatt
aaatttagaaaagggcaaatcaaaatata
atgcaaaatatgtttctcaaaatatcgga
atttataatttgtactcttcaaaaacaaa
agatcaaggtatatttggaaaaatcaatt
catatgactttaatggtgaatatatttta
attaccactcatggtgcatatgcaggaac
agttaaatatgtaaatgaaaagttttcca
caacaagtaattgttttattctaaaagtt
gacgaaaatattgctaagacaaaattttt 
aagctatttattattgttacaagaaaaaa
cattcaatgatatggctataggttcagca
tatggttatttaaaaaactataatataaa
tgattttgaagttaatttacctaacttaa
aaactcaaagtgcaa 
As 
above 
As above tattaggtat
tattgaacca
ttgcataaaa
aaattaatct
tttaaaacaa
aagaaaaaat
tgcttgaaaa
aagatctata
tactgtcaaa
atcacttaat
caaggagaaa
atcaaagatg
agtag 
Additional gene segment sequences (MpuT8): 
 
taattaagattattgaacctctagaaaaacaaataaa
tgcatttgatgaactgattttgagtgagcaaaaaagt
ctccaacattatttaaattattttttaaataaacttg
catcaattaatccttcaattttcaaaaattataaact
tggtcagatattaaatttagaaaagggcaaatcaaaa
tataatgcaaaatatgtttctcaaaatatcggaattt
ataatttgtactcttcaaaaacaagagatcaaggtat
atttggaaaaatcaattcatatgactttaatggtgaa
tatattttaattaccactcatggtgcatatgcaggaa
cagttaaatatgtaaatgaaaagttttccacaacaag
taattgttttattctaaaagttaatgaaaatattgtt
aagacaaaatttttaagttatttattattgttacaag
aaaaaacattcaatgatatggctataggttctgcata
tggttatttaaaaaactataacataaatgattttgaa
gttaatttacctaacttaaaaattcaaagtgcaa 
As 
above 
taattaagattattgaacctttagaaaaacaaataaa
tgcatttgatgaattgattttgagtgagcaaaaaagt
cttcaacattatttgaattatttttttggaaaattct
atcaaattgaaccttcattgtttcatgattataaact
cgaaaagattgcaaaaataagaagaggtaagataata
aattcatttgacctaaaagaaaatcctggagattatc
ctgtaatttcatcaaatacaaaaaataatggaatttt
tggttatttaaattcctatatgtatgatggtgagtat
ataactataagtgcagatggtgcatatgctggaactg
tgtttttgaataatggaaaattttctataactaatgt
gtgtttcattttgttgctaaatgacaaagtaaacctt
cttacaaaatttctcttttattatttgaaaaagaatg
aaaatatcatacaaaaaaaatcaatagtaggttcttc
aagaccatcagttagagaatatactctctcagaaata
gctatcaaaataccttctctagaaatccaaagtgcaa 
tatt
aggt
atta
atga
acac
tttc
atta
tgtt
taa 
 
 
 
 
 
 
Table II/1. Nucleotide sequences of hsdS gene segments. 
Nucleotide sequences are shown in a 5’-3’ direction. Colours correspond to gene 
segments of Fig II/4. Differences between hsd1 and hsd2 sequences are highlighted 
in white on a black background. Bold: sequences coding for predicted recognition 
sites, compare Fig II/5-7. 
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hsdS 
variant 
Structure Length 
[nt] 
Size 
MpuUI 
 
1206 Standard 
MpuUII 
 
1110 Standard 
MpuUIII 
 
1101 Standard 
MpuUIV 
 
1197 Standard 
MpuUV 
 
1011 Standard 
MpuUVI 
 
1200 Standard 
MpuUVIII 
 
1098 Standard 
MpuT1 
 
1761 Large 
MpuT2 
 
1752 Large 
MpuT4 
 
456 Small 
MpuT6 
 
546 Small 
MpuT7 
 
1671 Large 
MpuT8 
 
1662 Large 
MpuT9 
 
1116 Standard 
MpuT10 
 
1008 Standard 
MpuT11 
 
1107 Standard 
MpuT14 
 
1752 Large 
MpuT15 
 
1671 Large 
MpuT16 
 
1662 Large 
MpuT17 
 
1761 Large 
MpuT18 
 
1662 Large 
MpuT19 
 
1017 Standard 
MpuT20 
 
1752 Large 
MpuT22 
 
1107 Standard 
MpuT23 
 
1671 Large 
MpuT25 
 
1761 Large 
MpuT26 
 
1662 Large 
MpuT27 
 
1671 Large 
MpuT28 
 
1752 Large 
MpuT29 
 
1761 Large 
 
 
 
 
Table II/2. hsdS variants produced by the Mpu shufflon. 
Colours correspond to gene segments of Fig II/4, for exact nucleotide sequences see 
Table II/1. Odd-numbered variants can be produced by hsd1 and even-numbered 
variants by hsd2. MpuU-designated subunits were previously described in Dybvig, 
Sitaraman and French (1998). Small and Standard sized subunits are most likely to be 
active in vivo. 
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produced by hsd2. Additionally, due to homology of gene segments between loci, 
we found that several subunit variants can be produced by either hsd locus. 
These include MpuT4/3, MpuT6/5, MpuUV/T12, MpuUII/T13, MpuUVI/T21, and 
MpuUIII/T24, each referred to by their first designation. When cross-comparing 
theoretical subunits to previous work, we found that, while MpuT2 and MpuT5 
hadn’t been sequenced or tested against phage, these hsdS confirmations had 
been found in vivo by PCR when analysing a mixed population of M. pulmonis 
(Sitaraman and Dybvig, 1997). This indicates that the diversity generated by the 
Mpu shufflon indeed reaches further than MpuU-designated subunits found in 
cultured clones, and demonstrates that our in silico constructed MpuT subunits 
are valid hsdS recombinations in M. pulmonis. However, this does not verify 
whether MpuT subunits will produce biologically active HsdS proteins.  
To establish which hsdS recombinations may be biologically active, we grouped 
all subunit variants according to their size into 3 categories: small, standard, and 
large. Small variants range from 456-546 nt and are made up of 2 gene seg-
ments, standard variants range from 1008-1206 nt and are made up of 3-4 gene 
segments, and large variants range from 1662-1761 nt and are made up of 5 
segments (Table II/2). This variation in gene lengths indicates that large differ-
ences in protein structure may exist for different HsdS variants, and it is likely 
they will not all be functional. As all previously detailed hsdS that are biologically 
active as a RM specificity subunit are standard sized, MpuT9-11, MpuT19, and 
MpuT22 (the other five standard sized variants) are the variants most likely to be 
active. Of these 12 standard sized variants, some vary only slightly in their se-
quence, with the only difference being the short final gene segment (orange or 
violet). Should this very short gene segment not be involved in sequence speci-
ficity, the number of standard sized variants with unique sequence recognition 
properties would drop to 6. This would also mean that MpuUIII and MpuUV as 
well as MpuUII and MpuUVI have the same sequence specificities; from Dybvig 
et al.’s (1998) restriction profiling of HsdS variants it remains uncertain whether 
these subunits confer different specificities. 
In order to make more accurate predictions of the biological activity of different 
sized variants, we localised target recognition domains (TRDs) to hsdS se-
quences. Previous work predicted the positions for TRDs in hsd1 by alignment to 
similar proteins (Sturrock and Dryden, 1997). This allowed us to assign the TRD 
to the grey (TRD1a), yellow (TRD1b), and blue (TRD1c) gene segments. Due to 
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gene segment homologies between hsd1 and hsd2, we extrapolated the location 
of TRD2a (which shares 95% homology with TRD1a) to be within the green gene 
segment (Fig II/5a and Fig II/6a). As the nucleotide sequence coding for TRD2a 
is shorter than that coding for TRD1a, we cannot presume that both domains 
recognise the same DNA sequence. 
In order to understand whether all HsdS variants that we generated in silico are 
functional, we modelled various subunits as 3-dimensional HsdS proteins using 
Phyre2 (Kelly et al., 2015). These homology-directed protein models are largely 
based on the solved crystal structure of a Type I RM specificity subunit found in 
Methanococcus jannaschii (Kim et al., 2005). Standard-sized HsdS subunits such 
as MpuUI are predicted to fold into a 46 kDa protein with rotational symmetry (Fig 
II/5 left). The 5’-most grey gene segment coding for TRD1a gets translated as a 
globular DNA-binding domain. In the case of MpuUI, a helical spacer domain de-
rived from the red gene segment forms a bridge between this first and a second 
globular DNA binding domain, which is derived from the TRD1c-encoding blue 
segment. The final orange segment codes for a second helical spacer domain, 
which spans the gap between DNA-binding domains parallel to the red spacer 
domain. Both globular domains have a small groove on the face furthest from 
linker domains, which is perhaps the DNA-binding section of the protein. In HsdS 
variants that lack a gene segment corresponding to the helical linker between 
globular domains, e.g. MpuT11 (Fig II/5 right), a portion of the second globular 
domain is predicted to adopt a helical shape to become a spacer domain. This is 
highly likely to change DNA specificity, as it requires a change in shape of glob-
ular domain. However, as homology-directed models can have severe limitations 
in accuracy of structures more detailed than overall protein shape, we suggest 
an alternative model (Fig II/5c left) in which the aforementioned portion of the 
second globular domain (blue) always forms a short helical spacer. In this alter-
native model, presence of an additional spacer domain would result in a protein 
with increased spacing between globular DNA-binding domains whilst leaving the 
DNA interaction sites unchanged, which will nevertheless change the DNA recog-
nition sequences because spacing between recognized sequences is altered. In 
contrast, HsdS variants that lack a TRD-coding gene segment (e.g. MpuT6; Fig 
II/7 left), form a truncated protein. In other Type I RM systems, truncated HsdS 
proteins with only one TRD can dimerise to form a functional specificity subunit 
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(Meister et al., 1993). Acting in this way, MpuT4 or MpuT6 could become 
functional subunits with an entirely new sequence specificity by dimerising with 
Figure II/5. Structure of MpuUI and MpuT11 genes and their proteins. 
a Gene structures with positions of Target Recognition Domain (TRD)-coding 
regions superimposed. b Homology-directed protein models. Colours 
correspond to gene segments in (a). MpuUI model shows positions of amino 
acids which are substituted in hsd2 gene segments in pink. Note that the orange 
segment contains two substitutions, one of which is omitted in the model. c 
Simplified models of HsdS proteins based on models in (b). For description of 
alternative models, see text. 
 
MpuUI 
TRD1a TRD1c 
side 
top 
TRD1a TRD1c 
MpuT11 
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b 
c 
a 
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themselves or each other. In HsdS variants with an additional TRD-coding 
segment (e.g. MpuT2; Fig II/7 right), the first linker domain (red) is predicted to 
fold up on  
Figure II/6. Structure of MpuUV and MpuUIV genes and their proteins. 
a Gene structures with positions of Target Recognition Domain (TRD)-coding 
regions superimposed. b Homology-directed protein models. Colours 
correspond to gene segments in (a). c Simplified models of HsdS proteins 
based on models in (b). For description of alternative models, see text. 
MpuUV 
TRD1a TRD1b 
MpuUIV 
TRD1a TRD2a 
side 
top 
TRD1a TRD1b 
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c 
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Figure II/7. Small and large sized HsdS proteins. 
Left: MpuT6, Right: MpuT11 a Gene structures with positions of Target 
Recognition Dmain (TRD)-coding regions superimposed. b Homology-
directed protein models. Colours correspond to gene segments in (a). c 
Simplified models of HsdS proteins based on models in (b). Left: MpuT6 
dimer model.  
MpuT2 
TRD1a TRD2a TRD1b 
side 
top 
TRD2a TRD1b 
TRD1a 
MpuT6 
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top 
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Dimer model 
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itself and adopt a U-shaped helical structure, which places the second globular 
domain directly underneath the first. This results in a protein in which the second 
TRD-containing segment (yellow) adopts the role of the first globular domain, with 
the remaining TRD-containing segment folding into a spacer domain as well as 
second globular domain. The surplus globular domain (grey) protrudes from the 
top of the otherwise standard HsdS structure and blocks access to the other DNA-
binding domains. Therefore, if the additional globular domain is not removed in 
post-translational processing, HsdS variants containing three TRDs are likely to 
be non-functional.  
Homology-based protein modelling also has its limits, however. Phyre 2 is likely 
not to change the structure of the coiled coil spacer domains, even when their 
sequence changes. Therefore, these models are likely to under-estimate the 
amount of diversity that can be generated by the Mpu RM shufflon, in particular 
within the spacer region between TRDs. 
Finally, we mapped amino acid changes between grey and orange hsd1 and 
hsd2 gene segments to our model of MpuUI to determine whether our earlier 
assumption that these mutations do not change gene segment properties can be 
upheld (Fig II/5b). Firstly, the orange segment is unlikely to show altered proper-
ties as it forms a spacer domain; their properties are largely resistant to amino 
acid changes (Cowan, Gann and Murray, 1989). Secondly, only two of the three 
amino acid changes in the TRD-containing grey gene segment are at the protein 
surface, but they are not on the protein’s DNA-facing side. Rather, they can be 
found in the interface of TRD and spacer domains, a region typically associated 
with binding of HsdM (Zinkevich et al., 1992). This indicates that the differences 
in hsd1 and hsd2 gene segments may be for optimisation of association with the 
respective HsdM1 or HsdM2 methyltransferase. Therefore, as HsdS subunits 
from either hsd locus can associate with either methyltransferase and restriction 
endonuclease, we can disregard the minor differences between grey and orange 
hsd1 and hsd2 gene segments as it is highly likely that these do not produce 
functionally different proteins. 
In summary, we found that the Mpu shufflon hsd loci have the capacity to produce 
30 different hsdS genes that can be grouped into small, standard, and large sized 
subunits. Standard sized variants include all previously described MpuU HsdS 
proteins and contain two TRDs. Small sized variants encode one TRD and may 
dimerise to form a functional HsdS complex, while large sized variants contain 
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three TRDs and are unlikely to form functional specificity subunits. Overall, the 
Mpu shufflon can encode 14 different standard and small sized subunits, all of 
which are likely to be functional. With our database of nucleotide sequences for 
all hsdS variants of the Mpu shufflon, it will be easier to, in future, express and 
analyse these proteins in vitro to answer structural questions, such as which gene 
fragments are essential for a change in specificity, and whether HsdS with three 
TRDs can be functional. 
 
In M. pulmonis and other shufflons, recombination occurs in a very rapid 
timeframe, so that clones with different genotypes can be found within a bacterial 
population (Dybvig, Sitaraman and French, 1998; Tettelin et al., 2001). This 
demonstrates that shufflons are a means of generating population-level RM di-
versity, such a population with multiple RM specificities will be resistant to meth-
ylated escape phage sweeping through the entire population. A different bacterial 
diversity-generating immune mechanism, the adaptive response CRISPR-Cas, 
functions by integrating short phage DNA sequences into its own genome as 
spacers, and later targeting phage that carry the same sequence in their genome. 
In comparison to RM shufflons, CRISPR has the capacity to generate far more 
diversity by integrating a large range of different spacers. An experiment tracking 
emerging CRISPR escape phage showed not only that this diversity can rapidly 
drive phage extinct, but also indicated that there may be a threshold level past 
which additional CRISPR diversity is redundant (van Houte et al., 2016). If a shuf-
flon can produce enough diversity to pass this threshold, it may limit phage epi-
demics and the emergence of escape phage just as effectively as CRISPR-Cas.  
Another key difference between these two immune responses is the mechanism 
of phage escape. To escape RM, a phage needs to become methylated. This 
can occur by chance, or can be enabled by phage-encoded proteins (Krüger and 
Bickle, 1983). Alternatively, some phage encode anti-restriction mechanisms to 
directly block aspects of RM (Labrie, Samson and Moineau, 2010). To escape 
CRISPR, phage need to acquire point mutations in the region of their genome 
targeted by the bacteria’s spacer, which can be costly to the phage if the spacer 
targets an essential gene. However, a phage can become resistant to multiple 
CRISPR spacers by acquiring several point mutations, while it can only be re-
sistant to one RM diversity at a time. Therefore, if a RM shufflon can produce 
enough diversity, it may be a more effective means of limiting phage infections in 
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a bacterial population than CRISPR-Cas. However, costs of RM shufflons to bac-
teria need to be considered too. As RM systems cleave unmethylated DNA, a 
switch in DNA sequence specificity may be toxic as new recognition sequences 
will be unmethylated on host DNA. While several restriction alleviation mecha-
nisms exist (Murray, 2000), none are known in M. pulmonis. These speculative 
costs of switching specificity in shufflons may make CRISPR the more feasible 
immune system for population-level diversity and would help explain why RM 
shufflons are not more common throughout bacteria.  
In order to approach these evolutionary questions, we aim to set up an experi-
mental system to study phage-bacteria coevolution in presence of RM shufflons 
as well as interactions between RM and CRIPSR in the next chapter while also 
addressing RM costs. Encoding the Mpu shufflon on artificial gene constructs 
with fixed hsdS variants will allow us, in future, to generate a bacterial population 
with various RM specificities in a very controlled way.  
 
Methods 
REBASE analysis 
For an analysis of the presence of multiple hsdS genes in Type I RM systems, 
we downloaded all Type I RM genes from REBASE as of 22/9/16 (Roberts et al., 
2015). Genes on REBASE are listed under their systematic names; hsdR with a 
unique species/strain/gene identifier, e.g. EcoKI, hsdM with the prefix “M.”, e.g. 
M.EcoKI, and hsdS with the prefix “S.”, e.g. S.EcoKI. If more than one hsdS gene 
is present for an RM system, they are appended with the prefixes “S1.”, “S2.”, 
etc. We searched for genes starting with “M.” or “M1.” to return the number of 
methylases listed as an indication of number of unique RM systems. To deter-
mine the number of RM systems with >1 hsdS subunit, we searched for genes 
starting with “S2.” A search for genes beginning with “S3.” gave us those with >2 
hsdS subunits, and so on.  
 
hsdS sequences 
Nucleotide sequences for hsdS genes MpuUI-MpuUVIII were found on Genbank 
(Clark et al., 2016) under accession numbers AF076984 (MpuUI), AF076985 
(MpuUII), AF076986 (MpuUIII), AF076987 (MpuUIV), AF076988 (MpuUV), 
AF076989 (MpuUVI), and AF076990 (MpuUVIII). These sequenced were anno-
tated for vip and hrs sites, from which gene segments could be deduced. We 
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defined segments to split at the last two nucleotides of vip sites (5’-
CAAAGTGCAA-TA-3’), and immediately upstream of hrs sites. This ensures that 
gene segments can be seamlessly reshuffled in silico without changing the 
gene’s reading frame, even at gene segment junctions where vip and hrs sites 
overlap. 
Theoretical HsdS subunits were built by generating a database with hsdS gene 
segment sequences and the hsd loci architecture. Systematically, we simulated 
inversions between matching recombination sites. To verify in silico recombina-
tion, MpuU variants generated in silico were compared to reported subunits using 
BLAST (Altschul et al., 1990), and their sequence uniformity confirmed (100% 
identity).  
 
TRD mapping and protein models 
TRDs in MpuU proteins predicted by Sturrock and Dryden (1997) were mapped 
onto translations of in silico generated Mpu variants, obtained by ExPASy’s trans-
late tool (Artimo et al., 2012) and the nucleotide sequence coding for each TRD 
tracked back onto gene segments. The alignment between TRD1a and TRD2a 
was carried out with BLAST (Altschul et al., 1990). 
We produced protein fold models of HsdS variants with Phyre2 (Kelly et al., 2015) 
in normal modelling mode; to ensure that the entire amino acid chain was used 
to predict the model intensive modelling mode was used for MpuT2 and MpuT4. 
We coloured protein models according to gene segments and mapped point mu-
tations using UCSF Chimera (Pettersen et al., 2004). 
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Chapter III: Restriction-Modification in Pseudomonas 
aeruginosa  
 
Abstract 
Restriction-Modification (RM) is one of the most widespread bacterial immune 
mechanisms, but in many cases it is unclear what the costs and benefits of this 
system are. This is especially true for Type I RM shufflons, which rapidly recom-
bine their specificity subunit to generate a new sequence specificity. We gener-
ated synthetic gene constructs coding for the Mpu shufflon found in Mycoplasma 
pulmonis, and this shufflon was expressed in a Pseudomonas aeruginosa PA14 
strain lacking CRISPR-Cas to establish a model system for RM study. In un-
methylated hosts, introduction of this new RM system is toxic due to self-DNA 
cleavage. By initially transforming with an RM construct lacking hsdR (the re-
striction endonuclease) and later introducing the full RM system, this toxicity can 
be circumvented. Even though the Mpu RM proteins are active in P. aeruginosa, 
they only confer marginal levels of resistance against Pseudomonas phages 
JBD5 and Φ1214. This gives an indication how introduction of a novel RM system 
may be associated with greater costs than benefits. 
 
Introduction 
As one of the most widespread bacterial immune systems, Restriction-Modifica-
tion (RM) is crucial for interactions of many bacteria with bacteriophage (phage) 
and other mobile genetic elements. However, RM not only provides a benefit 
through cleaving phage, these systems also methylate the genomes of their bac-
terial hosts. In some cases, this is a means of gene regulation through methylome 
maintenance and the main function of the RM system (Ishikawa, Fukuda and 
Kobayashi, 2010), but in other cases methylation patterns could provide little or 
no benefit, or even be costly to a bacterium. Unexpected methylation patterns 
can cause pleiotropic costs which are more difficult to quantify. Furthermore, au-
toimmunity through self-cleavage can attribute an obvious cost to carrying a RM 
system. This trade-off between costs and benefits becomes especially pertinent 
when bacteria acquire a new RM system, which is when autoimmunity or altered 
methylation patterns new to that bacterium are most likely to have an effect.  
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The Mpu shufflon found in Mycoplasma pulmonis (Dybvig, Sitaraman and 
French, 1998) encodes a Type I Restriction-Modification (RM) system that rapidly 
recombines its specificity subunit, hsdS, as described in the previous chapter. In 
such a shufflon, hosts will constantly be exposed to novel sequence specificities 
and may therefore be subject to the same costs associated with introducing an 
entirely novel RM system.  
As an immune system, RM needs to distinguish between self and non-self DNA 
to only cleave invasive DNA. RM achieves this by methylating the bacterial chro-
mosome. In instances where this fails, the bacteria’s own genome can be cleaved 
through autoimmunity (Pleška et al., 2016), therefore ensuring genome methyla-
tion is crucial. Vertical maintenance of methylation within a bacterium and its 
daughter cells is fairly straightforward. Daughter cells’ DNA will be methylated on 
one DNA strand only, such hemimethylation can induce the methylase to meth-
ylate the opposing DNA strand in the same pattern (Vovis and Zinder, 1975). The 
issue of self-restriction becomes more difficult when RM systems get transferred 
horizontally, which has occurred extensively throughout evolution (Nobusato, 
Uchiyama and Kobayashi, 2000; Kobayashi, 2001). How, if it is in a new host, 
can a RM system distinguish between self and non-self DNA?  
There are several mechanisms of restriction alleviation (RA) for RM systems. 
Generally, RA causes a delay of restriction activity, leaving enough time for the 
methylase to methylate the bacterial genome. In some Type I RM systems, the 
protein complex itself causes this necessary lag by an unknown post-translational 
mechanism (Kulik and Bickle, 1996). In E. coli, hsdR has its own promoter, and 
in this way its activity can be regulated separately from hsdM and hsdS. However, 
this is not the case in Mycoplasma pulmonis, and currently there is no described 
mechanism of RA for its shufflon. Therefore, we cannot predict whether changing 
specificity in this shufflon will be associated with large autoimmune costs that 
require RA.  
To simulate the costs of autoimmunity that might be associated with the introduc-
tion of a new RM specificity, and also to investigate benefits in the form of phage 
resistance, we attempt to transfer the Mpu shufflon to Pseudomonas aeruginosa 
in this chapter. Additionally, this groundwork will establish a model system for 
further study of how bacterial populations with diverse RM specificities co-evolve 
with their phages, and allow investigation of the interplay between RM and 
CRISPR-Cas systems. To do this, we will design gene constructs to express the 
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Mycoplasma pulmonis Mpu shufflon, with fixed specificities, in P. aeruginosa 
PA14.  
 
Results & Discussion 
With the great evolutionary distance between P. aeruginosa and M. pulmonis, it 
is unlikely that PA14 has ever encountered the Mpu shufflon or a similar RM sys-
tem. Therefore, when transferring the shufflon into a P. aeruginosa host, we will 
likely see the full costs associated with a novel RM system. To investigate the 
extent of these, we generated a gene construct in silico that codes for one variant 
of this shufflon (Fig III/1a).  
This synthetic “SRM construct” was designed to code for the proteins HsdS (in 
the MpuUI conformation), HsdM1, and HsdR1 exactly as they are produced in M. 
pulmonis, but the genes themselves were separated and their codon usage opti-
mised for P. aeruginosa PA14. Restriction sites as well as predicted ribosome 
binding sites (RBS) within the genes were removed and an artificial T7 RBS, the 
same as found on expression vector pHERD-30T, introduced in the non-coding 
region preceding each gene. The hsdS gene was flanked by NcoI and KpnI re-
striction sites to allow modular exchange with constructs coding for alternative 
variants of HsdS. BamHI was introduced as a restriction site downstream of hsdM 
to allow insertion of the entire SRM construct into pHERD-30T 
(pHERD30T_SRM; Fig III/1b). In this way, the Mpu shufflon can be expressed 
from an arabinose-inducible promoter (Qiu et al., 2008) in P. aeruginosa PA14. 
Additional “S constructs”, coding for all other standard sized HsdS subunits 
(MpuUII-MpuUVI, MpuUVIII, MpuT9-MpuT11, MpuT19, MpuT22) were created in 
silico as above and flanked by NcoI and KpnI restriction sites. In future, synthe-
sising these S constructs on separate plasmids will allow for easy directed ex-
pression of specificity subunits when cloning a new hsdS gene into SRM-30T 
using the flanking restriction sites.  The main plasmids used throughout this study, 
pHERD30T_SRM and pHERD30T_SM, are summarised in Figure III/1c. We 
transformed P. aeruginosa PA14 lacZ::csy3 with these plasmids to generate RM 
transformant strains Csy3::Lacz pHERD30T_SRM and Csy3::LacZ 
pHERD30T_SM respectively. 
 
To understand if the RM system was functionally expressed, we tested the in vitro 
restriction abilities of Mpu shufflon proteins in lysate. Accordingly, we isolated  
 54 
genomic DNA (gDNA) from PA14 WT as well as Pseudomonas phage Φ1214 
and incubated it together with protein lysate obtained from Csy3::LacZ 
pHERD30T_SRM where RM expression had been induced by arabinose. Results 
show that SRM lysate induces cleavage of both PA14 WT and Φ1214 gDNA 
overnight (Fig III/2). The empty vector control as well as Csy3::LacZ 
pHERD30T_SM lysate do not induce DNA cleavage in the same timeframe. More 
efficient cleavage might have been achieved by using more concentrated reac-
tion buffer, or by optimising lysate extraction or restriction reactions.  These data 
demonstrate that the Mpu shufflon can be functionally expressed in P. aeruginosa  
hsdS1A hsdM1 hsdR1 hsdS1B 
8 nt overlap 3 nt gap 
Ribosome Bind-
ing Site 
ggatcc 
hsdS hsdM hsdR 
ggtacc ccatgg 
T7 Ribosome 
Binding Site 
Restriction 
Site araBAD 
Promoter 
pHERD30T_SRM 
ggatcc ggtacc ccatgg 
ggatcc ggtacc ccatgg 
pHERD30T_SM 
HsdR 
HsdM 
a 
b 
c 
HsdS 
Figure III/1. Synthetic gene constructs coding for the M. pulmonis Mpu shufflon. 
a Gene locus hsd1 as found on M. pulmonis in inverted orientation (Fig II/3b; Genbank 
acc. number L25415). b Genes were seperated and codon-optimised for P. aeruginosa 
PA14. Synthetic T7 ribosome binding sites and restriction sites were introduced be-
tween genes. Semi-transparent elements indicate the promoter and RBS found on the 
expression vector pHERD-30T. c Synthetic gene constructs (left, expression vector not 
shown) and their protein products (right). pHERD30T_SRM codes for the complete RM 
system with specificity subunit MpuUI, pHERD30T codes for HsdS (MpuUI) and HsdM. 
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from an expression plas-
mid, and how the RM pro-
teins show activity in this 
bacterial host. As ex-
pected, HsdR is an es-
sential component for 
DNA cleavage. Further-
more, MpuUI has the ca-
pacity to restrict Φ1214. 
Typical Type I RM DNA 
recognition sites contain 
three nucleotides, a 
stretch of unspecific nu-
cleotides, and another 
four specific nucleotides 
that are required to 
match. Therefore, in a 
random DNA sequence, 
we would expect one 
recognition site every 
16.4 kb. As two recognition sites are required for cleavage, we expect phages 
with a genome of over 33 kb to be targeted by Type I RM without knowing its 
recognition sequence. Φ1214 has one of the smallest genome sizes of phages 
used throughout this thesis (~37 kb, Table S2), therefore we can tentatively pre-
dict all Pseudomonas phages to be targeted by MpuUI. Additionally, as these 
results show that the Mpu RM system has the capacity to cleave unmethylated 
PA14 DNA, they suggest that an induction of RM expression may be toxic due to 
autoimmunity. 
To examine this hypothetical toxicity of RM we first compared the efficiency of 
transformation (EOT) of plasmids encoding the RM system to the EOT of the 
empty vector. Strikingly, EOT of pHERD30T_SRM, but not of the empty vector, 
is drastically decreased at 1% (w/v) arabinose, compared to transformations with-
out arabinose (Fig III/3). These data suggest that RM expression is toxic, pre-
sumably because the host DNA is cleaved by the novel RM system. We also 
observed that Csy3::LacZ pHERD30T_SRM strains grew very poorly on plates  
Figure III/2. pHERD30T_SRM lysate can cleave 
genomic DNA.  
Genomic DNA cleavage induced by protein lysate af-
ter overnight incubation at 37°C. a Cleavage of 1 μg 
PA14 WT gDNA with lysate isolated from 1-no-lysate 
control, 2-Csy3::LacZ pHERD30T, 3-Csy3::LacZ 
pHERD30T_SM, 4-Csy3::LacZ pHERD30T_SRM. 
Similar results were obtained in three experiments. 
b Cleavage of 300 ng Φ1214 gDNA with lysate iso-
lated from 1-Csy3::LacZ pHERD30T, 2-Csy3::LacZ 
pHERD30T_SRM.  
 56 
(not shown), further suggesting that RM expression resulted in cytotoxicity. To 
examine this in more detail, we measured Csy3::LacZ pHERD30T_SRM growth 
in the presence of arabinose over 16 hours by measurement of OD600. At both 
moderate (0.1% (w/v)) and high (1% (w/v)) arabinose concentrations, growth of 
bacteria transformed with pHERD30T_SRM was drastically reduced compared 
to those with empty vectors (Fig III/4). While growth for Csy3::LacZ 
pHERD30T_SM at 1% 
(w/v) arabinose is reduced 
compared to empty vector 
control bacteria, it is con-
siderably higher compared 
to pHERD30T_SRM trans-
formants and might merely 
be due to the cost of protein 
overproduction. Im-
portantly however, growth 
at 0.1% (w/v) arabinose for 
Csy3::LacZ 
pHERD30T_SRM is ex-
tremely limited, whereas it 
appears normal for 
pHERD30T_SM trans-
formants. This demon-
strates the toxicity of the re-
striction subunit HsdR. To-
gether with the EOT re-
sults, the above data indi-
cate that the transformation 
of this new RM system is 
toxic to Csy3::LacZ. 
 
To test whether Csy3::LacZ pHERD30T_SRM bacteria could adapt to their con-
structs, thus circumventing RM toxicity, we gradually  
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Figure III/3. pHERD30T_SRM reduces EOT in 
the presence of arabinose. 
Efficiency of Transformation (EOT) of Csy3::LacZ 
with pHERD30T_SRM or empty vector control 
was calculated by counting colonies on transfor-
mation plates, with colonies on 0% (w/v) arabi-
nose plates being set as 100%. Shown are means 
of 4-5 experiments with their standard error. Sig-
nificance tested by Wilcoxon-ranked sums for 
each treatment. *p<0.05 (p≈0.021); **p<0.01 
(p≈0.0075) 
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transferred these transformants to incrementally higher arabinose concentration 
in three replicates (Fig III/5a). When plating these Csy3::LacZ pHERD30T_SRM 
onto 1% (w/v) arabinose, we observed a considerably lower number of colonies 
compared to empty vector control in the early stages of this adaptation. In later 
Figure III/4. pHERD30T_SRM causes reduced growth in unmethylated strains.   
Culture density measurements as a proxy of bacterial growth at different arabinose 
concentrations over a course of 16 hours. All data points are shown. Ctrl: Csy3::LacZ 
pHERD30T, *p≈0.0034; SM: Csy3::LacZ pHERD30T_SM, ***p≈5x10-5; SRM: 
Csy3::LacZ pHERD30T_SRM (none previously induced), ***p<10-7; SRM (previously 
methylated): Csy3::LacZ where the genome was methylated before transformation 
with pHERD30T_SRM, **p≈0.0039. N=4, similar results were obtained for each strain 
in 2-3 additional experiments. P values refer to differences to 0% arabinose treat-
ment, see Methods.  
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stages of adaptation, the number of colonies of Csy3::LacZ pHERD30T_SRM on 
1% (w/v) arabinose rose to nearly 95% of colonies of empty vector controls trans-
ferred in the same way (Fig III/5b). This shows that Csy3::LacZ can become ac-
customed to SRM toxicity if it is incrementally adapted to high arabinose concen-
trations over four days. Additionally, to evaluate whether these adapted bacteria 
would show the same growth restrictions as un-adapted Csy3::LacZ 
pHERD30T_SRM, we measured their growth over 16 hours as before. Adapted 
Csy3::LacZ pHERD30T_SRM of all three replicates show growth curves indistin-
guishable from empty vector control bacteria with and without arabinose (Fig 
III/6). Together, these data suggest that by slowly increasing pHERD30T_SRM 
expression, RM toxicity can be circumvented.  
There are two plausible explanations for this alleviation of toxicity; either some 
form of RA occurred and Csy3::LacZ transformants successfully became meth-
ylated, or the construct was so toxic to bacteria that RM mutants were selected 
for. A loss of HsdS or HsdR function, or a complete loss of HsdM would result in 
a RM system unable to cleave DNA, and therefore alleviate toxicity. In order to 
resolve whether this alleviation of SRM toxicity was due to a loss of RM function, 
we tested infectivity of a range of phages on adapted Csy3::LacZ 
pHERD30T_SRM. In the three replicates the efficiency of plaquing (EOP) of 
phages used did not significantly differ from their EOP on empty vector control 
bacteria (Fig III/5c). This indicates that adapted pHERD30T_SRM does not con-
fer immune functions to PA14. Additionally, we determined EOTs for adapted 
pHERD30T_SRM constructs by isolating plasmid DNA from bacterial cultures af-
ter the four-day transfers. Two out of three replicates show a significantly higher 
EOT than ancestral pHERD30T_SRM at 1% (w/v) arabinose and are on par with 
the empty vector control (Fig III/5d). These data show that after undergoing ad-
aptation, the SRM construct has lost its properties. While the mean EOT for the 
final replicate (A) is also higher than EOT of ancestral pHERD30T_SRM, this 
difference is non-significant due to high variation. In summary, while construct 
toxicity is lost when adapting Csy3::LacZ pHERD30T_SRM to higher arabinose 
concentrations, this is due to loss of RM function rather than host DNA methyla-
tion. In order to determine which RM component mutates to make the immune 
system non-functional, we could in future studies isolate plasmid DNA from these 
strains for re-sequencing.  
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Figure III/5. Adaptation to high arabinose concentrations restores Csy3::LacZ 
pHERD30T_SRM viability but causes loss of RM function. 
a Csy3::LacZ pHERD30T_SRM (not previously induced) was transferred in three 
replicates with a daily increasing arabinose concentration and plated onto 1% (w/v) 
arabinose plates. b Colony forming units (CFU) relative to the control throughout the 
experiment. c Efficiency of Plaquing (EOP) as a measure of phage infectivity com-
pared to infection of an empty vector control. pHERD - control strain, not from exper-
iment. A, B, C - colonies from the three replicates at T4. ctrl - colony from control 
treatment at T4. N = 3. No significant differences to pHERD were detected. d Plasmid 
DNA extracted from cultures A, B, C, ctrl as described in (c) was used to transform 
Csy3::LacZ. Efficiency of Transformation (EOT) at 1% (w/v) arabinose was calcu-
lated relative to that of the respective plasmid at 0% (w/v) arabinose. SRM – ances-
tral pHERD30T_SRM isolated from E. coli. N = 2-5. b, c, d Shown are means with 
their respective standard errors. Significance was tested by analysis of variances 
and post-hoc Tukey’s multiple comparison of means. * statistically significant ((b) p 
≈ 0.034, (d) top to bottom: p ≈ 0.016, 0.0074, 0.027, n.s.: not significant 
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Therefore, to ensure methylation of Csy3::LacZ, we transformed cells with 
pHERD20S_SM, which confers streptomycin resistance and encodes HsdS and 
HsdM, but not HsdR. This incomplete RM system has the ability to methylate, but 
not to cleave DNA. pHERD20S_SM transformants were grown for 4 days in the 
SRM in  
Figure III/6. Arabinose-adapted unmethylated Csy3::LacZ pHERD30T_SRM do 
not show reduced growth.  
Culture density measurements as a proxy of bacterial growth at different arabinose 
concentrations over a course of 16 hours. All data points are shown. Strains shown 
are from adaptation experiment as detailed in Figure III/5 and were grown overnight 
without arabinose prior to this experiment. N = 4. ***p≈0.00027. P value refers to 
differences to 0% (w/v) arabinose treatment, see methods. All other differences are 
non-significant. 
✱✱✱ 
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presence of 0.2% (w/v) arabinose to ensure complete methylation, followed by 
transformation with pHERD30T_SRM. Transforming methylated Csy3::LacZ with 
SRM in this way returned a higher EOT than transformation of unmethylated 
Csy3::LacZ at moderate arabinose concentrations (0.1-0.2% (w/v)) (Fig III/7). 
 To determine whether 
induction of the RM sys-
tem bears the same 
costs as in unmethyl-
ated bacteria, we meas-
ured growth of premeth-
ylated 
pHERD30T_SRM 
transformants over 16 
hours. Premethylated 
Csy3::LacZ 
pHERD30T_SRM does 
not show the same lim-
ited growth as seen in 
unmethylated trans-
formants (Fig III/4 “pre-
viously methylated”). 
Together, these data 
show that premethylat-
ing the PA14 genome alleviates the toxicity of HsdR, presumably preventing self- 
DNA cleavage. In this way, the most drastic costs of carrying a novel RM system 
can be circumvented. This premethylation effectively simulates a lag before HsdR 
activity, which is the basis for various RA mechanisms (Prakash-Cheng and Ryu, 
1993; Kulik and Bickle, 1996; Makovets, Doronina and Murray, 1999). Therefore, 
we might speculate such a RA mechanism is in place in M. pulmonis to ensure 
that the shufflon can switch specificity without causing toxicity.  
In order to determine whether there are additional fitness costs associated with 
an established RM system, we directly compared growth of premethylated 
Csy3::LacZ pHERD30T_SRM with empty vector control at 0.1% (w/v) arabinose. 
Bacteria carrying the RM system grew slower, and reached a lower culture den-
sity after 16 hours (Fig III/8). This shows that even though initial RM toxicity can  
Figure III/7. Premethylation of Csy3::LacZ re-
stores EOT of pHERD30T_SRM at moderate arab-
inose concentrations.  
Efficiency of Transformation (EOT) of pHERD30T_ 
SRM at different arabinose concentrations for un-
methylated and premethylated (Csy3::LacZ 
pHERD20S_SM) bacteria. 100% EOT corresponds 
to colony forming units at 0% (w/v) arabinose, single 
replicate data shown. 
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be alleviated by premethylation, expressing RM proteins still bears a certain fit-
ness cost.  
Apart from these fitness 
costs, RM will also provide 
fitness benefits, such as 
phage resistance – for ex-
ample, Mycoplasma 
phage P1 infectivity in a 
strain expressing only 
MpuUI is 500 times lower 
than when it infects a non-
RM host (Dybvig, 
Sitaraman and French, 
1998). To examine 
whether RM with the same 
specificity provides similar 
fitness benefits in the con-
text of phage infection of P. 
aeruginosa, we exposed 
lawns of premethylated 
Csy3::LacZ 
pHERD30T_SRM trans-
formants to four different 
Pseudomonas phages 
(DMS3vir, Φ1214, JBD5, 
LUZ24; Table S2). Intri-
guingly, we observed vari-
ation in our phenotypes 
between independent transformants for reasons that are currently unclear. In four 
of seven transformants, we observed partial immunity against some phages, 
mostly Φ1214 and JBD5 (Fig III/9). Three transformants reduced the EOP of 
these phages to ~0.5 compared to their empty vector control (as in transformant 
A in Fig III/9; other two transformants not shown), a single transformant (B in Fig 
III/9) reduced Φ1214 and JBD5 EOPs to ~0.2-0.5 compared to its empty vector 
Figure III/8. Premethylated Csy3::LacZ pHERD_ 
30T grows slower than bacteria without RM sys-
tem.  
Growth of Csy3::LacZ transformants over 16 hours 
at 0.1% (w/v) arabinose, as in Fig III/4. All data points 
are shown, with their average as a black line. Ctrl – 
Csy3::LacZ pHERD30T, SRM (previously methyl-
ated) – Csy3::LacZ pHERD30T_SRM (premethyl-
ated). N = 4. Intrinsic growth rate r estimated using 
Growthcurver (Sprouffske and Wagner 2016) and 
found to be significantly different by a T-test; 
p=3.87x10-5. 
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control, and the final three transformants did not reduce phage EOPs (as in trans-
formant C in Fig III/9; other two transformants not shown). This shows that RM 
provides partial protection against phages Φ1214 and JBD5, but is not sufficient 
as a stand-alone immune system.  
This large discrepancy in phage restriction between MpuUI in P. aeruginosa 
(EOP=0.2-0.5) and MpuUI in M. pulmonis (EOP=0.002) could be due to several 
reasons. Firstly, M. pulmonis experiments were carried out with Mycoplasma 
phage P1. As we can see a difference in resistance levels to different Pseudo-
monas phages, phage P1 might simply have more RM recognition sites than any 
Pseudomonas phages trialled; restriction activity is known to be directly propor-
tional to the number of restriction sites on the target (Wilson and Murray, 1991). 
The Mpu shufflon evolved in the background of M. pulmonis, therefore it might 
be adapted to restrict Mycoplasma phages with high efficiency. Mycoplasma 
phage P1 has a genome far smaller than all Pseudomonas phages used in this 
thesis (11.6 kb vs. 36-48 kb). Most Type I RM systems can be predicted to cleave 
Figure III/9. pHERD30T_SRM confers low-level phage resistance to some 
premethylated Csy3::LacZ transformants. 
Efficiency of Plaquing (EOP) as a measure of phage infectivity. Phages were spotted 
onto lawns of premethylated Csy3::LacZ transformants (A, B, C) at varying arabinose 
concentrations, and their number of plaques relative to their empty vector control at 
0% (w/v) arabinose (not shown) recorded as EOP. Similar results as in A or C were 
obtained for two further strains each (not shown). Bars are means with standard er-
rors; N = 4. Significance was tested by analysis of variances and post-hoc Tukey’s 
multiple comparison of means. *p<0.05 (from left to right p≈0.013, p≈0.028, p≈0.014, 
p≈0.014, p≈0.035, p≈0.028); **p<0.01 (from left to right p≈0.0054, p≈0.005, 
p≈0.0053, p≈0.0044); ***p<0.001 (from left to right p≈0.0004, p≈3.3x10-5, p≈0.00034) 
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a random DNA sequence of at least 33 kb in length (see above), phage P1’s 
genome being considerably smaller may indicate that MpuUI targets conserved 
sequences that code for essential phage proteins. Alternatively, there might be 
as of yet undescribed Mycoplasma proteins that enhance activity of the RM sys-
tem in its native host that are absent in PA14. In order to confirm whether this 
discrepancy is due to a smaller number of recognition sites in Pseudomonas 
phages, future experiments could determine the MpuUI receognition site by 
Csy3::LacZ pHERD30T_SRM methylome analysis (e.g. by PacBio sequencing 
(Rhoads and Au, 2015)) and map these onto phage genomes. Generally, RM 
immunity observed against Pseudomonas phages remains very limited and can-
not be observed in all pHERD30T_SRM transformants. Nonetheless, the above 
experiments outlining in vitro activity, toxicity, and partial immunity together show 
that the Mycoplasma RM proteins can be active in PA14 and provide a basis for 
further investigations into RM effectivity, diversity, and interplay with CRISPR-
Cas. Together, these results indicate that RM might not provide a great benefit, 
but show how RM carries significant costs, especially when first induced in an 
unmethylated host.  
 
In summary, we found that introduction of the Mpu shufflon into CRISPR-KO P. 
aeruginosa is toxic. This toxicity can be circumvented by premethylation, where 
only the hsdS and hsdM subunits are introduced before transforming with the full 
RM system. These RM proteins are active within P. aeruginosa, and can cleave 
DNA in vitro as well as provide low-level phage resistance.  
It remains unclear how fitness benefits can outweigh costs for shufflons if chang-
ing RM specificity bears the same costs as introducing an entirely novel RM sys-
tem. M. pulmonis KD735-15, a strain without any active RM system, is referred 
to as “more stable” than M. pulmonis variants with RM activity (such as KD735-
16), meaning KD735-15 is less likely to recombine hsdS pseudogenes to acquire 
RM activity (Dybvig, Sitaraman and French, 1998). This might be due to toxicity 
of RM induction even in its native M. pulmonis. Together, this could indicate that 
acquiring an entirely new RM system is very costly (KD735-15 is stable and does 
not recombine often to express RM; our data show high toxicity when inducing 
RM for the first time in P. aeruginosa), but introducing new specificity subunits is 
less costly and can occur more readily (KD735-16 strains are heterogeneous, 
indicating high frequency of specificity switches (Dybvig, Sitaraman and French, 
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1998)). One mechanism for this alleviation of toxicity when switching specificities 
could be the presence of more HsdS subunits: when switching specificity, “old” 
HsdS proteins will remain in the cell until they are degraded, free to bind HsdM 
and HsdR. This means that HsdR is more likely to be bound to a subunit which 
recognises a methylated sequence (the “old” HsdS protein) than in a scenario in 
which a bacterium acquires a new RM system, in which no HsdS proteins would 
be present.  
In the future, we will be able to test this proposition by repeating the above ex-
periments and trial toxicity with Csy3::LacZ pHERD30T_SRM transformed with a 
different SRM vector encoding alternative hsdS subunits, simulating a recombi-
nation event. If the costs of new specificity subunits remain high, it would mean 
that there is probably an additional mechanism for RA in place in shufflon-encod-
ing bacteria.  
Additionally, it will be interesting to see whether the benefits of RM will increase 
when trialling the RM system with alternative hsdS subunits – perhaps other 
specificities will be better suited to recognise Pseudomonas phages than MpuUI, 
and lead to a more drastic drop in EOP. If this is the case, RM benefits might only 
outweigh its costs for certain hsdS conformations, which would indicate that M. 
pulmonis and other bacteria encoding RM shufflons might favour certain speci-
ficity variants over others when exposed to phage.  
 
Methods 
in silico construct building  
hsdS (MpuUI), hsdR, and hsdM sequences of hsd1 were found on Genbank 
(Clark et al., 2016) under accession number L25415 (Dybvig & Yu 1994). The 
genes were separated and gene sequences were codon optimised for Pseudo-
monas aeruginosa PA14 using OPTIMIZER (Puigbò et al., 2007). Where needed, 
unwanted restriction sites or predicted ribosome binding sites (RBS) within the 
optimised genes (identified using Prodigal (Hyatt et al., 2010)) were removed by 
changing affected codons to the codon with the highest usage in PA01. After 
optimisation, protein sequences were verified by comparing the translation of co-
don optimisation (achieved with ExPASY (Artimo et al., 2012)) with reported se-
quences using BLAST (Altschul et al., 1990).  
The T7 RBS together with surrounding nucleotides (32 nt stretch upstream of 
initiation codon) as found on pHERD-30T was introduced directly upstream of 
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each gene in non-coding regions. Further constructs were designed using DNA 
editing tools on Benchling (Benchling, 2015). For annotated sequences of all syn-
thetic gene constructs see the supplemental data section at the end of this thesis. 
 
Construct cloning 
Construct synthesis and plasmid creation 
The synthetic gene constructs were synthesised using ThermoFischer’s GeneArt 
service. The synthesised SRM construct was subcloned into Novagen’s pCDF-
1b using NcoI and BamHI restriction sites. Afterwards, the construct was cloned 
into pHERD-30T using NcoI and HindIII restriction sites, generating 
pHERD30T_SRM. pHERD30T_SM was created by amplifying pHERD30T_SRM 
using primers S-KpnI-bwd and M-KpnI-fwd (Table S1). The product was re-li-
gated, resulting in a deletion of hsdR. To generate pHERD20S_SM, hsdS and 
hsdM were removed from pHERD30T_SRM and inserted into pHERD-20T using 
NcoI and HindIII sites. Subsequently, the streptomycin resistance gene from 
pCDF-1b was cut out and inserted upstream of pHERD-20T’s multiple cloning 
site in a non-coding region using AgeI and SgrAI.  
Restriction 
NEB restriction enzymes NcoI-HF, KpnI-HF, BamHI-HF, HindIII-HF, SgrAI, and 
AgeI-HF were used as indicated. Approximately 1 μg of DNA was degraded in 
NEB CutSmart buffer using 10-20 U of each enzyme and topped up to a total 
reaction volume of 50 μl with nuclease-free distilled water. Restriction reactions 
were incubated at 37°C for 1-2 hours and successful restriction was verified by 
comparing to a no-restriction-enzyme control reaction under the same conditions 
using gel electrophoresis.  
Vector de-phosphorylation and gel extraction 
Without a clean-up of restriction reactions, restricted vectors were de-phosphor-
ylised in 60 μl volumes using 5 U of NEB Antarctic Phosphatase and its supplied 
buffer. De-phosphorylation reactions were carried out at 37°C for one hour. De-
sired restriction fragments were isolated using Qiagen’s Gel Extraction Kit per the 
manufacturer’s instructions.  
Plasmid ligation 
Desired fragments were inserted into the appropriate vectors in 20 μl reactions 
using 200 U of NEB T4 ligase and its supplied buffer. Amounts of vector and 
insert for ligation reactions were calculated using a ligation calculator tool by the 
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University of Düsseldorf (Insilico, 2017). Reactions were carried out for 10 
minutes at room temperature and, if no successful ligation occurred, at 4°C over-
night.  
Expression in E. coli, plasmid extraction, and cloning verification 
Ligated plasmids were expressed in NEB 5-α electrocompetent E. coli per the 
manufacturer’s instructions. Amplified plasmids were extracted from liquid cul-
tures derived from a single colony using ThermoFischer’s GeneJET Plasmid Min-
iprep Kit as per the manufacturer’s instructions. A successful cloning process was 
verified by restriction fragment analysis (restriction reactions as above followed 
by visualisation using gel electrophoresis) and by PCR or Sanger sequencing 
where appropriate.  
 
 
pHERD30T_SRM amplification 
SM was amplified using a high-fidelity recombinant Pfu polymerase from Thermo 
Scientific. The amplification reaction was carried out in a total volume of 50 μl 
with 2 ng template plasmid DNA, 1 μM of each primer, 0.2 μM of each dNTP, and 
2.5 U Pfu polymerase in the supplied buffer. The reaction was cycled as recom-
mended in Thermo Scientific’s documentation. Forward and reverse primers am-
plified SRM-30T in such a way that the entire plasmid bar most of the hsdR gene 
was copied, both primers contain KpnI restriction sites with an additional three-
nucleotide overhang (Table S1). Therefore, the PCR-product was digested and 
then ligated to be re-circularised as described above. 
 
In vitro analysis 
Pseudomonas transformation 
Pseudomonas aeruginosa PA14 strains were made electrocompetent by pellet-
ing 1-1.5 ml of an overnight culture in LB. The pellet was washed twice with 1 ml 
of a 300 mM sucrose solution, and resuspended in 100 μl sucrose.  
300-500 ng of plasmid DNA were added to the resuspended pellet and mixed by 
flicking. These were electroporated at 2.5 kV for 3-5 ms in 1 mm gap cuvettes. 
Immediately, 1 ml room temperature LB was added and the culture resuspended 
in this, taking care not to damage the cells. After a shaking incubation at 37°C for 
0.5 - 2 hours, 50 - 100 μl of undiluted cultures were plated onto LB with appropri-
ate antibiotics (50 µg/ml gentamycin or streptomycin) and incubated overnight at 
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37°C. Controls included cells transformed with H2O rather than DNA, resulting in 
no colonies on antibiotics plates.  
Protein lysate extraction 
Csy3::LacZ pHERD30T_SRM was grown overnight at 37°C in 15 ml LB + 50 
µg/ml gentamycin (GM50). Arabinose was added to a total concentration of 1% 
(w/v), and the bacteria were incubated at 28°C for 3 hours before being centri-
fuged (15 min, 3500 rpm). Culture pellets were resuspended in 10 ml Tris buffer 
(20 mM Tris, 150 mM NaCl, 1mM DTT). Resuspended pellets were sonicated (10 
second pulse/rest cycle) for 1-2 minutes and centrifuged. The supernatant was 
filtered through a 0.45 µm filter and the lysate stored at -80°C in 40% (w/v) Glyc-
erol. Lysate was extracted in two replicates. 
To restrict, 1 µg PA14 WT gDNA (extracted using QIAamp DNA Kit as per the 
manufacturer’s instructions) or 300 ng Φ1214 gDNA (sample kindly provided by 
Sean Meaden; extracted using Norgen Biotek phage DNA isolation kit as per the 
manufacturer’s intructions) was digested in 0.44 x TMD buffer (50 mM Tris, 10 
mM MgCl2, 1 mM DTT, pH = 8.0) together with 4mM ATP (pH = 7.0) using 5 µl 
of lysate (or H2O as control) in a total volume of 20 µl. The reaction was incubated 
at 37° overnight (~15 hours). 
DNA was separated using electrophoresis on a 1% (w/v) agarose gel and visual-
ised using RedSafe.  
 
Construct toxicity 
Growth curves 
Overnight cultures of bacteria as indicated were diluted 1:100 into LB + GM50 
containing 0%, 0.1%, and 1% (w/v) Arabinose. Diluted cultures were aliquoted 
into a 96-well plate with 4 replicates each. Overnight, a measurement was taken 
by a Biotek Synergy 2 plate reader, on a protocol that shook the plate at the 
setting “slow” at 37°C while taking an OD600 measurement of every well every 
10 minutes for 16 hours.   
Adaptation Experiment  
Csy3::LacZ pHERD30T_SRM cultures (not pre-exposed to arabinose) were 
grown in LB + GM50 overnight in three replicates (T0), and then transferred into 
LB + GM50 + 0.001% (w/v) arabinose (T1). T1 bacteria were grown overnight 
and then transferred into LB + GM50 + 0.01% (w/v) Arabinose (T2). In the same 
way, further timepoints included T3 at 0.1% (w/v) Arabinose and T4 at 1% (w/v) 
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Arabinose. As a control, Csy3::LacZ pHERD30T was transferred in the same 
way. Cultures of every timepoint were plated out onto LB + GM50 + 1% (w/v) 
arabinose in a 10-5 dilution. Colony forming units (CFU) were counted and the 
growth calculated by (CFU for Csy3::LacZ pHERD30T_SRM) / (CFU for 
Csy3::LacZ pHERD30T) at the respective timepoint (Fig III/5a). 
Csy3::LacZ was transformed with pHERD30T, ancestral  pHERD30T_SRM, or 
pHERD30T_SRM isolated from T4 cells in 4-5 replicates. The same transfor-
mation mixture was plated on LB + GM50 plates as well as on LB + GM50 + 1% 
(w/v) arabinose plates in equal volumes. Controls included H2O - transformed 
bacteria as well as transformants plated on LB. Colonies on all plates were 
counted. Efficiency of Transformation (EOT) was calculated as (number of colo-
nies on 1% (w/v) arabinose) / (number of colonies on 0% (w/v) arabinose). 
 
 
Phage infectivity 
Phage infectivity was measured by carrying out spot assays: Appropriate strains 
were grown overnight as indicated, then 300 - 600 μl of culture were mixed with 
12.5 ml LB broth containing 0.5% (w/v) Agar and antibiotics/arabinose as indi-
cated and plated onto a square plate with LB agar. Phages were diluted from 100 
- 10-7 in M9 salts (0.6% Na2HPO4∙7H2O, 0.3% KH2PO4, 0.05% NaCl, 0.1% NH4Cl; 
all w/v) and 5 μl of each dilution spotted onto bacterial lawns.  
After overnight incubation at 37°C, apparent titres could be calculated by counting 
plaques at appropriate dilutions. Efficiency of Plaquing (EOP) was calculated as 
a measure of phage infectivity by (titre on Csy3::LacZ pHERD30T_SRM strain) / 
(titre on empty vector control) as indicated. 
  
Statistical analyses 
Statistical analyses were carried out using R software (R Core Team, 2017), spe-
cific tests used for each experiment are highlighted in figure legends. For bacte-
rial growth curves (Figs III/4 and III/6), the package Growthcurver (Sprouffske 
and Wagner, 2016) was used to estimate various growth curve statistics. As a 
proxy for bacterial growth, carrying capacity k of bacterial growth at moderate 
(0.1% w/v) and high (1% w/v) arabinose concentrations for each strain was com-
pared to k for its respective growth in the absence of arabinose and their differ-
ence assessed with an analysis of variances and a Tukey’s post-hoc test. 
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Restriction-Modification and CRISPR act synergistically 
to provide high levels of phage resistance 
 
Abstract 
The interplay of the two most common bacterial immune systems, Restriction-
Modification (RM) and CRISPR-Cas remains insufficiently investigated. We 
transformed Pseudomonas aeruginosa PA14 with an artificially encoded RM sys-
tem to generate a strain with both a Type I-F CRISPR-Cas and a Type I RM 
system. Together, these immune systems provide complete resistance against 
all pilus-specific bacteriophages tested, and reduce infections of LPS-specific 
LMA2 by 2-3 orders of magnitude. Some transformants only show partial re-
sistance, perhaps due to incomplete RM expression. When transforming different 
CRISPR-knockout PA14 strains, resistance cannot be detected, indicating 
CRISPR-Cas is an essential component for this resistance. CRISPR spacer ac-
quisition can be detected after coevolution with DMS3vir, but it is unlikely that RM 
aiding spacer acquisition is the mechanism behind this resistance. More likely, 
RM methylation patterns regulate genes responsible for resistance in a CRISPR-
dependent manner, as the restriction endonuclease HsdR is not essential for the 
effect of joint resistance. As this model leaves some data unexplained, the mech-
anism of joint RM and CRISPR resistance remains to be investigated. 
 
Introduction  
Bacterial growth in many environments is limited by their natural predator, the 
bacteriophage (phage). Bacteria have evolved sophisticated defense mecha-
nisms against phage and other predatory genetic elements. Restriction-Modifica-
tion is a nearly ubiquitous (>90% of bacteria encode RM-systems (Stern and 
Sorek, 2011)) innate bacterial immune response that functions by self-recognition 
through methylation patterns and cleavage of non-self DNA, as discussed in de-
tail in the previous chapters. CRISPR-Cas (Clustered Regularly Interspaced 
Short Palindromic Repeats - CRISPR associated) on the other hand is a more 
recently discovered adaptive bacterial immune response, but is nonetheless 
common throughout bacteria as well as archaea (50 and 80% respectively 
(Grissa, Vergnaud and Pourcel, 2007b)).  
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CRISPR-Cas adaptation functions by integrating short segments of phage ge-
nome (protospacers) into the CRISPR locus as spacers (Modell, Jiang and 
Marraffini, 2017). In a process known as expression, these CRISPR loci are tran-
scribed as pre-CRISPR RNA (pre-crRNA) and processed into short crRNAs that 
are composed of a single spacer sequence flanked by partial repeats (Brouns et 
al., 2008). In type I CRISPR-Cas systems, these crRNA molecules act as a guide 
for target DNA recognition by the Cascade complex, which is a ribonucleoprotein 
complex comprised of several Cas proteins and crRNA (Makarova et al., 2015). 
Upon re-infection by the same phage, the Cascade complex specifically binds 
phage DNA through base-pairing between the crRNA and the protospacer se-
quence (Wiedenheft et al., 2011). Subsequent recruitment of the nuclease Cas3 
causes cleavage of the target DNA in a process known as CRISPR interference 
(Westra et al., 2012). Our model organism Pseudomonas aeruginosa PA14 pos-
sesses a Type I-F CRISPR-Cas system with two CRISPR loci, the second of 
which is highly active (Westra et al., 2015). Its Cas1 nuclease is active in the 
adaptation step, whilst Cas2 and Cas3 are fused (Makarova et al., 2015). For 
interference, Cas2-3 are recruited to the Cascade complex, which is formed by 
Csy1-4 and crRNA (Wiedenheft et al., 2011).  
To date, there have been limited investigations into the direct interplay between 
CRISPR-Cas and RM, even though they are often coexpressed in bacterial hosts. 
Immunity genes such as these tend to cluster in defense islands within the bac-
terial genome, which may be an indication of functional coupling (Makarova, Wolf 
and Koonin, 2013). In a Streptococcus thermophilus model, RM and CRISPR 
were shown to increase phage resistance when combined (Dupuis et al., 2013). 
Building on this study, it was found that the presence of defective phage particles 
aid in CRISPR spacer acquisition. RM-deactivated phage particles were most 
effective in promoting spacer acquisition, indicating there might be synergistic 
interactions (where the combinatory effect is greater than the sum of parts) be-
tween the two immune systems (Hynes, Villion and Moineau, 2014). In Entero-
coccus faecalis, CRISPR and RM form a non-synergistic barrier to horizontal 
gene transfer by plasmids (Price et al., 2016). All three studies described inter-
actions of a Type II RM and a Type II CRISPR-Cas system. Another level of 
complexity is added to this through gene regulation by methylation – RM systems 
can up- or downregulate genes due to their methylation activity, making it more 
 72 
difficult to tease apart mechanistic basis of synergistic effects (i.e. direct interac-
tions as opposed to gene regulatory epigenetic effects). Furthermore, in some 
cases CRISPR may play a role in gene regulation (Westra, Buckling and Fineran, 
2014).  
For the model organism P. aeruginosa PA14, bacteria-phage dynamics in the 
presence of CRISPR-Cas are well-investigated (van Houte et al., 2016). In the 
previous chapter, we established a model system to study CRISPR-RM dynamics 
by adapting a Type I RM shufflon found in Mycoplasma pulmonis for expression 
in PA14, and we further investigated bacteria-phage dynamics in the presence of 
RM but absence of CRISPR-Cas. Therefore, in this chapter we aim to investigate 
the interplay of the Mpu RM-system and a Type I-F CRISPR-Cas in a P. aeru-
ginosa host, and determine the combined effect of these immune systems on 
phage resistance. 
 
Results and Discussion 
Our RM system of choice is derived from a Type I RM shufflon found in M. pul-
monis, and was adapted for expression in PA14 by cloning the RM genes into an 
expression plasmid under control of an arabinose-inducible promoter (Table S1). 
Initially, we transformed PA14 WT with pHERD20S_SM (which encodes RM with-
out HsdR, ensuring restriction cannot occur) and induced construct expression 
with arabinose to achieve genome methylation. These strains were then trans-
formed with pHERD30T_SRM to introduce the entire RM system. We isolated 6 
premethylated transformants from two independent transformations (hereafter 
called WT pHERD30T_SRM A-F, or transformants A-F for brevity).  
 
Initially, we tested infectivity of pilus-specific Pseudomonas phages DMS3vir and 
JBD5, and of LPS-specific LMA2 against bacteria co-expressing CRISPR and 
RM (note that bacteria do not have a priori CRISPR resistance, i.e. bacteria lack 
CRISPR spacers targeting phages, but the presence of the CRISPR-Cas genes 
allows bacteria to acquire CRISPR-based phage resistance in response to infec-
tion). To these ends, we measured Efficiency of Plaquing (EOP) of these phages 
on lawns of WT pHERD30T_SRM transformants compared to empty vector con-
trols (which therefore express CRISPR but not RM) at 0.2% (w/v) arabinose in 5-
6 replicates. We found that all transformants show resistance against all phages 
with two distinct phenotypes of resistance (Fig IV/1a): Transformants B and E 
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were found to have a “partial-resistance” phenotype, in which LMA2 EOP were 
reduced by 1-2 orders of magnitude (EOP ~0.03-0.05) compared to the empty 
vector control. JBD5 and DMS3vir titres were difficult to count because plaques 
were faint, estimated EOPs for these phages were 2-3 orders of magnitude lower 
(EOP ~0.002-0.004) on transformants B and E compared to the control. All other 
WT pHERD30T_SRM transformants showed a “complete-resistance” phenotype, 
in which titres of DMS3vir and JBD5 on pHERD30T_SRM-transformed bacteria 
remained below the limit of detection (~200 pfu/ml). LMA2 retained the ability to 
infect these strains, albeit with an EOP reduced by 2-3 orders of magnitude com-
pared to the empty vector control (EOP ~0.005-0.007). Despite its infection only 
Fig IV/1 
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being partially blocked, LMA2 EOPs remained significantly higher on partial-re-
sistance WT pHERD30T_SRM transformants compared to complete-resistance 
transformants. These data reveal that co-expressed CRISPR-Cas and RM pro-
vide P. aeruginosa with phage resistance to a higher degree than from either 
CRISPR-Cas (empty vector control) or RM (Chapter III) alone. Additionally, this 
result uncovers a certain degree of variation in phage resistance (Fig IV/1a, Table 
IV/1 WT); perhaps the two transformants with partial resistance express their RM 
system at a lower level than transformants with complete resistance. Future re-
verse-transcription qPCR of hsd RNA in these transformants would help to con-
firm whether this is the case. Furthermore, JBD5 encodes anti-CRISPR (Acr) pro-
teins that block Type I-E as well as Type I-F systems (Pawluk et al., 2014), there-
fore WT pHERD30T_SRM resistance against this phage indicates that resistance 
is not mediated through a classical CRISPR immune response.  
 
Figure IV/1. Coexpression of CRISPR and RM leads to phage resistance. 
Efficiency of plaquing (EOP) of DMS3vir, JBD5, and LMA2 on lawns of PA14 WT (a) 
and CRISPR-knockout (b) pHERD30T_SRM transformants compared to their re-
spective empty vector controls (black line at EOP=1). Bars represent means and 
their standard error, N=5-6. Bars extending downwards signify EOP below the limit 
of detection. a Most transformants (A, C, D, F) have a “complete-resistance” pheno-
type and are completely resistant against DMS3vir and JBD5. Transformants B and 
E have a “partial-resistance” phenotype and are partially resistant against all phages 
tested. * p<0.05. Significance tested with analysis of variances and post-hoc Tukey’s 
HSD. EOPs of LMA2 on B and E are significantly higher than EOPs on A, C, D, F 
(difference between A and E is nonsignificant at p≈0.068, between E and F is non-
significant at p≈0.052. B-A p≈0.0095, B-C p≈0.0040, B-D p≈0.0040, B-F p≈0.0070, 
E-C p≈0.031, E-D p≈0.031). b No CRISPR-knockout transformant has a complete-
resistance phenotype. EOP on most transformants does not change compared to 
their empty vector control, ΔCRISPR1,2 and ΔCsy2 show levels of resistance similar 
to partial-resistance phenotype transformants in (a). Missing values for trans-
formants C of ΔCsy2 and Csy3::LacZ are due to bacterial lawns too faint to enumer-
ate plaques, their phenotype is scored in Table IV/1. 
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To further explore this question, we first examined whether all components of the 
CRISPR-Cas immune response are essential to this synergistic resistance phe-
notype of CRISPR-Cas and RM. We transformed several PA14 CRISPR knock-
out strains (ΔCRISPR1,2, ΔCRISPR/Cas, ΔCas1, ΔCas3, ΔCsy1, ΔCsy2, 
Csy3::LacZ, and ΔCsy4) with pHERD30T_SRM (by first premethylating strains 
with pHERD20S_SM as described previously) and isolated three transformants 
from each transformation. EOP of DMS3vir, JBD5, and LMA2 compared to their 
infectivity on a corresponding empty-vector control was determined at 0.2% (w/v) 
arabinose in 5-6 replicates for each transformant. Strikingly, nearly all CRISPR-
mutants that were transformed with the RM system were susceptible to phage 
and show levels of infection similar to their empty vector controls (Fig IV/1b). 
Strain Transformant 
WT A B C D E F 
ΔCR/Cas A B C    
ΔCRISPR1,2 A B C 
 
 
ΔCas1 A B C 
 
 
ΔCas3 A B C 
 
 
ΔCsy1 A B C 
 
 
ΔCsy2 A B C 
 
 
Csy3::LacZ A B C 
 
 
ΔCsy4 A B C  
All three ΔCRISPR1/2 pHERD30T_SRM transformants (lacking both CRISPR 
loci) as well as ΔCsy2 pHERD30T_SRM A showed more phage resistance than 
their empty vector control, in a pattern reminiscent of the partial-resistance phe-
notype observed in WT transformants. In summary, these data clearly indicate 
that presence of all CRISPR-Cas components is necessary for the complete-re-
sistance phenotype.  
Table IV/1. Phenotypes of pHERD30T_SRM transformants. 
pHERD30T_SRM transformants of several PA14 strains were tested for re-
sistance to DMS3vir, JBD5, and LMA2. Green-susceptible (only low-level or no 
resistance to any phage), Orange-“partial-resistance” phenotype (partially re-
sistant, decreasing EOPs to ~0.001-0.002 for DMS3vir and JBD5 and to ~0.008-
0.05 for LMA2), Red-Complete-resistance phenotype (entirely resistant to 
DMS3vir and JBD5, decreasing LMA2 EOP to ~0.01). Phenotypes were deter-
mined by spot assays, N = 5-6 per phage. See text for more detailed description 
of phenotypes.  
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As before, some transformants showed a partial-resistance phenotype, including 
transformants of PA14 mutants that lack both CRISPR loci or the Csy2 gene (Ta-
ble IV/1, Figure IV/1b). We believe that this variation in the levels of resistance is 
likely due to variation in RM expression levels between different transformants. 
Perhaps partial resistance is observed when the MpuUI RM system is fully func-
tional, and full sensitivity is observed when mutations are acquired in the RM 
genes, which we demonstrated can be rapidly selected for because of the large 
fitness costs of RM (see Chapter 3). This could indicate that constraints of suc-
cessfully introducing a functional RM system are larger than assumed in the pre-
vious chapter. Therefore, future experiments should examine in more detail 
whether CRISPR-knockout pHERD30T_SRM transformants without any appar-
ent resistance encode functional RM systems. This could for example be done 
by sequencing pHERD30T_SRM isolated from CRISPR-knockout transformants. 
Alternatively, we could test the RM activity of isolated pHERD30T_SRM in vitro 
using the assays described in Chapter 3 (see Fig. III/2) as well as in vivo (by 
transforming strains with plasmids containing MpuUI’s recognition sites, which 
are yet to be identified (see Chapter 3)). Transformants of each CRISPR mutant 
were isolated from the same transformed population, therefore transformants are 
likely to be genetically identical, hence explaining why replicate transformants of 
the same mutant all have the same resistance phenotype (with few exceptions). 
Collectively, the data above are consistent with the idea that the full resistance 
phenotype is due to a CRISPR-mediated immune response that is facilitated by 
the presence of the RM system. However, as mentioned above, this appears in-
consistent with the fact that one of the phages encodes an Acr, which would be 
expected to reduce or eliminate such a CRISPR-dependent synergistic effect on 
phage resistance.  
 
To probe this in more detail, we directly measured the evolution of CRISPR-
mediated resistance in bacteria encoding both CRIPSR and RM, and in bacteria 
encoding CRISPR only. A previous study suggested that synergistic resistance 
of RM and CRISPR-Cas may be due to RM enhancing spacer acquisition (Hynes, 
Villion and Moineau, 2014), and observing a lack of phage resistance in ΔCas1 
pHERD30T_SRM transformants (Cas1 is the nuclease responsible for spacer 
acquisition; Fig IV/1b) may corroborate this hypothesis. Therefore, we allowed 
WT pHERD30T_SRM transformants to evolve together with DMS3vir or JBD5 to 
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transformants as well as a no-phage control for all treatments. Every day, the 
growing cultures were transferred into fresh LB + 50 µg/ml gentamycin (GM50) + 
0.2% (w/v) arabinose medium, and 109 pfu phage were added, giving us an initial 
MOI (multiplicity of infection) of ~20. As expected, we could not detect any spacer 
acquisition after three days in any of the control treatments (in LB and with a high 
MOI, CRISPR-mediated resistance does not evolve (Westra et al., 2015)). In the  
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Figure IV/2. RM expression can promote CRISPR spacer acquisition. 
a Representation of 3-day bacterial evolution together with DMS3vir. Strains were 
transferred into fresh medium daily and 109 DMS3vir or JBD5 (not shown) added with 
each transfer. Additional controls (not shown) included Csy3::LacZ pHERD30T_SRM 
and empty vector transformants, as well as a no-phage control for each treatment. 
Colours represent phenotypes. Red: complete-resistance, orange: partial-resistance, 
green: susceptible (Table IV/1). WT SRM – WT pHERD30T_SRM transformant; ctrl 
– WT pHERD30T empty vector control. b After 3 days, spacer acquisition was sur-
veyed in all treatments and replicates by PCR of CRISPR loci. Only WT SRM B 
showed spacer acquisition (10/21 clones screened had acquired a spacer in 
CRISPR2), shown is a representative image of a 2% (w/v) agarose gel.  
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only instance where spacer acquisition was observed, we found that nearly half 
(10/21) of clones of WT pHERD30T_SRM B treated with DMS3vir had acquired 
a spacer in the CRISPR2 locus (Fig IV/2). These data show that the co-expres-
sion of CRISPR-Cas and RM can promote CRISPR spacer acquisition. However, 
as this was only observed in one transformant with a partial-resistance pheno-
type, enhanced spacer acquisition cannot explain the complete-resistance phe-
notype seen in most transformants.  
Therefore, we hypothesised that complete-resistance phenotypes observed may 
be due to gene regulatory effects of RM and CRISPR coexpression. In particular, 
the combined activity of these immune systems may cause downregulation of the 
pilus, because we observed higher resistance of WT pHERD30T_SRM trans-
formants against pilus-specific phages than against LMA2.  
 
To examine whether the mechanism of RM-CRISPR synergistic resistance may 
be pilus downregulation, we investigated bacterial streaks of WT 
pHERD30T_SRM A for a visible change in phenotype, as can readily be ob-
served for pilus mutants of PA14 which causes a small colony morphology 
(Westra et al., 2015). We found that streaks for both WT pHERD30T_SRM as 
well as WT pHERD30T_SM resembled pilus mutants of PA14, whilst the mor-
phology of empty vector and CRISPR-knockout (Csy3::LacZ) controls resembled 
that of untransformed PA14 Csy3::LacZ (Fig IV/3a). These data confirm that co-
expression of RM and CRISPR could cause loss of pilus, resulting in resistance 
to pilus-specific phages. Intriguingly, RM causes a change in morphology in the 
WT PA14 strain even in the absence of the HsdR gene (WT pHERD30T_SM). 
This indicates that resistance may be dependent on methylation rather than re-
striction activity, which is consistent with RM regulating gene expression. Further-
more, these data suggest that the resistance phenotype is constitutively ex-
pressed, since the altered colony morphology was also observed in absence of 
phage.  
To further explore putative pilus loss, we assayed phage adsorption which would 
be predicted to be reduced when bacteria have a lower pilus expression. To these 
means, we infected WT pHERD30T_SRM, WT pHERD30T_SM, and an empty-
vector control with Φ1214 and determined the titre of phage in free solution after 
eight minutes of incubation for an estimate of percentage of phage bound to bac-
teria. As an additional control, we incubated phage in the absence of bacteria.  
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We found that WT pHERD30T_SRM A showed a significant reduction in phage 
adsorption compared to the empty vector control (p ≈ 0.013; Fig IV/3b). There-
fore, these results further corroborate the hypothesis that RM and CRISPR-Cas 
coexpression induces phage resistance through loss of the pilus. As the syner-
gistic resistance effect of CRISPR and RM may be possible without HsdR (Fig 
IV/3a WT pHERD30T_SM), perhaps resistance is due to CRISPR-dependent RM 
gene regulation through methylation. 
a 
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Figure IV/3. WT pHERD30T_SRM transformants resemble surface mutants.  
a Streaks of different transformants. Untransformed WT, Csy3::LacZ, and PA14 Δpi-
lus (pilus mutant) were streaked onto LB; all other strains onto LB + GM50 + 0.2% 
(w/v) arabinose and incubated for ~24 hours b Phage adsorption assay. Φ1214 was 
extracted after incubation with different WT transformants for 8 minutes. Percentage 
of phage bound to cells was calculated by comparing extracted phage titres with titres 
of phage initially added. Bars show means with their standard error; n = 3. SRM: WT 
pHERD30T_SRM, SM: WT pHERD30T_SM, ev: WT pHERD30T, ctrl: no-bacteria 
control. Significance tested by T-test of means between SRM and ev, *p<0.05 
(p≈0.013) 
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To confirm whether the complete-resistance phenotype can be observed in ab-
sence of HsdR, we tested infectivity of an assortment of phages (DMS3vir, 
Φ1214, JBD5, LUZ24, Φ68, JBD18, and JBD25) on lawns of WT pHERD20S_SM 
and WT pHERD30T_SRM A. As controls, we infected untransformed and empty 
vector control bacteria as well as the corresponding CRISPR-knockout 
Csy3::LacZ pHERD30T_SRM and pHERD20S_SM transformants. We found 
that, while control bacteria showed similar levels of infection with relatively small 
variations (not shown), EOP on both WT pHERD30T_SRM and WT 
pHERD20S_SM was below the limit of detection (~ 200 pfu/ml; Fig IV/4) for all 
Pseudomonas phages tested. This resistance was very consistently observed in 
more than five repeat experiments, and no phage infections could be observed 
when testing infectivity with plaque assays (not shown) which have a lower limit 
of detection of ~100 pfu/ml. These data confirm that HsdR is not an essential 
component for the complete-resistance phenotype, which may therefore be 
caused by methylation patterns. Additionally, the repertoire of phages against 
which P. aeruginosa can become entirely resistant is expanded by Φ1214, 
LUZ24, Φ68, JBD18, and JBD25, all of which are known to bind to P. aeru-
ginosa’s pilus (LUZ24’s receptor is unknown, but experiments in our lab show 
that it cannot infect a PA14 surface mutant lacking the pilus). 
 
Figure IV/4. HsdR is not essential for synergistic RM and CRISPR resistance. 
Spot assays of phage infecting lawns of PA14 WT transformants. Phage infection re-
mains entirely under the level of detection for WT RM-transformants. Pictures of rep-
resentative spot assays at 0.2% (w/v) arabinose comparing empty vector control to 
pHERD30T_SRM/pHERD30T_SM transformants. Phages from left-right: DMS3vir, 
Φ1214, JBD5, LUZ24, Φ68, JBD18. Identical results were obtained in at least 4 repeat 
experiments and with phage JBD25. 
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In our model for CRISPR- and RM-dependent downregulation of pilus expres-
sion, RM methylates the CRISPR locus, enhancing its expression and constitu-
tively activating it. In turn, activated Cas proteins will use crRNA derived from pre-
existing spacers as guides to its own genome. With a partial match between 
crRNA and genome, CRISPR-Cas can have gene-regulatory rather than nucleo-
lytic activities (Zegans et al., 2009; Westra, Buckling and Fineran, 2014). There-
fore, to test whether there is capacity for pilus gene regulation through CRISPR-
Cas to occur, we analysed the PA14 genome for partial matches to spacers pre-
sent in either PA14 CRISPR locus. For more relevant matches, we restricted the 
search to sequences that exactly match the spacers’ seed sequence and found 
27 partial matches across the PA14 genome. Three matches additionally fulfilled 
PAM (proto-spacer adjacent motif) requirements to be targeted by CRISPR (Ta-
ble IV/2a). These include a hypothetical protein with unknown function, an auto-
transporter domain-containing esterase, and serB, a gene coding for a phos-
phoserine phosphatase that plays a role in serine biosynthesis. When removing 
the restriction for PAM complementarity, other metabolic genes and some DNA 
binding proteins can be targeted, too (Table IV/2b). In conclusion, while CRISPR 
cannot directly target a sequence in or near a pilus gene to regulate its expres-
sion, there are other viable targets present that might affect pilus expression fur-
ther downstream. To identify whether this is the case, we would have to investi-
gate whether a knockout or overexpression of serB or other targets can modulate 
pilus expression. Furthermore, we would have to find the recognition sequence 
of MpuUI to determine whether RM can enhance CRISPR expression in the first 
place.  
During the above bioinformatics analyses, we also identified a partial match 
within hsdR on pHERD30T_SRM to CRISPR spacer 2.18 (match fulfils seed re-
striction, but not PAM; not shown) that may enable CRISPR to modulate hsdR 
expression, which could result in lower toxicity of RM induction in a host express-
ing CRISPR than observed in CRISPR-deficient hosts in the previous chapter. 
Therefore, we investigated toxicity of pHERD30T_SRM to unmethylated WT 
transformants to determine whether induction of a novel RM system is associated 
with the same toxicity as in a CRISPR-knockout background. To these means, 
we tracked growth of unmethylated WT pHERD30T_SRM and WT 
pHERD30T_SM while inducing RM expression with arabinose. While RM induc-
tion limited WT pHERD30T_SRM growth compared to its empty vector control to  
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a Partial matches in PA14 genome fulfilling seed and PAM restrictions 
Spacer Match  Gene Product 
2.21 6026892-
6026878 
PA14_RS27540 autotransporter domain-containing ester-
ase  
1.2 3729879-
3729853 
PA14_RS16950 Hypothetical protein 
1.2 5840199-
5840175 
serB Phosphoserine phosphatase 
b Partial matches in PA14 genome fulfilling only seed restriction 
2.2 5881986-
5881959 
PA14_RS26955 acyl-CoA dehydrogenase 
2.18 1461715-
1461689 
PA14_RS06835 Bifunctional uridylyltransferase/uridylyl-re-
moving protein 
1.2 3207203-
3207176 
PA14_RS14650 MCE family protein 
1.2 5533142-
5533115 
PA14_RS25340 MCE family protein 
1.2 5451699-
5451670 
PA14_RS24975 hypothetical protein 
1.2 3365462-
3365486 
PA14_RS15350 carbamoyltransferase 
2.6 4454017-
4454038 
PA14_RS20355 flagellar assembly protein FliH. Partial 
match sequence is 98nt upstream of fliI (a 
flagellum-specific ATP synthase). 
2.6 567437-
567409 
PA14_RS02600 allophanate hydrolase 
2.17 1091372-
1091396 
PA14_RS05130 cysteine hydrolase 
2.17 5174166-
5174141 
PA14_RS23705 septum formation inhibitor Maf 
2.17 4784617-
4784599 
acnD Fe/S dependent 2-methylisocitrate dehy-
dratase 
2.4 108344-
108372 
clpV type VI secretion ATPase 
2.6 4148640-
4148664 
PA14_RS18920 AcrB/AcrD/AcrF family protein – trans-
porter for acriflavin resistance 
2.15 367555-
367581 
PA14_RS01670 amino acid ABC transporter permease 
2.20 1770525-
1770505 
PA14_RS08260 ATP-dependent Clp protease ATP-binding 
subunit 
1.2 6290248-
6290234 
PA14_RS28750 DNA-binding protein HU-alpha 
2.17 6288448-
6288430 
PA14_RS28740 hypothetical protein 
2.16 613388-
613412 
PA14_RS02845 reductase 
2.6 2706841-
2706859 
PA14_RS12735 DNA-binding protein 
2.18 484064-
484082 
PA14_RS02230 amine oxidase 
2.8 6245496-
6245512 
PA14_RS28535 D-amino acid dehydrogenase small subu-
nit 
2.16 1580314-
1580336 
PA14_RS07385 alginate O-acetyltransferase 
2.16 6100958-
6100942 
cysQ 3’(2’),5’-bisphosphate nucleotidase (sulfate 
assimilation, phosphatidylinositol phos-
phorylation) 
2.16 6463649-
6463631 
PA14_RS29530 Ribonucleoside-diphosphate reductase, 
adenosylcobalamin-dependent 
 
 
 
Table IV/2. Partial matches of CRISPR spacers with PA14 genome. 
Spacer: [CRISPR locus].[spacer number]; Match: position of match in PA14 ge-
nome (NC_008463.1). Matches sorted from strongest to weakest. 
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a certain extent (Fig IV/5a), this was not as drastic at intermediate arabinose con-
centrations (0.1% (w/v)) as previously observed for Csy3::LacZ 
pHERD30T_SRM (Fig III/4), indicating that CRISPR-Cas may help to alleviate 
the cost of RM expression. Additionally, to determine whether unmethylated WT 
pHERD30T_SRM could adopt the same phenotype as premethylated WT 
pHERD30T_SRM in the presence of arabinose, we transferred WT SRM trans-
formants into fresh medium containing 1% (w/v) arabinose daily. Each day, we 
evaluated whether the bacteria had acquired the resistance phenotype of WT 
pHERD30T_SRM transformants (Fig IV/1a) by performing plaque assays with 
DMS3vir. After three days, one of three replicates became entirely resistant to 
DMS3vir; both other replicates remained susceptible even after an additional 
transfer (Fig IV/5b). This result suggests that an RM system can become estab-
lished without premethylation in WT bacteria when exposed to high arabinose 
concentrations. Unexpectedly, this occurs without a loss of RM function (which 
we observed in Csy3::LacZ bacteria; Fig III/5) in some cases. Together, these 
Figure IV/5. Novel RM induction seems less toxic when 
CRISPR is expressed. 
a Growth of WT transformants as indicated by culture density 
measurements at different arabinose concentrations tracked 
over a course of 16 hours. All data points are shown. N=4. From 
left to right: ***p=1.26x10-5, p=1.2x10-6, p=4.51x10-5. P-values 
refer to differences to 0% (w/v) arabinose treatment, see Meth-
ods. b Unmethylated WT pHERD30T was transferred in 1% 
(w/v) arabinose medium over 4 days in 3 replicates. For T2-4, 
phage resistance phenotype was tested by infecting a lawn with 
DMS3vir. Green: phage susceptible, red: phage resistant. 
These results show less RM toxicity than observed for 
Csy3::LacZ (Fig III/4-5). 
b 
a
 
✱✱✱ 
 
✱✱✱ 
 
✱✱✱ 
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data suggest that toxicity of inducing a novel RM system is considerably lower 
when a functional CRISPR-Cas system is present, which is perhaps due to HsdR 
downregulation by a partial match between a CRISPR spacer and hsdR. For con-
firmation of this putative downregulation, it would be interesting to extract lysate 
from WT pHERD30T_SRM and compare it to lysate extracted from Csy3::LacZ 
pHERD30T_SRM strains in order to confirm whether HsdR is present at lower 
levels in WT transformants. Additionally, we suggest that more extensive anal-
yses be carried out to determine whether toxicity is unique to Csy3::LacZ trans-
formants or can be found in all strains lacking CRISPR. 
 
Overall, our data leaves no doubt that there is a joint effect of CRISPR and RM 
on phage resistance in our model system. Most PA14 transformants expressing 
both CRISPR and RM show complete resistance against all pilus-specific phages 
and partial resistance against LPS-specfic LMA2, reducing its titres by 1-2 orders 
of magnitude. While all Cas proteins seem to be essential for this effect, re-
sistance can be observed if HsdR is not expressed. This led us to believe that 
RM methylation patterns may lead to constitutive activation of CRISPR-cas loci, 
in turn altering downstream gene expression and ultimately leading to a lack of 
pilus expression. As aspects of our data remain unexplained by this model, future 
studies will be needed to shed light on the mechanistic basis of RM and CRISPR 
synergy in this model system. 
 
 
Methods 
Transformation of WT and CRISPR-knockout strains 
Transformations were carried out as described in Chapter III. To generate 
premethylated RM-transformants, strains were initially transformed with 
pHERD20S_SM and grown in LB + 50 µg/ml streptomycin + 0.2% (w/v) arabinose 
over 3 daily transfers to ensure complete methylation of the bacterial genome. 
Afterwards, these strains were transformed with pHERD30T_SRM and hence-
forth grown in LB + GM50 + 0.2% (w/v) arabinose. As empty vector control, 
pHERD-30T was used for pHERD30T_SRM and pHERD30T_SM, and pCDF-1b 
for pHERD20S_SM constructs. 
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Resistance phenotype determination 
Strains were grown overnight as indicated, then 300 - 600 μl of culture was mixed 
with 12.5 ml LB broth containing 0.5% (w/v) agar with 0.2% (w/v) arabinose and 
appropriate antibiotics, and plated onto a square plate of LB agar. Phage were 
diluted from 100 - 10-7 in M9 salts (0.6% Na2HPO4∙7H2O, 0.3% KH2PO4, 0.05% 
NaCl, 0.1% NH4Cl; all w/v) and 5 μl of each dilution were spotted onto bacterial 
lawns. After overnight incubation at 37°C, apparent titres could be calculated by 
counting plaques at appropriate dilutions. EOP was calculated as a measure of 
phage infectivity by (titre on pHERD30T_SRM strain) / (titre on empty vector con-
trol) as indicated. Similarly, for plaque assays 150 µl of overnight culture was 
mixed with 10 µl phage stock and 4 ml LB broth containing 0.5% (w/v) agar and 
antibiotics/arabinose as indicated; this was plated onto LB agar and incubated 
overnight at 37°C. Strains that showed levels of phage infection similar to empty 
vector control were scored as “susceptible”, and strains on which phage cannot 
plaque were scored as “resistance phenotype”.  
 
Bacterial morphology 
To investigate bacterial morphology, we streaked overnight cultures of different 
strains onto LB or LB + GM50 + 0.2% (w/v) arabinose and incubated these at 
37°C for ~24 hours. Morphology was visually scored by similarity to controls as 
shown in Fig IV/3a.  
Phage adsorption assays were carried out similar to a previously described pro-
tocol (Chibeu et al., 2009). Overnight strains were diluted 1:100 in LB + 10 mM 
MgSO4 + GM50 + 0.2% (w/v) arabinose and grown to mid-log phase for 2.5-3 h 
at 37°C. Pellets were gathered by centrifugation (15 min, 3500 rpm), washed in 
the same medium and resuspended to an OD600 of 2.0 to generate cultures of 
~3x107 cfu/ml. 0.1 ml of these suspensions (or 0.1 ml medium for no-bacteria 
control) were mixed with 0.9 ml LB + 10 mM MgSO4 + GM50 + 0.2% (w/v) arab-
inose containing ~3x104 pfu/ml of Φ1214 in three replicates, resulting in an MOI 
of 0.001. The mixes were incubated at 37°C for 8 minutes, after which cells were 
removed by centrifugation (14700 rpm for 5 min at 4°C), and 960 μl of superna-
tant was treated with chloroform (1:10, followed by centrifugation at 3500 rpm for 
20 min at 4°C and filter-sterilisation of the supernatant) and spotted onto a lawn 
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of Csy3::LacZ in an M9 dilution series to determine the unbound phage titre. Per-
centage of bound phage was calculated as (3 x 104 - titre of unbound phage)/(3 
x 104). 
 
WT pHERD30T_SRM transfers, growth curves 
Three transformants of WT pHERD30T_SRM were transferred into fresh medium 
(LB + GM50 + arabinose as indicated) daily. Samples of each timepoint, including 
T0, were frozen at -80°C in 20% (w/v) glycerol. At timepoints 2, 3, and 4, infectivity 
of ~ 2 x 107 pfu DMS3vir was tested on lawns containing 150 μl bacteria of each 
replicate. After an overnight incubation at 37°C, bacterial phenotype was visually 
determined: plates with a smooth bacterial lawn without plaques indicated a re-
sistance phenotype, while normal phenotype plates showed hardly any bacterial 
growth.  
Growth of WT transformants was measured as described in chapter III. 
 
WT pHERD30T_SRM evolution 
Six pHERD30T_SRM transformants (A-F) and WT pHERD-30T were incubated 
together with DMS3vir, JBD5 (MOI ~20) or LB medium (in an equal volume to 
phage added as a no-phage control) at 37°C, and 50 μl of these cultures were 
transferred into fresh medium (LB + GM50 + 0.2% (w/v) arabinose) daily. Addi-
tional controls included Csy3::LacZ pHERD30T_SRM and Csy3::LacZ 
pHERD30T. With each transfer, an additional 109 pfu of appropriate phage or LB 
medium were added to each replicate. Samples of each timepoint, including T0, 
were frozen at -80°C in 20% (w/v) glycerol. 50 μl of a 10-5 dilution of T3 samples 
were plated onto LB + GM50 + 0.2% (w/v) arabinose and incubated overnight at 
37°C.    
To determine whether CRISPR spacer acquisition had occurred, 21 individual 
colonies per replicate were suspended in 10 μl H20 each, and 2 μl of resuspen-
sions used as a sample for a colony PCR. Primers 7 and 8 were used to amplify 
CRISPR1, and primers 10 and 11 to amplify CRISPR2 (Table S1). The PCR was 
carried out in a 10 μl reaction volume using Thermo Scientific’s DreamTaq PCR 
Master Mix according to the manufacturer’s instructions (Tmelt = 50°C, telongation = 
45 sec). 5 μl of amplifications were spotted onto a 2% (w/v) agarose gel and 
separated by electrophoresis for visualisation. Colonies that acquired a spacer 
had integrated it into the CRISPR array, resulting in a larger PCR fragment. 
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Partial spacer matches in PA14 genome  
We used CRISPRfinder (Grissa, Vergnaud and Pourcel, 2007a) to identify all 35 
spacers present in PA14 WT (14 in CRISPR1, 21 in CRISPR2). Partial spacer 
matches to the complete PA14 genome (NC_008463.1) were identified using 
CRISPRTarget (Biswas et al., 2013), disregarding the exact matches of the spac-
ers with themselves in the CRISPR loci. Restrictions included a seed region at 
the 3’ end of the protospacer (exact matches at nts 1-8, except nt 6) and, where 
mentioned, a PAM (protospacer adjacent motif) of GG adjacent to the 3’ end. 
Results were expanded to include all partial matches without a mismatch cutoff. 
The genes partial matches are found in were identified as listed on Genbank 
(Clark et al., 2016). 
 
Statistical Analyses  
Statistical analyses were carried out using R software, specific tests used for 
each experiment are highlighted in figure legends. For bacterial growth curves 
(Fig IV/5), the package Growthcurver (Sprouffske and Wagner, 2016) was used 
to estimate various growth curve statistics. As a proxy for bacterial growth, carry-
ing capacity k of bacterial growth at moderate (0.1% w/v) and high (1% w/v) arab-
inose concentrations for each strain was compared to k for its respective growth 
in the absence of arabinose and their difference assessed with an analysis of 
variances and a Tukey’s post-hoc test. 
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General Discussion 
Diversity-generating mechanisms (DGMs) provide a large benefit to hosts and 
can protect populations from parasite epidemics, accordingly species across the 
tree of life have evolved such mechanisms. CRISPR-Cas (Clustered Regularly 
Interspaced Short Palindromic Repats-CRISPR associated) is traditionally 
thought of as the DGM in bacteria, but due to the nature of its HsdS specificity 
subunit, some Type I Restriction-Modification systems have the capacity to gen-
erate diversity too. In Mycoplasma pulmonis, the Type I RM Mpu shufflon gener-
ates novel specificities by recombining its hsdS pseudogenes. In this way it can 
generate 30 unique sequences, 14 of which are most likely to be biologically ac-
tive as small and standard sized subunits with one or two target recognition do-
mains (TRDs) respectively. While we generated sequences of all possible hsdS 
conformations and some protein models, the functionality of small and large sized 
subunits remains to be investigated in vivo.  
When expressed in CRISPR-deficient Pseudomonas aeruginosa PA14, this Type 
I RM system is toxic. This autoimmunity can be alleviated by pre-methylating the 
bacterial genome before introducing the full RM system, but RM only provides 
low-level immunity against some Pseudomonas phages. This shows that RM 
may have more associated costs than benefits in this system, and further raises 
the question of whether shufflons are associated with the same autoimmune 
costs in nature. To determine whether overexpression of this RM system is gen-
erally costly, future studies could involve designing a RM construct with weaker 
ribosome binding sites to trial the impact of decreased RM protein production on 
toxicity. In order to confirm whether a shufflon specificity switch is associated with 
the same costs as introducing an entirely novel RM system, future studies should 
simulate such a switch. This would require encoding the SRM construct with a 
different hsdS subunit on a different vector backbone and transforming a strain 
with an established RM with this new construct. If toxicity costs are transferable 
to this specificity switch scenario, it postulates that certain hsdS conformations 
may be very stable as additional inversions are highly unfavourable due to auto-
immune costs and will therefore only occur under high phage selective pressures. 
Investigating natural populations of M. pulmonis and other shufflon-encoding bac-
teria for the abundance of RM specificities over time could give an indication of 
whether such stable hsdS conformations exist.  
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When CRISPR-Cas and RM are coexpressed, PA14 becomes completely re-
sistant to most Pseudomonas phages tested and partially resistant to LPS-
specific LMA2. Previous studies had indicated that RM could aid CRISPR-Cas 
by feeding RM-degraded DNA fragments as substrates to enhance spacer acqui-
sition (Dupuis et al., 2013; Hynes, Villion and Moineau, 2014). While our data 
does show resistance and even spacer acquisition when CRISPR and RM are 
jointly expressed, other observations contradict the theory that the RM system is 
stimulating CRISPR by creating spacer substrates. Most strikingly, resistance 
can still be observed when restriction endonuclease HsdR is not present. Addi-
tionally, different levels of resistance to pilus or LPS-specific phages remain un-
explained by this model. Therefore, resistance must be due to other interactions 
between CRISPR-Cas and RM. As our data conflicts with several explanations 
for the synergistic phage resistance when CRISPR and RM are coexpressed 
(such as CRISPR-dependent pilus downregulation or other interactions between 
RM and CRISPR), future experiments need to address the fundamental flaws in 
these models. 
 
Gene regulation 
With a partial match between the spacer and target, CRISPR-Cas can show gene 
regulatory rather than nucleolytic activity (Westra, Buckling and Fineran, 2014). 
This has been exploited in synthetic biology, where nucleolytically deficient Cas9 
variants are used to up- or downregulate gene expression (Lo and Qi, 2017). 
Therefore, we proposed a model in the previous chapter in which CRISPR-Cas 
and RM provide phage resistance by causing downregulation of the pilus gene. 
This would require RM methylation patterns to constitutively activate CRISPR-
Cas and in turn CRISPR-Cas to downregulate pilus expression. While this model 
explains how resistance can occur in the absence of HsdR, we would expect 
ΔCas1 (this nuclease is only important in spacer acquisition) pHERD30T_SRM 
transformants to also be resistant (unless Cas1 deletion impacts Csy gene tran-
scription or translation). This indicates that, if CRISPR-mediated gene regulation 
is occurring, it is probably through a different mechanism than previously de-
scribed for other CRISPR systems (e.g. Type II systems, which utilise non-
CRISPR sca-RNA to modulate expression of BLP-1 (Sampson et al., 2013)).  
To gather more evidence in support of gene regulation occurring, future studies 
need to identify the MpuUI RM recognition site. This can be done by analysing 
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methylomes of RM transformants and comparing them to empty vector strains. 
Alternatively, to more directly test whether RM activity enhances CRISPR expres-
sion, a Miller assay could measure β-galactosidase levels (Schaefer et al., 2016) 
in Csy3::LacZ pHERD30T_SRM transformants. In Csy3::LacZ, lacZ replaces 
csy3, so β-galactosidase levels will be a direct representation of CRISPR activity. 
Therefore, if RM methylation enhances CRISPR activity, β-galactosidase will be 
higher in Csy3::LacZ pHERD30T_SRM than in empty vector controls. Addition-
ally, other direct tests could confirm whether WT pHERD30T_SRM bacteria are 
surface mutants that have lost or downregulated their pilus. To these means, we 
could carry out motility or competition assays with empty vector controls (bacteria 
without their pilus are generally less fit than WT bacteria). Furthermore, we could 
extract protein lysate from WT pHERD30T_SRM and control bacteria and blot it 
with an antibody specific to the pilus to confirm whether WT pHERD30T_SRM 
expresses it at lower levels than WT bacteria. As such an antibody is not com-
mercially available, this experiment would involve isolating pilus proteins and pro-
ducing polyclonal antibodies against them. Alternatively, a qPCR assay could in-
dicate whether pilus expression is lower in RM transformants. Finally, it should 
be tested whether knocking out Cas1 impacts Csy protein production to further 
validate this hypothesis. 
 
General DNA damage response 
Perhaps the increased phage resistance observed when RM and CRISPR are 
coexpressed can be attributed to a more generalised response to DNA damage, 
which could be induced when CRISPR targets the bacteria’s genome with a par-
tial spacer mismatch. In a series of previous studies (Zegans et al., 2009; Cady 
and O’Toole, 2011; Heussler et al., 2015) an inhibition of P. aeruginosa biofilm 
formation was attributed to CRISPR-Cas targeting lysogenised DMS3 with a par-
tial spacer match, which resulted in damaged rather than cleaved DNA. This DNA 
damage induced the SOS-response, which was toxic to bacteria in biofilms in 
presence of phage protein. Therefore, even if RM methylation constitutively acti-
vates CRISPR-Cas as in the gene regulation model above, this may not lead to 
direct regulation of gene expression by CRISPR, but rather induction of the SOS 
or a generalised DNA damage response that causes pilus downregulation. In fu-
ture, this could be tested by experimentally inducing DNA damage or the SOS-
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response in PA14 WT, and determining whether this leads to pilus downregula-
tion.     
 
Protein-protein interaction 
As an alternative model, phage resistance may be due to interactions between 
RM and Cas protein complexes that promote spacer acquisition – not, as pro-
posed by Hynes, Villion and Moineau (2014), RM fragments acting as templates 
for spacer acquisition. This protein-protein interaction would have to occur be-
tween the M2S1 complex and CRISPR-Cas, perhaps with the RM specificity sub-
unit leading CRISPR spacer acquisition machinery towards phage DNA. One 
piece of evidence that points towards this model rather than gene regulation is 
spacer acquisition after three days of evolution with DMS3vir. Typically, popula-
tions that evolve CRISPR-resistance acquire various, often multiple spacers 
(Morley et al., 2017), however in our experiment no clone acquired more than 
one spacer. If future sequencing of these spacers should reveal that they are all 
identical, it would indicate that spacer acquisition was a rare event and only oc-
curred once throughout the evolution experiment. Were this the case, this spacer 
would be associated with a clear fitness benefit (as the initial clone carrying it 
expanded throughout half the population), but it would diminish the role of RM 
enhancing spacer acquisition (as it would be a rarer event).  
 
Overall, it seems that the gene regulation model, albeit by an unexplained mech-
anism, is the most likely of these alternative explanations. Bearing this in mind, 
we should trial the SRM construct with alternative hsdS conformations, which are 
predicted to have a different sequence specificity. These might not have such a 
drastic impact on CRISPR gene regulation due to different methylation patterns, 
and may allow us to investigate RM and CRISPR interactions without influencing 
pilus expression.  
 
In this thesis, I reviewed the literature to argue that different types of DGMs found 
across the entire tree of life lead to distinct coevolutionary dynamics depending 
on the level of diversity they generate. Specifically, the targeted bacterial DGMs 
CRISPR-Cas and diversity-generating Type I RM systems are crucial for bacte-
ria-phage coevolution. I analysed the M. pulmonis Mpu shufflon in silico and 
found that it has the capacity to generate 30 different specificity subunits, 12-14 
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of which are most likely to be biologically active due to their conventional number 
of 1-2 TRDs. I adapted this shufflon for expression in P. aeruginosa PA14 to cre-
ate an experimental system of studying bacteria-phage interactions in a popula-
tion with diverse RM specificities, and also to examine the joint impact of 
CRISPR-Cas and RM. Initially, I found that induction of a novel RM system is 
toxic while only providing low-level resistance in this model system, which indi-
cates shufflons may have larger costs and smaller benefits than anticipated. Fi-
nally, I coexpressed CRISPR-Cas and RM in a PA14 host and found unprece-
dented levels of complete resistance against most phages, which may be due to 
CRISPR and RM-dependent pilus downregulation. The true mechanism of com-
plete and partial resistance in RM and CRISPR coexpression remains to be re-
vealed.  
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Appendix  
Glossary 
Monoculture effect The increased incidence of diseases in monocultures 
of the same crop. 
Indels The insertion or deletion of bases in the DNA of an 
organism. 
Transposable element A DNA sequence that can mobilize to a new position 
within the genome. 
Genetic drift A change in allele frequencies as a result of the ran-
dom sampling of gametes that form the next genera-
tion. 
Parthenogenic  Reproducing in an asexual manner. 
Germinal centres Sites within secondary lymphoid tissue where B cell 
proliferation, selection and maturation take place dur-
ing antibody responses. 
CRISPR escape phage Phage that acquire mutations at positions in the pro-
tospacer (the sequence matching the CRISPR 
spacer) or the protospacer adjacent motif (a short 
DNA sequence required for CRISPR activity) that al-
low them to overcome CRISPR-Cas immunity. 
Arms-race dynamics (ARD). Co-evolutionary dynamics that are character-
ized by the increase of both host resistance and path-
ogen infectivity ranges: hosts evolve resistance to a 
broader range of pathogen genotypes and pathogens 
evolve infectivity to a broader range of host geno-
types. 
Fluctuating selection dynamics  
(FSD). Co-evolutionary dynamics that are character-
ized by fluctuations in host and pathogen genotypes 
owing to frequency dependent selection, whereby the 
fitness of host genotypes is inversely correlated with 
their frequency in the population. 
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Tables 
 
  
Plasmids and Vectors 
Plasmid Reference Antibiotic Re-
sistance gene 
Restriction En-
zymes used for 
cloning 
pHERD-30T (Qiu et al., 2008) Gentamycin n/a 
pHERD-20T (Qiu et al., 2008) Ampicillin n/a 
pCDF-1b Novagen vector Streptomycin n/a 
SRM construct This study n/a n/a 
pHERD30T_SRM This study Gentamycin NcoI, BamHI (sub-
cloning) 
NcoI, HindIII 
pHERD30T_SM This study Gentamycin KpnI 
pHERD20S_SM This study Ampicillin, Strepto-
mycin 
NcoI, HindIII (SM 
genes) 
AgeI, SgrAI (Strep 
resistance) 
Primers 
Primer Sequence (5’ à 3’) Usage 
pBAD forward ATGCCATAGCATTTTTATCC pBAD forward or 
Bam/AraI & R re-
verse amplify hsdS 
R reverse AGCAGTTCGTTGCGGGACAT 
Bam/AraI CAAAGCCATGACAAAAACGC 
S-KpnI-bwd AAGGTACCCTATTCGTCCTTGATCTTTTC Amplify 
pHERD30T_SRM 
while deleting 
hsdR, insert KpnI 
restriction sites at 
either end. 
M-KpnI-fwd CCGGTACCGAATCCAAGATCTAAAGT 
7 CTAAGCCTTGTACGAAGTCTC Amplify PA14 
CRISPR1 8 CGCCGAAGGCCAGCGCGCCGGTG 
10 GCCGTCCAGAAGTCACCACCCG Amplify PA14 
CRISPR2 11 TCAGCAAGTTACGAGACCTCG 
Table S1: Plasmids, Vectors, and Primers used throughout the thesis. 
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Bacterial Strains 
Strain Shorthand name Description/Reference 
NEB 5-alpha compe-
tent Escherichia coli 
fhuA2 Δ(argF-
lacZ)U169 phoA 
glnV44 Φ80 
Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-
1 hsdR17 
E. coli Used for cloning. 
Commercially available from New 
England Biolabs. 
Pseudomonas aeru-
ginosa UCBPP-PA14 
WT  
UCBPP-PA14 
csy3::lacZ 
Csy3::LacZ (Cady et al., 2012) 
UCBPP-PA14 
ΔCRISPR, ΔCas 
ΔCR/Cas (Cady and O’Toole, 2011) 
UCBPP-PA14 
ΔCRISPR1, ΔCRISPR2 
ΔCR1,2 (Cady and O’Toole, 2011) 
UCBPP-PA14 Δcas1 ΔCas1 (Cady and O’Toole, 2011) 
UCBPP-PA14 Δcas3 ΔCas3 (Cady and O’Toole, 2011) 
UCBPP-PA14 Δcsy1 ΔCsy1 (Cady and O’Toole, 2011) 
UCBPP-PA14 Δcsy2 ΔCsy2 (Cady and O’Toole, 2011) 
UCBPP-PA14 Δcsy4 ΔCsy4 (Zegans et al., 2009) 
Bacteriophages 
Phage Reference Genome size [nt] 
DMS3vir (Cady and O’Toole, 2011) 36415 
Φ1214 (Lindberg and Latta, 1974) 37053 
JBD5 (Bondy-Denomy et al., 2013) 37740 
LUZ24 (Ceyssens et al., 2009) 45625 
Φ68 (Lindberg and Latta, 1974) 48097 
JBD18 (Cady et al., 2012) 39014 
JBD25 (Cady et al., 2012) 39552 
Table S2: Bacterial Strains and phage used throughout the thesis.  
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Construct sequences 
Sequences in 5’-3’ direction of all synthetic Mpu shufflon sequences adapted for 
expression in Pseudomonas aeruginosa PA14 are listed below. 
Yellow: Restriction sites 
Green: T7 Ribosome Binding Site 
Blue: Codon optimised for Pseudomonas aeruginosa PA01 for 
restriction site avoidance 
 
>SRM construct 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGTCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGATCCAGTCCGCCATCATCAAGATCATCGAACCGAAGGAAGACCTGTTCTTCCGC
CACAAGAACCTGGTCCGCATCGACTCCGAAGAAAACACCAAGAAGGACCTGTCCATCC
TGATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCCTTCGACGAACTGATCCT
GTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCCTGAACAAGCTGGCCTCC
ATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCGAAATCGCCAAGATCCTGTCCG
GCAAGACCCCGTCCACCGCCAAGAAGGAACTGTGGAAGAAGGAAATCCCGTTCTTCGG
CCCGGGCGACCTGGACAACATGGTCCCGAAGCGCTTCATCACCTTCAACGAAAAGATG
ATCAAGCGCTCCGGCACCATCCTGTTCTCCTCCGCCGCCACCATCGGCAAGGTCGGCA
TCCTGGACAACCTGTCCTGGTTCAACCAGCAGATCACCTCCATCGAAGCCAACAACAA
CTACGTCATGGACAAGTTCCTGTTCTTCCTGCTGAAGAAGATCTCCTCCAAGATCAAG
TTCGAAAACTCCTCCGGCACCATCTTCCCGACCATCAAGAAGAAGTACTTCGAAAACT
TCACCCTGGAAATCCCGAACCTGAAGACCCAGTCCGCCATCCTGGGCATCATCGAACC
GCTGCACAAGAAGATCAACCTGCTGAAGCAGAAGAAGAAGCTGCTGGAAAAGCGCTTC
ATCTACTACCAGAACCACCTGATCAAGGAAAAGATCAAGGACGAATAGGGTACCTTAA
CTTTAAGAAGGAGATATACATACCCATGTCCCGCAACGAACTGCTGTACGAAAAGGAA
TTCGTCGACGACCTGGTCAAGAACCAGAAGTACGTCAAGCTGGACATCAAGAACGAAG
AAAAGATCTTCGAACTGATCTTCGAAAACATCGGCCGCCTGAACAACATCGAACTGAC
CCAGCAGAACATCCTGGACATCCGCCGCGAACTGCTGTCCAACAACTCCGCCTCCTCC
TACCGCTTCGCCCAGTACCTGTGGGGCTTCGACACCGTCAAGATCTACAAGAACGACG
GCCCGAAGAAGATCCGCCTGAAGTTCGTCGACTGGGAAAACTGGGCCAACAACGAATT
CTACGTCCTGCAGCAGTTCCCGACCCGCGACGCCAAGAACAACATGGGCAAGCGCTTC
GACTCCCTGATCCTGATCAACGGCTTCCCGCTGATCCTGTTCGAATTCAAGGACAAGT
CCGAAAACATCAACAAGGCCATCAACCAGATCGACGAATCCTACCGCGGCTCCGTCCT
GAACAAGGGCATCTTCCGCTTCATCCAGATCCTGATCGGCTCCAACTTCGAAGAAGTC
AAGTTCCTGGCCAACAACAAGCGCACCAACAACAACAAGATCCTGTCCTTCAAGTGGA
CCTCCGAAAACGGCGGCTCCTCCAAGGAACTGATCAAGGACTTCCTGAACAAGAACGC
CCTGGAAGAATACCTGAAGAACTACGTCGTCTTCCAGCGCTCCAAGGACGACGAAAAG
ATCATCCTGCTGCGCCCGTACCAGCAGCGCGCCATCAAGAAGGCCATCAACTTCGTCG
AAAAGCAGCTGAAGACCAACCTGGACGCCAAGCACAACCTGAACAACGCCTACATCTG
GCACACCACCGGCTCCGGCAAGACCCTGACCTCCTACAAGATCGCCGAAATCCTGTCC
AAGAACTCCGACATCGACCACGTCGTCTTCCTGGTCGACCGCAACGACCTGAACGACC
AGACCTCCCAGACCTTCCAGAAGCTGATGTCCTCCTCCAAGAACGAAAAGATCGACTT
CCTGAACCAGGACACCTCCAAGGACCTGTACGAAATCTTCCTGAAGAAGGAAAAGCTG
ATCATCACCACCATCCAGAAGCTGAACAACATCCTGTCCTCCTACAAGAACGAAAAGA
TCGAATTCCTGACCAACAAGAAGTTCGTCTTCATCATCGACGAATGCCACCGCTCCAA
CGCCGGCCTGATGGGCAAGCGCATCAAGGACTTCCTGAACAACTCCATCATGATCGGC
TTCTCCGGCACCCCGATCTTCGAAGAAAACAACGACCGCGAAACCCAGAAGATCTTCG
GCAACGAAATCGACTCCTACAACATGAAGGACGCCATCCTGGACAAGAACGTCCTGGG
CTTCAAGGTCGTCAACTACTACCAGGAAACCCGCATCTTCCGCGAAAACAACAACTCC
AACCTGGGCAAGATCAAGTCCATCATCAACGTCATCAAGTCCAAGCACCTGGACTTCA
CCAACAACCGCAACTACAACTCCATCATCGCCTTCGACACCATCCAGGACGCCCTGAC
CTTCTACGACGAATTCTACAAGATGGACGTCGGCGACATCTTCGCCACCCCGATCTTC
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TCCTCCTACTCCAACGAAGAAAAGAACGAAAAGTTCTTCAACCTGAAGGAACACAAGG
AAAAGATCCTGAAGCGCTACGAAGAAAAGTTCAACACCTCCTTCAAGGTCGAAGACTT
CGACAAGTACGTCAACGACGTCCAGTGGCGCTTCAAGGAATACAACTCCGAAAACAAC
TCCATCGACATCGTCATCGTCGTCGACATGCTGCTGACCGGCTTCGACTCCCCGCGCA
CCAACACCCTGTACATCAACAAGGAACTGAAGAACCACAACCTGATCCAGGCCTTCTC
CCGCACCAACCGCCTGTCCGACTACTCCAAGAAGCGCGGCATCATCGTCAACTTCTCC
CTGGAAGAACAGTCCATCAACGACGCCTTCAAGATCTACGCCAACTCCTCCGACAAGG
AAATCCAGCAGCTGGTCTACGGCGAAAAGTACGAACAGGTCGTCGAAGACTTCATCAA
CTTCTGGAACTCCCTGAAGATCTCCTTCTCCAACATCTACGACGAAAAGAACAACGAA
ATCTTCCGCAACATCTCCCTGGAAAACAAGAAGAAGTACCTGAAGAACCTGTCCCAGG
TCTCCAACATCTTCTCCTCCCTGAAGACCTTCAAGGAATACGGCAAGAACGAAAAGAT
CTCCGACTTCTCCCTGGAACAGCTGAACCAGTACCAGAAGTGGGCCAACGAAATCAAG
AAGAACCTGTCCACCAACGAAAAGGAAAAGATCTCCTACGAAGTCCTGAACTCCATCG
ACATCTCCAACATCAAGTTCGCCTACAAGGAAATGATCATCGACGAAATCTACCTGGA
AAACCTGCTGTTCTTCAACAAGAAGATCTCCAAGTACCCGAACAACCGCCTGACCTAC
GAAGACACCCTGTCCGAAATCGACAAGCACATCCAGCTGATCAAGAACAACTACAACC
AGGGCAAGATCAACCAGAAGGAATACGAAATCTTCCTGCTGCTGGTCCAGAAGTGGAA
GAACGAAATCAAGAACTTCTTCATCAAGAAGGACAAGTCCCTGGACGAAAAGGAATTC
ATCGACTACGGCAAGCGCATCCTGAAGTCCGTCTTCCAGAAGGTCAAGAACCAGATCG
AAGCCATGTGGCTGGAAAAGATCCTGAAGGAATACCACGGCATCAACAACGACCAGAT
CCGCAAGGACTGGAAGAAGCGCATCAACGACAAGGACCTGGACGACATCGAAAAGTCC
GAATTCATCAAGAAGTGGTCCCGCCGCTCCAAGGAAGTCGACAAGGACATCATCGACA
AGCTGTCCATCGAATACAAGGAATCCATCGAAGCCTTCCTGGACTTCGAAATCAAGAT
GAACAAGATCATCGAATCCAAGATCTAAAGTTTAACTTTAAGAAGGAGATATACATAC
CCATGTCCAACTCCAAGGAACTGATCGCCGTCGTCAAGAAGATCTGCGACCAGCTGCG
CTCCAAGATGGAAGTCACCGAATACCGCGACTACATCATGGGCTTCCTGTTCTTCAAG
TACCTGTCCGAACAGTCCGAAAAGAACTTCGAAGAATTCAAGGAACGCGTCGACTACA
TCAAGTACTCCGAATTCGACGAAAACCACGAACAGTTCAAGAAGATCAAGGAAATCAT
CATCCAGAACGACGACGACTTCTTCCTGGCCTACAAGTACTCCTTCCAGAACGTCGTC
GACATGATGAACCAGGGCAAGAACGTCATCCCGACCATCGAAGAATCCTTCAACAAGA
TCGAATCCATCAACTCCGAACTGAACGACGAAAAGAAGGAATTCTTCAAGGACCTGTT
CACCAACATCGACTTCTCCAACAAGAACCTGGGCAACATCGACGAAGAAAAGGAAAAG
ACCATCCAGCTGATCATCAAGGAAATCAACACCCTGAACCTGAGCATGGACGAAGTCG
ACCACTTCGGCAACACCTACGAATACCTGCTGTCCGAATTCGCCTCCGACACCGGCAA
GAAGGCCGGCGAATTCTACACCCCGTCCAAGGTCTCCGAACTGCTGGTCAAGATCGTC
TCCCACGGCAAGAACAAGATCAACAAGGCCTACGACCCGGCCTGCGGCTCCGGCTCCC
TGCTGATCAAGCTGGCCAACAAGGTCGGCAAGTACAACAAGATCTACGGCCAGGAAGT
CAAGACCGCCACCTACAACCTGGCCCGCATGAACTTCATCCTGCGCGGCGTCCCGTTC
TCCAAGCTGGACCTGCGCTCCGGCGACACCCTGATCAACCCGCTGCACATCGAAGAAG
AAGGCTCCTTCGACTGCATCGTCGCCAACCCGCCGTTCTCCCAGAAGTGGAACCCGAC
CCAGGAACTGTCCAAGGACCGCCGCTACAACTCCTACCCGTCCCTGGCCCCGAAGTCC
TACGCCGACTTCGCCTTCCTGCAGCACATGCTGTTCCACGTCAACAAGGACAACGGCA
TCATCGCCTCCGTCTTCTCCCTGGGCATCCTGTCCCGCAAGTCCCCGAAGGCCGAAGA
AGACATCCGCAAGTACATCATCGACAAGAACTACATCGACACCATCATCTTCCTGCCG
CCGAACCTGTTCTACAACACCTCCATCGAATCCTGCATCATCGTCGCCCGCAAGAACA
AGCCGACCAACGACAAGCGCATCTTCATGATCAACGCCACCAAGGAATTCCAGAACGC
CAAGAAGCAGAACACCCTGTCCGACGAAAACATCAACCGCATCTTCTCCGCCTGGAAG
GAAAAGCGCGAAGAAGAAAACTTCTCCAAGTACATCTCCTACGAAGACATCGTCAAGA
ACGAATACTCCCTGTCCATGCGCTTCTACGACCTGGACAACTTCGACGAAGAATCCGA
AGACATCGACATCGACTTCGTCGAATCCGAAATCGTCAAGATCAACGAAGAACTGCTG
AAGTACGAAAACGAATTCAAGAAGAACCTGAACGAATTCCTGAACAAGAAGAACTAAG
GATCC 
 
>MpuUII  
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCGACGAAAACATCGCCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
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CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGACCCAGTCCGCCATCATCAAGATCATCGAACCGAAGGAAGACCTGTTCTTCCGC
CACAAGAACCTGGTCCGCATCGACTCCGAAGAAAACACCAAGAAGGACCTGTCCATCC
TGATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCCTTCGACGAACTGATCCT
GTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCTTCGGCAAGTTCTACCAG
ATCGAACCGTCCCTGTTCCACGACTACAAGCTGGAAAAGATCGCCAAGATCCGCCGCG
GCAAGATCATCAACTCCTTCGACCTGAAGGAAAACCCGGGCGACTACCCGGTCATCTC
CTCCAACACCAAGAACAACGGCATCTTCGGCTACCTGAACTCCTACATGTACGACGGC
GAATACATCACCATCTCCGCCGACGGCGCCTACGCCGGCACCGTCTTCCTGAACAACG
GCAAGTTCTCCATCACCAACGTCTGCTTCATCCTGCTGCTGAACGACAAGGTCAACCT
GCTGACCAAGTTCCTGTTCTACTACCTGAAGAAGAACGAAAACATCATCCAGAAGAAG
TCCATCGTCGGCTCCTCCCGCCCGTCCGTCCGCGAATACACCCTGTCCGAAATCGCCA
TCAAGATCCCGTCCCTGGAAATCCAGTCCGCCATCCTGGGCATCAACGAACACTTCCA
CTACGTCTAAGGTACC 
 
>MpuUIII 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGTCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGATCCAGTCCGCCATCATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCC
TTCGACGAACTGATCCTGTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCT
TCGGCAAGTTCTACCAGATCGAACCGTCCCTGTTCCACGACTACAAGCTGGAAAAGAT
CGCCAAGATCCGCCGCGGCAAGATCATCAACTCCTTCGACCTGAAGGAAAACCCGGGC
GACTACCCGGTCATCTCCTCCAACACCAAGAACAACGGCATCTTCGGCTACCTGAACT
CCTACATGTACGACGGCGAATACATCACCATCTCCGCCGACGGCGCCTACGCCGGCAC
CGTCTTCCTGAACAACGGCAAGTTCTCCATCACCAACGTCTGCTTCATCCTGCTGCTG
AACGACAAGGTCAACCTGCTGACCAAGTTCCTGTTCTACTACCTGAAGAAGAACGAAA
ACATCATCCAGAAGAAGTCCATCGTCGGCTCCTCCCGCCCGTCCGTCCGCGAATACAC
CCTGTCCGAAATCGCCATCAAGATCCCGTCCCTGGAAATCCAGTCCGCCATCCTGGGC
ATCATCGAACCGCTGCACAAGAAGATCAACCTGCTGAAGCAGAAGAAGAAGCTGCTGG
AAAAGCGCTTCATCTACTACCAGAACCACCTGATCAAGGAAAAGATCAAGGACGAA-
TAGggtacc 
 
>MpuUIV 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCGACGAAAACATCGCCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGACCCAGTCCGCCATCATCAAGATCATCGAACCGAAGGAAGACCTGTTCTTCCGC
CACAAGAACCTGGTCCGCATCGACTCCGAAGAAAACACCAAGAAGGACCTGTCCATCC
TGATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCCTTCGACGAACTGATCCT
GTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCCTGAACAAGCTGGCCTCC
ATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGG
GCAAGTCCAAGTACAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTA
CTCCTCCAAGACCCGCGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAAC
GGCGAATACATCCTGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCA
ACGAAAAGTTCTCCACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGT
CAAGACCAAGTTCCTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATG
GCCATCGGCTCCGCCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCA
ACCTGCCGAACCTGAAGATCCAGTCCGCCATCCTGGGCATCATCGAACCGCTGCACAA
GAAGATCAACCTGCTGAAGCAGAAGAAGAAGCTGCTGGAAAAGCGCTCCATCTACTGC
CAGAACCACCTGATCAAGGAAAAGATCAAGGACGAATAGGGTACC 
 
 99 
>MpuUV 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGTCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGATCCAGTCCGCCATCATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCC
TTCGACGAACTGATCCTGTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCT
TCGGCAAGTTCTACCAGATCGAACCGTCCCTGTTCCACGACTACAAGCTGGAAAAGAT
CGCCAAGATCCGCCGCGGCAAGATCATCAACTCCTTCGACCTGAAGGAAAACCCGGGC
GACTACCCGGTCATCTCCTCCAACACCAAGAACAACGGCATCTTCGGCTACCTGAACT
CCTACATGTACGACGGCGAATACATCACCATCTCCGCCGACGGCGCCTACGCCGGCAC
CGTCTTCCTGAACAACGGCAAGTTCTCCATCACCAACGTCTGCTTCATCCTGCTGCTG
AACGACAAGGTCAACCTGCTGACCAAGTTCCTGTTCTACTACCTGAAGAAGAACGAAA
ACATCATCCAGAAGAAGTCCATCGTCGGCTCCTCCCGCCCGTCCGTCCGCGAATACAC
CCTGTCCGAAATCGCCATCAAGATCCCGTCCCTGGAAATCCAGTCCGCCATCCTGGGC
ATCAACGAACACTTCCACTACGTCTAAGGTACC 
 
>MpuUVI 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCGACGAAAACATCGCCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGACCCAGTCCGCCATCATCAAGATCATCGAACCGAAGGAAGACCTGTTCTTCCGC
CACAAGAACCTGGTCCGCATCGACTCCGAAGAAAACACCAAGAAGGACCTGTCCATCC
TGATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCCTTCGACGAACTGATCCT
GTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCTTCGGCAAGTTCTACCAG
ATCGAACCGTCCCTGTTCCACGACTACAAGCTGGAAAAGATCGCCAAGATCCGCCGCG
GCAAGATCATCAACTCCTTCGACCTGAAGGAAAACCCGGGCGACTACCCGGTCATCTC
CTCCAACACCAAGAACAACGGCATCTTCGGCTACCTGAACTCCTACATGTACGACGGC
GAATACATCACCATCTCCGCCGACGGCGCCTACGCCGGCACCGTCTTCCTGAACAACG
GCAAGTTCTCCATCACCAACGTCTGCTTCATCCTGCTGCTGAACGACAAGGTCAACCT
GCTGACCAAGTTCCTGTTCTACTACCTGAAGAAGAACGAAAACATCATCCAGAAGAAG
TCCATCGTCGGCTCCTCCCGCCCGTCCGTCCGCGAATACACCCTGTCCGAAATCGCCA
TCAAGATCCCGTCCCTGGAAATCCAGTCCGCCATCCTGGGCATCATCGAACCGCTGCA
CAAGAAGATCAACCTGCTGAAGCAGAAGAAGAAGCTGCTGGAAAAGCGCTCCATCTAC
TGCCAGAACCACCTGATCAAGGAAAAGATCAAGGACGAATAGGGTACC 
 
>MpuUVIII 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCGACGAAAACATCGCCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGACCCAGTCCGCCATCATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCC
TTCGACGAACTGATCCTGTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCC
TGAACAAGCTGGCCTCCATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCCAGAT
CCTGAACCTGGAAAAGGGCAAGTCCAAGTACAACGCCAAGTACGTCTCCCAGAACATC
GGCATCTACAACCTGTACTCCTCCAAGACCCGCGACCAGGGCATCTTCGGCAAGATCA
ACTCCTACGACTTCAACGGCGAATACATCCTGATCACCACCCACGGCGCCTACGCCGG
CACCGTCAAGTACGTCAACGAAAAGTTCTCCACCACCTCCAACTGCTTCATCCTGAAG
GTCAACGAAAACATCGTCAAGACCAAGTTCCTGTCCTACCTGCTGCTGCTGCAGGAAA
AGACCTTCAACGACATGGCCATCGGCTCCGCCTACGGCTACCTGAAGAACTACAACAT
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CAACGACTTCGAAGTCAACCTGCCGAACCTGAAGATCCAGTCCGCCATCCTGGGCATC
ATCGAACCGCTGCACAAGAAGATCAACCTGCTGAAGCAGAAGAAGAAGCTGCTGGAAA
AGCGCTCCATCTACTGCCAGAACCACCTGATCAAGGAAAAGATCAAGGACGAATAGGG
TACC 
 
>MpuT9 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGTCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGATCCAGTCCGCCATCATCAAGATCATCGAACCGAAGGAAGACCTGTTCTTCCGC
CACAAGAACCTGGTCCGCATCGACTCCGAAGAAAACACCAAGAAGGACCTGTCCATCC
TGATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCCTTCGACGAACTGATCCT
GTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCCTGAACAAGCTGGCCTCC
ATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCGAAATCGCCAAGATCCTGTCCG
GCAAGACCCCGTCCACCGCCAAGAAGGAACTGTGGAAGAAGGAAATCCCGTTCTTCGG
CCCGGGCGACCTGGACAACATGGTCCCGAAGCGCTTCATCACCTTCAACGAAAAGATG
ATCAAGCGCTCCGGCACCATCCTGTTCTCCTCCGCCGCCACCATCGGCAAGGTCGGCA
TCCTGGACAACCTGTCCTGGTTCAACCAGCAGATCACCTCCATCGAAGCCAACAACAA
CTACGTCATGGACAAGTTCCTGTTCTTCCTGCTGAAGAAGATCTCCTCCAAGATCAAG
TTCGAAAACTCCTCCGGCACCATCTTCCCGACCATCAAGAAGAAGTACTTCGAAAACT
TCACCCTGGAAATCCCGAACCTGAAGACCCAGTCCGCCATCCTGGGCATCAACGAACA
CTTCCACTACGTCTAAGGTACC 
 
>MpuT10 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCGACGAAAACATCGCCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGACCCAGTCCGCCATCATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCC
TTCGACGAACTGATCCTGTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCC
TGAACAAGCTGGCCTCCATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCCAGAT
CCTGAACCTGGAAAAGGGCAAGTCCAAGTACAACGCCAAGTACGTCTCCCAGAACATC
GGCATCTACAACCTGTACTCCTCCAAGACCCGCGACCAGGGCATCTTCGGCAAGATCA
ACTCCTACGACTTCAACGGCGAATACATCCTGATCACCACCCACGGCGCCTACGCCGG
CACCGTCAAGTACGTCAACGAAAAGTTCTCCACCACCTCCAACTGCTTCATCCTGAAG
GTCAACGAAAACATCGTCAAGACCAAGTTCCTGTCCTACCTGCTGCTGCTGCAGGAAA
AGACCTTCAACGACATGGCCATCGGCTCCGCCTACGGCTACCTGAAGAACTACAACAT
CAACGACTTCGAAGTCAACCTGCCGAACCTGAAGATCCAGTCCGCCATCCTGGGCATC
AACGAACACTTCCACTACGTCTAAGGTACC 
 
>MpuT11 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGTCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGATCCAGTCCGCCATCATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCC
TTCGACGAACTGATCCTGTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCC
TGAACAAGCTGGCCTCCATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCGAAAT
CGCCAAGATCCTGTCCGGCAAGACCCCGTCCACCGCCAAGAAGGAACTGTGGAAGAAG
GAAATCCCGTTCTTCGGCCCGGGCGACCTGGACAACATGGTCCCGAAGCGCTTCATCA
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CCTTCAACGAAAAGATGATCAAGCGCTCCGGCACCATCCTGTTCTCCTCCGCCGCCAC
CATCGGCAAGGTCGGCATCCTGGACAACCTGTCCTGGTTCAACCAGCAGATCACCTCC
ATCGAAGCCAACAACAACTACGTCATGGACAAGTTCCTGTTCTTCCTGCTGAAGAAGA
TCTCCTCCAAGATCAAGTTCGAAAACTCCTCCGGCACCATCTTCCCGACCATCAAGAA
GAAGTACTTCGAAAACTTCACCCTGGAAATCCCGAACCTGAAGACCCAGTCCGCCATC
CTGGGCATCATCGAACCGCTGCACAAGAAGATCAACCTGCTGAAGCAGAAGAAGAAGC
TGCTGGAAAAGCGCTTCATCTACTACCAGAACCACCTGATCAAGGAAAAGATCAAGGA
CGAATAGGGTACC 
 
>MpuT19 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGTCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGATCCAGTCCGCCATCATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCC
TTCGACGAACTGATCCTGTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCC
TGAACAAGCTGGCCTCCATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCGAAAT
CGCCAAGATCCTGTCCGGCAAGACCCCGTCCACCGCCAAGAAGGAACTGTGGAAGAAG
GAAATCCCGTTCTTCGGCCCGGGCGACCTGGACAACATGGTCCCGAAGCGCTTCATCA
CCTTCAACGAAAAGATGATCAAGCGCTCCGGCACCATCCTGTTCTCCTCCGCCGCCAC
CATCGGCAAGGTCGGCATCCTGGACAACCTGTCCTGGTTCAACCAGCAGATCACCTCC
ATCGAAGCCAACAACAACTACGTCATGGACAAGTTCCTGTTCTTCCTGCTGAAGAAGA
TCTCCTCCAAGATCAAGTTCGAAAACTCCTCCGGCACCATCTTCCCGACCATCAAGAA
GAAGTACTTCGAAAACTTCACCCTGGAAATCCCGAACCTGAAGACCCAGTCCGCCATC
CTGGGCATCAACGAACACTTCCACTACGTCTAAGGTACC 
 
>MpuT22 
CCATGGAAATCTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGGGCAAGTCCAAGTA
CAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTACTCCTCCAAGACC
AAGGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAACGGCGAATACATCC
TGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCAACGAAAAGTTCTC
CACCACCTCCAACTGCTTCATCCTGAAGGTCGACGAAAACATCGCCAAGACCAAGTTC
CTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATGGCCATCGGCTCCG
CCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCAACCTGCCGAACCT
GAAGACCCAGTCCGCCATCATCAAGATCATCGAACCGAAGGAAGACCTGTTCTTCCGC
CACAAGAACCTGGTCCGCATCGACTCCGAAGAAAACACCAAGAAGGACCTGTCCATCC
TGATCAAGATCATCGAACCGCTGGAAAAGCAGATCAACGCCTTCGACGAACTGATCCT
GTCCGAACAGAAGTCCCTGCAGCACTACCTGAACTACTTCCTGAACAAGCTGGCCTCC
ATCAACCCGTCCATCTTCAAGAACTACAAGCTGGGCCAGATCCTGAACCTGGAAAAGG
GCAAGTCCAAGTACAACGCCAAGTACGTCTCCCAGAACATCGGCATCTACAACCTGTA
CTCCTCCAAGACCCGCGACCAGGGCATCTTCGGCAAGATCAACTCCTACGACTTCAAC
GGCGAATACATCCTGATCACCACCCACGGCGCCTACGCCGGCACCGTCAAGTACGTCA
ACGAAAAGTTCTCCACCACCTCCAACTGCTTCATCCTGAAGGTCAACGAAAACATCGT
CAAGACCAAGTTCCTGTCCTACCTGCTGCTGCTGCAGGAAAAGACCTTCAACGACATG
GCCATCGGCTCCGCCTACGGCTACCTGAAGAACTACAACATCAACGACTTCGAAGTCA
ACCTGCCGAACCTGAAGATCCAGTCCGCCATCCTGGGCATCAACGAACACTTCCACTA
CGTCTAAGGTACC 
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